PMCID	SUBJECT_SCOPE_ID	S_START	S_END	SUBJECT_SCOPE	CONCEPT	IGNORANCE TYPE	C_START	C_END	CONCEPT_MENTION_ID
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_0	[0]	[316]	['Effects of interventions in pregnancy on maternal weight and obstetric outcomes: meta-analysis of randomised evidence\n\nAbstract\nObjective To evaluate the effects of dietary and lifestyle interventions in pregnancy on maternal and fetal weight and to quantify the effects of these interventions on obstetric outcomes.']	pregnancy	GO_BP_EXT	[28]	[37]	BMJ_2012_May_17_344_e2088_T15
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_0	[0]	[316]	['Effects of interventions in pregnancy on maternal weight and obstetric outcomes: meta-analysis of randomised evidence\n\nAbstract\nObjective To evaluate the effects of dietary and lifestyle interventions in pregnancy on maternal and fetal weight and to quantify the effects of these interventions on obstetric outcomes.']	pregnancy	GO_BP_EXT	[204]	[213]	BMJ_2012_May_17_344_e2088_T16
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_3	[452]	[638]	['Study selection Randomised controlled trials that evaluated any dietary or lifestyle interventions with potential to influence maternal weight during pregnancy and outcomes of pregnancy.']	pregnancy	GO_BP_EXT	[602]	[611]	BMJ_2012_May_17_344_e2088_T17
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_3	[452]	[638]	['Study selection Randomised controlled trials that evaluated any dietary or lifestyle interventions with potential to influence maternal weight during pregnancy and outcomes of pregnancy.']	pregnancy	GO_BP_EXT	[628]	[637]	BMJ_2012_May_17_344_e2088_T18
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_5	[754]	[922]	['Results We identified 44 relevant randomised controlled trials (7278 women) evaluating three categories of interventions: diet, physical activity, and a mixed approach.']	women	NCBITAXON_EXT	[823]	[828]	BMJ_2012_May_17_344_e2088_T235
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_5	[754]	[922]	['Results We identified 44 relevant randomised controlled trials (7278 women) evaluating three categories of interventions: diet, physical activity, and a mixed approach.']	women	UBERON_EXT	[823]	[828]	BMJ_2012_May_17_344_e2088_T291
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_6	[923]	[1073]	['Overall, there was 1.42 kg reduction (95% confidence interval 0.95 to 1.89 kg) in gestational weight gain with any intervention compared with control.']	gestational	GO_BP_EXT	[1005]	[1016]	BMJ_2012_May_17_344_e2088_T19
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_7	[1074]	[1472]	['With all interventions combined, there were no significant differences in birth weight (mean difference −50 g, −100 to 0 g) and the incidence of large for gestational age (relative risk 0.85, 0.66 to 1.09) or small for gestational age (1.00, 0.78 to 1.28) babies between the groups, though by itself physical activity was associated with reduced birth weight (mean difference −60 g, −120 to −10 g).']	birth	GO_BP_EXT	[1148]	[1153]	BMJ_2012_May_17_344_e2088_T20
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_7	[1074]	[1472]	['With all interventions combined, there were no significant differences in birth weight (mean difference −50 g, −100 to 0 g) and the incidence of large for gestational age (relative risk 0.85, 0.66 to 1.09) or small for gestational age (1.00, 0.78 to 1.28) babies between the groups, though by itself physical activity was associated with reduced birth weight (mean difference −60 g, −120 to −10 g).']	gestational	GO_BP_EXT	[1229]	[1240]	BMJ_2012_May_17_344_e2088_T21
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_7	[1074]	[1472]	['With all interventions combined, there were no significant differences in birth weight (mean difference −50 g, −100 to 0 g) and the incidence of large for gestational age (relative risk 0.85, 0.66 to 1.09) or small for gestational age (1.00, 0.78 to 1.28) babies between the groups, though by itself physical activity was associated with reduced birth weight (mean difference −60 g, −120 to −10 g).']	gestational	GO_BP_EXT	[1293]	[1304]	BMJ_2012_May_17_344_e2088_T22
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_7	[1074]	[1472]	['With all interventions combined, there were no significant differences in birth weight (mean difference −50 g, −100 to 0 g) and the incidence of large for gestational age (relative risk 0.85, 0.66 to 1.09) or small for gestational age (1.00, 0.78 to 1.28) babies between the groups, though by itself physical activity was associated with reduced birth weight (mean difference −60 g, −120 to −10 g).']	babies	UBERON_EXT	[1330]	[1336]	BMJ_2012_May_17_344_e2088_T292
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_7	[1074]	[1472]	['With all interventions combined, there were no significant differences in birth weight (mean difference −50 g, −100 to 0 g) and the incidence of large for gestational age (relative risk 0.85, 0.66 to 1.09) or small for gestational age (1.00, 0.78 to 1.28) babies between the groups, though by itself physical activity was associated with reduced birth weight (mean difference −60 g, −120 to −10 g).']	birth	GO_BP_EXT	[1420]	[1425]	BMJ_2012_May_17_344_e2088_T23
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_8	[1473]	[1675]	['Interventions were associated with a reduced the risk of pre-eclampsia (0.74, 0.60 to 0.92) and shoulder dystocia (0.39, 0.22 to 0.70), with no significant effect on other critically important outcomes.']	shoulder	UBERON_EXT	[1569]	[1577]	BMJ_2012_May_17_344_e2088_T293
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_9	[1676]	[1862]	['Dietary intervention resulted in the largest reduction in maternal gestational weight gain (3.84 kg, 2.45 to 5.22 kg), with improved pregnancy outcomes compared with other interventions.']	gestational	GO_BP_EXT	[1743]	[1754]	BMJ_2012_May_17_344_e2088_T24
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_10	[1863]	[2026]	['The overall evidence rating was low to very low for important outcomes such as pre-eclampsia, gestational diabetes, gestational hypertension, and preterm delivery.']	gestational	GO_BP_EXT	[1957]	[1968]	BMJ_2012_May_17_344_e2088_T25
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_10	[1863]	[2026]	['The overall evidence rating was low to very low for important outcomes such as pre-eclampsia, gestational diabetes, gestational hypertension, and preterm delivery.']	gestational	GO_BP_EXT	[1979]	[1990]	BMJ_2012_May_17_344_e2088_T26
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_10	[1863]	[2026]	['The overall evidence rating was low to very low for important outcomes such as pre-eclampsia, gestational diabetes, gestational hypertension, and preterm delivery.']	delivery	GO_BP_EXT	[2017]	[2025]	BMJ_2012_May_17_344_e2088_T27
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_11	[2027]	[2178]	['Conclusions Dietary and lifestyle interventions in pregnancy can reduce maternal gestational weight gain and improve outcomes for both mother and baby.']	lifestyle	GO_BP_EXT	[2051]	[2060]	BMJ_2012_May_17_344_e2088_T28
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_11	[2027]	[2178]	['Conclusions Dietary and lifestyle interventions in pregnancy can reduce maternal gestational weight gain and improve outcomes for both mother and baby.']	pregnancy	GO_BP_EXT	[2078]	[2087]	BMJ_2012_May_17_344_e2088_T29
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_11	[2027]	[2178]	['Conclusions Dietary and lifestyle interventions in pregnancy can reduce maternal gestational weight gain and improve outcomes for both mother and baby.']	gestational	GO_BP_EXT	[2108]	[2119]	BMJ_2012_May_17_344_e2088_T30
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_11	[2027]	[2178]	['Conclusions Dietary and lifestyle interventions in pregnancy can reduce maternal gestational weight gain and improve outcomes for both mother and baby.']	baby	UBERON_EXT	[2173]	[2177]	BMJ_2012_May_17_344_e2088_T294
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_12	[2179]	[2350]	['Among the interventions, those based on diet are the most effective and are associated with reductions in maternal gestational weight gain and improved obstetric outcomes.']	gestational	GO_BP_EXT	[2294]	[2305]	BMJ_2012_May_17_344_e2088_T31
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_13	[2352]	[2422]	['Introduction\nObesity is a growing threat to women of childbearing age.']	women	NCBITAXON_EXT	[2396]	[2401]	BMJ_2012_May_17_344_e2088_T236
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_13	[2352]	[2422]	['Introduction\nObesity is a growing threat to women of childbearing age.']	women	UBERON_EXT	[2396]	[2401]	BMJ_2012_May_17_344_e2088_T295
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_13	[2352]	[2422]	['Introduction\nObesity is a growing threat to women of childbearing age.']	childbearing	GO_BP_EXT	[2405]	[2417]	BMJ_2012_May_17_344_e2088_T32
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_13	[2352]	[2422]	['Introduction\nObesity is a growing threat to women of childbearing age.']	childbearing	UBERON_EXT	[2405]	[2417]	BMJ_2012_May_17_344_e2088_T296
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_14	[2423]	[3464]	['Half the population is either overweight (body mass index (BMI) 25.0-29.9) or obese (BMI ≥30).1In Europe and the United States, 20-40% of women gain more than the recommended weight during pregnancy.2Increased maternal weight or excessive weight gain in pregnancy is associated with adverse pregnancy outcomes.3Half the women who die during pregnancy, childbirth, or puerperium in the United Kingdom are either obese or overweight.4For the offspring, maternal obesity is a major risk factor for childhood obesity, which persists into adulthood independent of other factors.5Obesity costs the UK National Health Service (NHS) around £0.5bn a year and the UK economy a further £2.3bn in indirect costs.6\nThe antenatal period, with opportunities for regular contact with health professionals, is considered an ideal time to intervene as mothers are motivated to make changes that could optimise their outcome and that of the baby.7There is a need to identify appropriate weight management interventions that are effective and safe in pregnancy.']	body	UBERON_EXT	[2465]	[2469]	BMJ_2012_May_17_344_e2088_T297
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_14	[2423]	[3464]	['Half the population is either overweight (body mass index (BMI) 25.0-29.9) or obese (BMI ≥30).1In Europe and the United States, 20-40% of women gain more than the recommended weight during pregnancy.2Increased maternal weight or excessive weight gain in pregnancy is associated with adverse pregnancy outcomes.3Half the women who die during pregnancy, childbirth, or puerperium in the United Kingdom are either obese or overweight.4For the offspring, maternal obesity is a major risk factor for childhood obesity, which persists into adulthood independent of other factors.5Obesity costs the UK National Health Service (NHS) around £0.5bn a year and the UK economy a further £2.3bn in indirect costs.6\nThe antenatal period, with opportunities for regular contact with health professionals, is considered an ideal time to intervene as mothers are motivated to make changes that could optimise their outcome and that of the baby.7There is a need to identify appropriate weight management interventions that are effective and safe in pregnancy.']	women	NCBITAXON_EXT	[2561]	[2566]	BMJ_2012_May_17_344_e2088_T237
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_14	[2423]	[3464]	['Half the population is either overweight (body mass index (BMI) 25.0-29.9) or obese (BMI ≥30).1In Europe and the United States, 20-40% of women gain more than the recommended weight during pregnancy.2Increased maternal weight or excessive weight gain in pregnancy is associated with adverse pregnancy outcomes.3Half the women who die during pregnancy, childbirth, or puerperium in the United Kingdom are either obese or overweight.4For the offspring, maternal obesity is a major risk factor for childhood obesity, which persists into adulthood independent of other factors.5Obesity costs the UK National Health Service (NHS) around £0.5bn a year and the UK economy a further £2.3bn in indirect costs.6\nThe antenatal period, with opportunities for regular contact with health professionals, is considered an ideal time to intervene as mothers are motivated to make changes that could optimise their outcome and that of the baby.7There is a need to identify appropriate weight management interventions that are effective and safe in pregnancy.']	pregnancy	GO_BP_EXT	[2612]	[2621]	BMJ_2012_May_17_344_e2088_T33
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_14	[2423]	[3464]	['Half the population is either overweight (body mass index (BMI) 25.0-29.9) or obese (BMI ≥30).1In Europe and the United States, 20-40% of women gain more than the recommended weight during pregnancy.2Increased maternal weight or excessive weight gain in pregnancy is associated with adverse pregnancy outcomes.3Half the women who die during pregnancy, childbirth, or puerperium in the United Kingdom are either obese or overweight.4For the offspring, maternal obesity is a major risk factor for childhood obesity, which persists into adulthood independent of other factors.5Obesity costs the UK National Health Service (NHS) around £0.5bn a year and the UK economy a further £2.3bn in indirect costs.6\nThe antenatal period, with opportunities for regular contact with health professionals, is considered an ideal time to intervene as mothers are motivated to make changes that could optimise their outcome and that of the baby.7There is a need to identify appropriate weight management interventions that are effective and safe in pregnancy.']	pregnancy	GO_BP_EXT	[2677]	[2686]	BMJ_2012_May_17_344_e2088_T34
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_14	[2423]	[3464]	['Half the population is either overweight (body mass index (BMI) 25.0-29.9) or obese (BMI ≥30).1In Europe and the United States, 20-40% of women gain more than the recommended weight during pregnancy.2Increased maternal weight or excessive weight gain in pregnancy is associated with adverse pregnancy outcomes.3Half the women who die during pregnancy, childbirth, or puerperium in the United Kingdom are either obese or overweight.4For the offspring, maternal obesity is a major risk factor for childhood obesity, which persists into adulthood independent of other factors.5Obesity costs the UK National Health Service (NHS) around £0.5bn a year and the UK economy a further £2.3bn in indirect costs.6\nThe antenatal period, with opportunities for regular contact with health professionals, is considered an ideal time to intervene as mothers are motivated to make changes that could optimise their outcome and that of the baby.7There is a need to identify appropriate weight management interventions that are effective and safe in pregnancy.']	pregnancy	GO_BP_EXT	[2714]	[2723]	BMJ_2012_May_17_344_e2088_T35
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_14	[2423]	[3464]	['Half the population is either overweight (body mass index (BMI) 25.0-29.9) or obese (BMI ≥30).1In Europe and the United States, 20-40% of women gain more than the recommended weight during pregnancy.2Increased maternal weight or excessive weight gain in pregnancy is associated with adverse pregnancy outcomes.3Half the women who die during pregnancy, childbirth, or puerperium in the United Kingdom are either obese or overweight.4For the offspring, maternal obesity is a major risk factor for childhood obesity, which persists into adulthood independent of other factors.5Obesity costs the UK National Health Service (NHS) around £0.5bn a year and the UK economy a further £2.3bn in indirect costs.6\nThe antenatal period, with opportunities for regular contact with health professionals, is considered an ideal time to intervene as mothers are motivated to make changes that could optimise their outcome and that of the baby.7There is a need to identify appropriate weight management interventions that are effective and safe in pregnancy.']	women	NCBITAXON_EXT	[2743]	[2748]	BMJ_2012_May_17_344_e2088_T238
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_14	[2423]	[3464]	['Half the population is either overweight (body mass index (BMI) 25.0-29.9) or obese (BMI ≥30).1In Europe and the United States, 20-40% of women gain more than the recommended weight during pregnancy.2Increased maternal weight or excessive weight gain in pregnancy is associated with adverse pregnancy outcomes.3Half the women who die during pregnancy, childbirth, or puerperium in the United Kingdom are either obese or overweight.4For the offspring, maternal obesity is a major risk factor for childhood obesity, which persists into adulthood independent of other factors.5Obesity costs the UK National Health Service (NHS) around £0.5bn a year and the UK economy a further £2.3bn in indirect costs.6\nThe antenatal period, with opportunities for regular contact with health professionals, is considered an ideal time to intervene as mothers are motivated to make changes that could optimise their outcome and that of the baby.7There is a need to identify appropriate weight management interventions that are effective and safe in pregnancy.']	women	UBERON_EXT	[2743]	[2748]	BMJ_2012_May_17_344_e2088_T298
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_14	[2423]	[3464]	['Half the population is either overweight (body mass index (BMI) 25.0-29.9) or obese (BMI ≥30).1In Europe and the United States, 20-40% of women gain more than the recommended weight during pregnancy.2Increased maternal weight or excessive weight gain in pregnancy is associated with adverse pregnancy outcomes.3Half the women who die during pregnancy, childbirth, or puerperium in the United Kingdom are either obese or overweight.4For the offspring, maternal obesity is a major risk factor for childhood obesity, which persists into adulthood independent of other factors.5Obesity costs the UK National Health Service (NHS) around £0.5bn a year and the UK economy a further £2.3bn in indirect costs.6\nThe antenatal period, with opportunities for regular contact with health professionals, is considered an ideal time to intervene as mothers are motivated to make changes that could optimise their outcome and that of the baby.7There is a need to identify appropriate weight management interventions that are effective and safe in pregnancy.']	die	GO_BP_EXT	[2753]	[2756]	BMJ_2012_May_17_344_e2088_T36
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_14	[2423]	[3464]	['Half the population is either overweight (body mass index (BMI) 25.0-29.9) or obese (BMI ≥30).1In Europe and the United States, 20-40% of women gain more than the recommended weight during pregnancy.2Increased maternal weight or excessive weight gain in pregnancy is associated with adverse pregnancy outcomes.3Half the women who die during pregnancy, childbirth, or puerperium in the United Kingdom are either obese or overweight.4For the offspring, maternal obesity is a major risk factor for childhood obesity, which persists into adulthood independent of other factors.5Obesity costs the UK National Health Service (NHS) around £0.5bn a year and the UK economy a further £2.3bn in indirect costs.6\nThe antenatal period, with opportunities for regular contact with health professionals, is considered an ideal time to intervene as mothers are motivated to make changes that could optimise their outcome and that of the baby.7There is a need to identify appropriate weight management interventions that are effective and safe in pregnancy.']	pregnancy	GO_BP_EXT	[2764]	[2773]	BMJ_2012_May_17_344_e2088_T37
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_14	[2423]	[3464]	['Half the population is either overweight (body mass index (BMI) 25.0-29.9) or obese (BMI ≥30).1In Europe and the United States, 20-40% of women gain more than the recommended weight during pregnancy.2Increased maternal weight or excessive weight gain in pregnancy is associated with adverse pregnancy outcomes.3Half the women who die during pregnancy, childbirth, or puerperium in the United Kingdom are either obese or overweight.4For the offspring, maternal obesity is a major risk factor for childhood obesity, which persists into adulthood independent of other factors.5Obesity costs the UK National Health Service (NHS) around £0.5bn a year and the UK economy a further £2.3bn in indirect costs.6\nThe antenatal period, with opportunities for regular contact with health professionals, is considered an ideal time to intervene as mothers are motivated to make changes that could optimise their outcome and that of the baby.7There is a need to identify appropriate weight management interventions that are effective and safe in pregnancy.']	childbirth	GO_BP_EXT	[2775]	[2785]	BMJ_2012_May_17_344_e2088_T38
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_14	[2423]	[3464]	['Half the population is either overweight (body mass index (BMI) 25.0-29.9) or obese (BMI ≥30).1In Europe and the United States, 20-40% of women gain more than the recommended weight during pregnancy.2Increased maternal weight or excessive weight gain in pregnancy is associated with adverse pregnancy outcomes.3Half the women who die during pregnancy, childbirth, or puerperium in the United Kingdom are either obese or overweight.4For the offspring, maternal obesity is a major risk factor for childhood obesity, which persists into adulthood independent of other factors.5Obesity costs the UK National Health Service (NHS) around £0.5bn a year and the UK economy a further £2.3bn in indirect costs.6\nThe antenatal period, with opportunities for regular contact with health professionals, is considered an ideal time to intervene as mothers are motivated to make changes that could optimise their outcome and that of the baby.7There is a need to identify appropriate weight management interventions that are effective and safe in pregnancy.']	puerperium	UBERON_EXT	[2790]	[2800]	BMJ_2012_May_17_344_e2088_T299
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_14	[2423]	[3464]	['Half the population is either overweight (body mass index (BMI) 25.0-29.9) or obese (BMI ≥30).1In Europe and the United States, 20-40% of women gain more than the recommended weight during pregnancy.2Increased maternal weight or excessive weight gain in pregnancy is associated with adverse pregnancy outcomes.3Half the women who die during pregnancy, childbirth, or puerperium in the United Kingdom are either obese or overweight.4For the offspring, maternal obesity is a major risk factor for childhood obesity, which persists into adulthood independent of other factors.5Obesity costs the UK National Health Service (NHS) around £0.5bn a year and the UK economy a further £2.3bn in indirect costs.6\nThe antenatal period, with opportunities for regular contact with health professionals, is considered an ideal time to intervene as mothers are motivated to make changes that could optimise their outcome and that of the baby.7There is a need to identify appropriate weight management interventions that are effective and safe in pregnancy.']	childhood	UBERON_EXT	[2918]	[2927]	BMJ_2012_May_17_344_e2088_T300
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_14	[2423]	[3464]	['Half the population is either overweight (body mass index (BMI) 25.0-29.9) or obese (BMI ≥30).1In Europe and the United States, 20-40% of women gain more than the recommended weight during pregnancy.2Increased maternal weight or excessive weight gain in pregnancy is associated with adverse pregnancy outcomes.3Half the women who die during pregnancy, childbirth, or puerperium in the United Kingdom are either obese or overweight.4For the offspring, maternal obesity is a major risk factor for childhood obesity, which persists into adulthood independent of other factors.5Obesity costs the UK National Health Service (NHS) around £0.5bn a year and the UK economy a further £2.3bn in indirect costs.6\nThe antenatal period, with opportunities for regular contact with health professionals, is considered an ideal time to intervene as mothers are motivated to make changes that could optimise their outcome and that of the baby.7There is a need to identify appropriate weight management interventions that are effective and safe in pregnancy.']	adulthood	UBERON_EXT	[2957]	[2966]	BMJ_2012_May_17_344_e2088_T301
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_14	[2423]	[3464]	['Half the population is either overweight (body mass index (BMI) 25.0-29.9) or obese (BMI ≥30).1In Europe and the United States, 20-40% of women gain more than the recommended weight during pregnancy.2Increased maternal weight or excessive weight gain in pregnancy is associated with adverse pregnancy outcomes.3Half the women who die during pregnancy, childbirth, or puerperium in the United Kingdom are either obese or overweight.4For the offspring, maternal obesity is a major risk factor for childhood obesity, which persists into adulthood independent of other factors.5Obesity costs the UK National Health Service (NHS) around £0.5bn a year and the UK economy a further £2.3bn in indirect costs.6\nThe antenatal period, with opportunities for regular contact with health professionals, is considered an ideal time to intervene as mothers are motivated to make changes that could optimise their outcome and that of the baby.7There is a need to identify appropriate weight management interventions that are effective and safe in pregnancy.']	baby	UBERON_EXT	[3345]	[3349]	BMJ_2012_May_17_344_e2088_T302
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_14	[2423]	[3464]	['Half the population is either overweight (body mass index (BMI) 25.0-29.9) or obese (BMI ≥30).1In Europe and the United States, 20-40% of women gain more than the recommended weight during pregnancy.2Increased maternal weight or excessive weight gain in pregnancy is associated with adverse pregnancy outcomes.3Half the women who die during pregnancy, childbirth, or puerperium in the United Kingdom are either obese or overweight.4For the offspring, maternal obesity is a major risk factor for childhood obesity, which persists into adulthood independent of other factors.5Obesity costs the UK National Health Service (NHS) around £0.5bn a year and the UK economy a further £2.3bn in indirect costs.6\nThe antenatal period, with opportunities for regular contact with health professionals, is considered an ideal time to intervene as mothers are motivated to make changes that could optimise their outcome and that of the baby.7There is a need to identify appropriate weight management interventions that are effective and safe in pregnancy.']	pregnancy	GO_BP_EXT	[3454]	[3463]	BMJ_2012_May_17_344_e2088_T39
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_15	[3465]	[3770]	['Existing reviews and guidelines are limited in their recommendations because of the small number of included studies.89They have not been able to identify the best intervention that optimises the outcomes for the mother and baby.910There is also a lack of consensus on what constitutes important outcomes.']	baby	UBERON_EXT	[3689]	[3693]	BMJ_2012_May_17_344_e2088_T303
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_16	[3771]	[4168]	['Guidelines from the Institute of Medicine (IOM) provide reference ranges for optimal weight gain in pregnancy for normal weight, overweight, and obese women based on observational evidence.11Given the potential importance of weight management interventions in pregnancy, we systematically reviewed the effects of dietary and lifestyle interventions on various outcomes ranked for their importance.']	pregnancy	GO_BP_EXT	[3871]	[3880]	BMJ_2012_May_17_344_e2088_T40
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_16	[3771]	[4168]	['Guidelines from the Institute of Medicine (IOM) provide reference ranges for optimal weight gain in pregnancy for normal weight, overweight, and obese women based on observational evidence.11Given the potential importance of weight management interventions in pregnancy, we systematically reviewed the effects of dietary and lifestyle interventions on various outcomes ranked for their importance.']	women	NCBITAXON_EXT	[3922]	[3927]	BMJ_2012_May_17_344_e2088_T239
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_16	[3771]	[4168]	['Guidelines from the Institute of Medicine (IOM) provide reference ranges for optimal weight gain in pregnancy for normal weight, overweight, and obese women based on observational evidence.11Given the potential importance of weight management interventions in pregnancy, we systematically reviewed the effects of dietary and lifestyle interventions on various outcomes ranked for their importance.']	women	UBERON_EXT	[3922]	[3927]	BMJ_2012_May_17_344_e2088_T304
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_16	[3771]	[4168]	['Guidelines from the Institute of Medicine (IOM) provide reference ranges for optimal weight gain in pregnancy for normal weight, overweight, and obese women based on observational evidence.11Given the potential importance of weight management interventions in pregnancy, we systematically reviewed the effects of dietary and lifestyle interventions on various outcomes ranked for their importance.']	pregnancy	GO_BP_EXT	[4031]	[4040]	BMJ_2012_May_17_344_e2088_T41
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_20	[5173]	[5294]	['The search term combination captured the concept “pregnancy and weight” incorporating MeSH, free text, and word variants.']	pregnancy	GO_BP_EXT	[5223]	[5232]	BMJ_2012_May_17_344_e2088_T42
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_20	[5173]	[5294]	['The search term combination captured the concept “pregnancy and weight” incorporating MeSH, free text, and word variants.']	variants	SO_EXT	[5285]	[5293]	BMJ_2012_May_17_344_e2088_T288
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_25	[5723]	[5808]	['In cases of duplicate publication, we selected the most recent and complete versions.']	duplicate	SO_EXT	[5735]	[5744]	BMJ_2012_May_17_344_e2088_T289
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_27	[5981]	[6217]	['Two independent reviewers (ER, SG) classified interventions as mainly diet based, physical activity based, or mixed approach (with both diet and physical activity components that might or might not be underpinned by behavioural theory).']	behavioural	GO_BP_EXT	[6197]	[6208]	BMJ_2012_May_17_344_e2088_T43
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_29	[6292]	[6363]	['We excluded studies on pregnant women who were underweight (BMI <18.5).']	pregnant	GO_BP_EXT	[6315]	[6323]	BMJ_2012_May_17_344_e2088_T44
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_29	[6292]	[6363]	['We excluded studies on pregnant women who were underweight (BMI <18.5).']	women	NCBITAXON_EXT	[6324]	[6329]	BMJ_2012_May_17_344_e2088_T240
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_38	[7462]	[7722]	['For each outcome, the subgroups defined a priori were clinical characteristics such as BMI and diabetes in pregnancy; type of intervention; responders, defined as women with significant reduction in gestational weight gain with intervention; and study quality.']	pregnancy	GO_BP_EXT	[7569]	[7578]	BMJ_2012_May_17_344_e2088_T45
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_38	[7462]	[7722]	['For each outcome, the subgroups defined a priori were clinical characteristics such as BMI and diabetes in pregnancy; type of intervention; responders, defined as women with significant reduction in gestational weight gain with intervention; and study quality.']	responders	GO_BP_EXT	[7602]	[7612]	BMJ_2012_May_17_344_e2088_T46
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_38	[7462]	[7722]	['For each outcome, the subgroups defined a priori were clinical characteristics such as BMI and diabetes in pregnancy; type of intervention; responders, defined as women with significant reduction in gestational weight gain with intervention; and study quality.']	women	NCBITAXON_EXT	[7625]	[7630]	BMJ_2012_May_17_344_e2088_T241
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_38	[7462]	[7722]	['For each outcome, the subgroups defined a priori were clinical characteristics such as BMI and diabetes in pregnancy; type of intervention; responders, defined as women with significant reduction in gestational weight gain with intervention; and study quality.']	women	UBERON_EXT	[7625]	[7630]	BMJ_2012_May_17_344_e2088_T305
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_38	[7462]	[7722]	['For each outcome, the subgroups defined a priori were clinical characteristics such as BMI and diabetes in pregnancy; type of intervention; responders, defined as women with significant reduction in gestational weight gain with intervention; and study quality.']	gestational	GO_BP_EXT	[7661]	[7672]	BMJ_2012_May_17_344_e2088_T47
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_43	[8201]	[8446]	['We used Egger’s test to test for funnel plot asymmetry.18All analyses were carried out with Revman19and Stata statistical software.20\n\nPrioritisation and rating of evidence\nOur primary outcomes were weight related changes in the mother and baby.']	baby	UBERON_EXT	[8441]	[8445]	BMJ_2012_May_17_344_e2088_T306
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_44	[8447]	[8736]	['We prioritised the other maternal and fetal outcomes related to pregnancy and ranked them for importance by a two round Delphi survey of clinicians with expertise in this specialty.15Nineteen clinicians (19/20, 95% response rate) participated in the first round and 16 (84%) in the second.']	pregnancy	GO_BP_EXT	[8511]	[8520]	BMJ_2012_May_17_344_e2088_T48
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_45	[8737]	[8860]	['The list of outcomes ranked as critically important to weight management in pregnancy is provided in appendix 1 on bmj.com.']	pregnancy	GO_BP_EXT	[8813]	[8822]	BMJ_2012_May_17_344_e2088_T49
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_50	[9726]	[10026]	['Safety of the interventions in pregnancy\nWe undertook the review of safety of interventions based on recommended methods, including those of Cochrane adverse effects subgroup.2223We designed a separate search strategy to evaluate safety by including text words and indexing terms for adverse effects.']	pregnancy	GO_BP_EXT	[9757]	[9766]	BMJ_2012_May_17_344_e2088_T50
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_51	[10027]	[10168]	['We limited the search by including search filters for “adverse events”, “human studies”, and “study type” (excluding editorials and letters).']	human	NCBITAXON_EXT	[10100]	[10105]	BMJ_2012_May_17_344_e2088_T242
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_54	[10362]	[10635]	['The number of adverse events reported in pregnant women and children were obtained for each intervention to compute a percentage of the total number of women and children in whom the occurrence of that particular adverse event, or confirmation of its absence, was reported.']	pregnant	GO_BP_EXT	[10403]	[10411]	BMJ_2012_May_17_344_e2088_T51
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_54	[10362]	[10635]	['The number of adverse events reported in pregnant women and children were obtained for each intervention to compute a percentage of the total number of women and children in whom the occurrence of that particular adverse event, or confirmation of its absence, was reported.']	women	NCBITAXON_EXT	[10412]	[10417]	BMJ_2012_May_17_344_e2088_T243
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_54	[10362]	[10635]	['The number of adverse events reported in pregnant women and children were obtained for each intervention to compute a percentage of the total number of women and children in whom the occurrence of that particular adverse event, or confirmation of its absence, was reported.']	women	UBERON_EXT	[10412]	[10417]	BMJ_2012_May_17_344_e2088_T307
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_54	[10362]	[10635]	['The number of adverse events reported in pregnant women and children were obtained for each intervention to compute a percentage of the total number of women and children in whom the occurrence of that particular adverse event, or confirmation of its absence, was reported.']	children	NCBITAXON_EXT	[10422]	[10430]	BMJ_2012_May_17_344_e2088_T244
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_54	[10362]	[10635]	['The number of adverse events reported in pregnant women and children were obtained for each intervention to compute a percentage of the total number of women and children in whom the occurrence of that particular adverse event, or confirmation of its absence, was reported.']	children	UBERON_EXT	[10422]	[10430]	BMJ_2012_May_17_344_e2088_T308
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_54	[10362]	[10635]	['The number of adverse events reported in pregnant women and children were obtained for each intervention to compute a percentage of the total number of women and children in whom the occurrence of that particular adverse event, or confirmation of its absence, was reported.']	women	NCBITAXON_EXT	[10514]	[10519]	BMJ_2012_May_17_344_e2088_T245
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_54	[10362]	[10635]	['The number of adverse events reported in pregnant women and children were obtained for each intervention to compute a percentage of the total number of women and children in whom the occurrence of that particular adverse event, or confirmation of its absence, was reported.']	women	UBERON_EXT	[10514]	[10519]	BMJ_2012_May_17_344_e2088_T309
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_54	[10362]	[10635]	['The number of adverse events reported in pregnant women and children were obtained for each intervention to compute a percentage of the total number of women and children in whom the occurrence of that particular adverse event, or confirmation of its absence, was reported.']	children	NCBITAXON_EXT	[10524]	[10532]	BMJ_2012_May_17_344_e2088_T246
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_54	[10362]	[10635]	['The number of adverse events reported in pregnant women and children were obtained for each intervention to compute a percentage of the total number of women and children in whom the occurrence of that particular adverse event, or confirmation of its absence, was reported.']	children	UBERON_EXT	[10524]	[10532]	BMJ_2012_May_17_344_e2088_T310
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_57	[10820]	[10935]	['Forty four randomised trials (7278 women) reported the effects of dietary and lifestyle interventions in pregnancy.']	women	NCBITAXON_EXT	[10855]	[10860]	BMJ_2012_May_17_344_e2088_T247
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_57	[10820]	[10935]	['Forty four randomised trials (7278 women) reported the effects of dietary and lifestyle interventions in pregnancy.']	women	UBERON_EXT	[10855]	[10860]	BMJ_2012_May_17_344_e2088_T311
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_57	[10820]	[10935]	['Forty four randomised trials (7278 women) reported the effects of dietary and lifestyle interventions in pregnancy.']	pregnancy	GO_BP_EXT	[10925]	[10934]	BMJ_2012_May_17_344_e2088_T52
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_58	[10936]	[11872]	['The interventions in the trials were broadly classified into three groups: those mainly based on diet (13 randomised trials)24252627282930313233343536or physical activity (18 randomised trials)37383940414243444546474849505152535455and a mixed approach with diet and physical activity components that might or might not be underpinned by behavioural counselling (13 randomised trials).7565758596061626364656667\n\nCaption (FIG)\n\nFig 1 Identification of studies in systematic review of effects of dietary and lifestyle interventions in pregnancy on maternal and fetal outcomes\n\nCharacteristics of the included studies and interventions\nThe included trials studied the effect of interventions on women with any BMI,725262728293032373839404243444546474849505254555657585960616263646566mostly obese and overweight women,313353or only obese women2429343536515967(clinical characteristics of all identified studies are in appendix 3 on bmj.com).']	behavioural	GO_BP_EXT	[11273]	[11284]	BMJ_2012_May_17_344_e2088_T53
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_58	[10936]	[11872]	['The interventions in the trials were broadly classified into three groups: those mainly based on diet (13 randomised trials)24252627282930313233343536or physical activity (18 randomised trials)37383940414243444546474849505152535455and a mixed approach with diet and physical activity components that might or might not be underpinned by behavioural counselling (13 randomised trials).7565758596061626364656667\n\nCaption (FIG)\n\nFig 1 Identification of studies in systematic review of effects of dietary and lifestyle interventions in pregnancy on maternal and fetal outcomes\n\nCharacteristics of the included studies and interventions\nThe included trials studied the effect of interventions on women with any BMI,725262728293032373839404243444546474849505254555657585960616263646566mostly obese and overweight women,313353or only obese women2429343536515967(clinical characteristics of all identified studies are in appendix 3 on bmj.com).']	pregnancy	GO_BP_EXT	[11468]	[11477]	BMJ_2012_May_17_344_e2088_T54
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_58	[10936]	[11872]	['The interventions in the trials were broadly classified into three groups: those mainly based on diet (13 randomised trials)24252627282930313233343536or physical activity (18 randomised trials)37383940414243444546474849505152535455and a mixed approach with diet and physical activity components that might or might not be underpinned by behavioural counselling (13 randomised trials).7565758596061626364656667\n\nCaption (FIG)\n\nFig 1 Identification of studies in systematic review of effects of dietary and lifestyle interventions in pregnancy on maternal and fetal outcomes\n\nCharacteristics of the included studies and interventions\nThe included trials studied the effect of interventions on women with any BMI,725262728293032373839404243444546474849505254555657585960616263646566mostly obese and overweight women,313353or only obese women2429343536515967(clinical characteristics of all identified studies are in appendix 3 on bmj.com).']	women	NCBITAXON_EXT	[11627]	[11632]	BMJ_2012_May_17_344_e2088_T248
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_58	[10936]	[11872]	['The interventions in the trials were broadly classified into three groups: those mainly based on diet (13 randomised trials)24252627282930313233343536or physical activity (18 randomised trials)37383940414243444546474849505152535455and a mixed approach with diet and physical activity components that might or might not be underpinned by behavioural counselling (13 randomised trials).7565758596061626364656667\n\nCaption (FIG)\n\nFig 1 Identification of studies in systematic review of effects of dietary and lifestyle interventions in pregnancy on maternal and fetal outcomes\n\nCharacteristics of the included studies and interventions\nThe included trials studied the effect of interventions on women with any BMI,725262728293032373839404243444546474849505254555657585960616263646566mostly obese and overweight women,313353or only obese women2429343536515967(clinical characteristics of all identified studies are in appendix 3 on bmj.com).']	women	UBERON_EXT	[11627]	[11632]	BMJ_2012_May_17_344_e2088_T312
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_58	[10936]	[11872]	['The interventions in the trials were broadly classified into three groups: those mainly based on diet (13 randomised trials)24252627282930313233343536or physical activity (18 randomised trials)37383940414243444546474849505152535455and a mixed approach with diet and physical activity components that might or might not be underpinned by behavioural counselling (13 randomised trials).7565758596061626364656667\n\nCaption (FIG)\n\nFig 1 Identification of studies in systematic review of effects of dietary and lifestyle interventions in pregnancy on maternal and fetal outcomes\n\nCharacteristics of the included studies and interventions\nThe included trials studied the effect of interventions on women with any BMI,725262728293032373839404243444546474849505254555657585960616263646566mostly obese and overweight women,313353or only obese women2429343536515967(clinical characteristics of all identified studies are in appendix 3 on bmj.com).']	women	NCBITAXON_EXT	[11743]	[11748]	BMJ_2012_May_17_344_e2088_T249
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_58	[10936]	[11872]	['The interventions in the trials were broadly classified into three groups: those mainly based on diet (13 randomised trials)24252627282930313233343536or physical activity (18 randomised trials)37383940414243444546474849505152535455and a mixed approach with diet and physical activity components that might or might not be underpinned by behavioural counselling (13 randomised trials).7565758596061626364656667\n\nCaption (FIG)\n\nFig 1 Identification of studies in systematic review of effects of dietary and lifestyle interventions in pregnancy on maternal and fetal outcomes\n\nCharacteristics of the included studies and interventions\nThe included trials studied the effect of interventions on women with any BMI,725262728293032373839404243444546474849505254555657585960616263646566mostly obese and overweight women,313353or only obese women2429343536515967(clinical characteristics of all identified studies are in appendix 3 on bmj.com).']	women	UBERON_EXT	[11743]	[11748]	BMJ_2012_May_17_344_e2088_T313
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_58	[10936]	[11872]	['The interventions in the trials were broadly classified into three groups: those mainly based on diet (13 randomised trials)24252627282930313233343536or physical activity (18 randomised trials)37383940414243444546474849505152535455and a mixed approach with diet and physical activity components that might or might not be underpinned by behavioural counselling (13 randomised trials).7565758596061626364656667\n\nCaption (FIG)\n\nFig 1 Identification of studies in systematic review of effects of dietary and lifestyle interventions in pregnancy on maternal and fetal outcomes\n\nCharacteristics of the included studies and interventions\nThe included trials studied the effect of interventions on women with any BMI,725262728293032373839404243444546474849505254555657585960616263646566mostly obese and overweight women,313353or only obese women2429343536515967(clinical characteristics of all identified studies are in appendix 3 on bmj.com).']	women2429343536515967	NCBITAXON_EXT	[11769]	[11790]	BMJ_2012_May_17_344_e2088_T250
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_59	[11873]	[12165]	['Five randomised trials included pregnant women with a diagnosis of gestational diabetes mellitus2831345758and one included women with pre-existing diabetes.32Typical dietary interventions included a balanced diet consisting of carbohydrates, proteins, and fat and maintenance of a food diary.']	pregnant	GO_BP_EXT	[11905]	[11913]	BMJ_2012_May_17_344_e2088_T55
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_59	[11873]	[12165]	['Five randomised trials included pregnant women with a diagnosis of gestational diabetes mellitus2831345758and one included women with pre-existing diabetes.32Typical dietary interventions included a balanced diet consisting of carbohydrates, proteins, and fat and maintenance of a food diary.']	women	NCBITAXON_EXT	[11914]	[11919]	BMJ_2012_May_17_344_e2088_T251
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_59	[11873]	[12165]	['Five randomised trials included pregnant women with a diagnosis of gestational diabetes mellitus2831345758and one included women with pre-existing diabetes.32Typical dietary interventions included a balanced diet consisting of carbohydrates, proteins, and fat and maintenance of a food diary.']	women	UBERON_EXT	[11914]	[11919]	BMJ_2012_May_17_344_e2088_T314
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_59	[11873]	[12165]	['Five randomised trials included pregnant women with a diagnosis of gestational diabetes mellitus2831345758and one included women with pre-existing diabetes.32Typical dietary interventions included a balanced diet consisting of carbohydrates, proteins, and fat and maintenance of a food diary.']	gestational	GO_BP_EXT	[11940]	[11951]	BMJ_2012_May_17_344_e2088_T56
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_59	[11873]	[12165]	['Five randomised trials included pregnant women with a diagnosis of gestational diabetes mellitus2831345758and one included women with pre-existing diabetes.32Typical dietary interventions included a balanced diet consisting of carbohydrates, proteins, and fat and maintenance of a food diary.']	women	NCBITAXON_EXT	[11996]	[12001]	BMJ_2012_May_17_344_e2088_T252
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_59	[11873]	[12165]	['Five randomised trials included pregnant women with a diagnosis of gestational diabetes mellitus2831345758and one included women with pre-existing diabetes.32Typical dietary interventions included a balanced diet consisting of carbohydrates, proteins, and fat and maintenance of a food diary.']	women	UBERON_EXT	[11996]	[12001]	BMJ_2012_May_17_344_e2088_T315
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_59	[11873]	[12165]	['Five randomised trials included pregnant women with a diagnosis of gestational diabetes mellitus2831345758and one included women with pre-existing diabetes.32Typical dietary interventions included a balanced diet consisting of carbohydrates, proteins, and fat and maintenance of a food diary.']	carbohydrates	CHEBI_EXT	[12100]	[12113]	BMJ_2012_May_17_344_e2088_T0
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_59	[11873]	[12165]	['Five randomised trials included pregnant women with a diagnosis of gestational diabetes mellitus2831345758and one included women with pre-existing diabetes.32Typical dietary interventions included a balanced diet consisting of carbohydrates, proteins, and fat and maintenance of a food diary.']	proteins	CHEBI_EXT	[12115]	[12123]	BMJ_2012_May_17_344_e2088_T1
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_59	[11873]	[12165]	['Five randomised trials included pregnant women with a diagnosis of gestational diabetes mellitus2831345758and one included women with pre-existing diabetes.32Typical dietary interventions included a balanced diet consisting of carbohydrates, proteins, and fat and maintenance of a food diary.']	proteins	CHEBI_EXT	[12115]	[12123]	BMJ_2012_May_17_344_e2088_T286
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_59	[11873]	[12165]	['Five randomised trials included pregnant women with a diagnosis of gestational diabetes mellitus2831345758and one included women with pre-existing diabetes.32Typical dietary interventions included a balanced diet consisting of carbohydrates, proteins, and fat and maintenance of a food diary.']	fat	CHEBI_EXT	[12129]	[12132]	BMJ_2012_May_17_344_e2088_T2
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_59	[11873]	[12165]	['Five randomised trials included pregnant women with a diagnosis of gestational diabetes mellitus2831345758and one included women with pre-existing diabetes.32Typical dietary interventions included a balanced diet consisting of carbohydrates, proteins, and fat and maintenance of a food diary.']	fat	CHEBI_EXT	[12129]	[12132]	BMJ_2012_May_17_344_e2088_T316
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_59	[11873]	[12165]	['Five randomised trials included pregnant women with a diagnosis of gestational diabetes mellitus2831345758and one included women with pre-existing diabetes.32Typical dietary interventions included a balanced diet consisting of carbohydrates, proteins, and fat and maintenance of a food diary.']	food	CHEBI_EXT	[12154]	[12158]	BMJ_2012_May_17_344_e2088_T3
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_61	[12315]	[12501]	['The interventions in the mixed approach included counselling sessions, education concerning the potential benefit of diet and physical activity, and feedback on weight gain in pregnancy.']	pregnancy	GO_BP_EXT	[12491]	[12500]	BMJ_2012_May_17_344_e2088_T57
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_62	[12502]	[12673]	['The mixed approach used techniques of behavioural modification to give the women insight into controlling periods of emotional eating and preventing binge eating sessions.']	behavioural	GO_BP_EXT	[12540]	[12551]	BMJ_2012_May_17_344_e2088_T58
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_62	[12502]	[12673]	['The mixed approach used techniques of behavioural modification to give the women insight into controlling periods of emotional eating and preventing binge eating sessions.']	women	NCBITAXON_EXT	[12577]	[12582]	BMJ_2012_May_17_344_e2088_T253
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_62	[12502]	[12673]	['The mixed approach used techniques of behavioural modification to give the women insight into controlling periods of emotional eating and preventing binge eating sessions.']	women	UBERON_EXT	[12577]	[12582]	BMJ_2012_May_17_344_e2088_T317
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_62	[12502]	[12673]	['The mixed approach used techniques of behavioural modification to give the women insight into controlling periods of emotional eating and preventing binge eating sessions.']	controlling	GO_BP_EXT	[12596]	[12607]	BMJ_2012_May_17_344_e2088_T59
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_62	[12502]	[12673]	['The mixed approach used techniques of behavioural modification to give the women insight into controlling periods of emotional eating and preventing binge eating sessions.']	eating	GO_BP_EXT	[12629]	[12635]	BMJ_2012_May_17_344_e2088_T60
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_62	[12502]	[12673]	['The mixed approach used techniques of behavioural modification to give the women insight into controlling periods of emotional eating and preventing binge eating sessions.']	eating	GO_BP_EXT	[12657]	[12663]	BMJ_2012_May_17_344_e2088_T61
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_64	[12717]	[13379]	['One study was available only as an abstract, and data were not included in the meta-analysis.24\n\nCaption (FIG)\n\nFig 2 Quality of randomised controlled trials included in systematic review of dietary and lifestyle interventions in pregnancy on maternal and fetal outcomes\n\nEffect of intervention on maternal weight\nThirty four randomised trials (5481 women) evaluated the effect of interventions on maternal weight gain in pregnancy.7252627283132333435363738394243454647485051525354565960616263656667Compared with control women, there was a reduction in weight gain of 1.42 kg with interventions (95% confidence interval 0.95 to 1.89 kg; P<0.001, I2=80%) (fig 3).']	pregnancy	GO_BP_EXT	[12947]	[12956]	BMJ_2012_May_17_344_e2088_T62
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_64	[12717]	[13379]	['One study was available only as an abstract, and data were not included in the meta-analysis.24\n\nCaption (FIG)\n\nFig 2 Quality of randomised controlled trials included in systematic review of dietary and lifestyle interventions in pregnancy on maternal and fetal outcomes\n\nEffect of intervention on maternal weight\nThirty four randomised trials (5481 women) evaluated the effect of interventions on maternal weight gain in pregnancy.7252627283132333435363738394243454647485051525354565960616263656667Compared with control women, there was a reduction in weight gain of 1.42 kg with interventions (95% confidence interval 0.95 to 1.89 kg; P<0.001, I2=80%) (fig 3).']	women	NCBITAXON_EXT	[13067]	[13072]	BMJ_2012_May_17_344_e2088_T254
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_64	[12717]	[13379]	['One study was available only as an abstract, and data were not included in the meta-analysis.24\n\nCaption (FIG)\n\nFig 2 Quality of randomised controlled trials included in systematic review of dietary and lifestyle interventions in pregnancy on maternal and fetal outcomes\n\nEffect of intervention on maternal weight\nThirty four randomised trials (5481 women) evaluated the effect of interventions on maternal weight gain in pregnancy.7252627283132333435363738394243454647485051525354565960616263656667Compared with control women, there was a reduction in weight gain of 1.42 kg with interventions (95% confidence interval 0.95 to 1.89 kg; P<0.001, I2=80%) (fig 3).']	pregnancy	GO_BP_EXT	[13139]	[13148]	BMJ_2012_May_17_344_e2088_T63
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_64	[12717]	[13379]	['One study was available only as an abstract, and data were not included in the meta-analysis.24\n\nCaption (FIG)\n\nFig 2 Quality of randomised controlled trials included in systematic review of dietary and lifestyle interventions in pregnancy on maternal and fetal outcomes\n\nEffect of intervention on maternal weight\nThirty four randomised trials (5481 women) evaluated the effect of interventions on maternal weight gain in pregnancy.7252627283132333435363738394243454647485051525354565960616263656667Compared with control women, there was a reduction in weight gain of 1.42 kg with interventions (95% confidence interval 0.95 to 1.89 kg; P<0.001, I2=80%) (fig 3).']	women	NCBITAXON_EXT	[13238]	[13243]	BMJ_2012_May_17_344_e2088_T255
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_66	[13518]	[13708]	['There was no significant difference between the two groups in their adherence to the Institute of Medicine (IOM) recommended gestational target weight gain (relative risk 0.85, 0.66 to 1.1).']	gestational	GO_BP_EXT	[13643]	[13654]	BMJ_2012_May_17_344_e2088_T64
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_67	[13710]	[15574]	['Caption (FIG)\n\nFig 3 Mean difference in gestational weight gain (kg) with dietary and lifestyle interventions in pregnancy\n\nCaption (TABLE-WRAP): TABLE 1 \n\nEffect of dietary and lifestyle interventions in pregnancy on primary outcomes (weight gain in pregnancy and birth weight) and secondary weight related outcomes ranked as critically important by Delphi survey (except for exceeding IOM recommendations)No of studiesNo of participantsSummary estimate (95% CI)P valueI2(%) Dietary intervention Weight gain in pregnancy (kg)1025-28 31-362560−3.84* (−5.22 to −2.45)<0.00192Birth weight (g)1026-28 30-362861−60* (−190 to 80)0.4184Small for gestational age328 30 3122521.02† (0.75 to 1.37)0.910Large for gestational age528 29 31 34 3523780.78† (0.51 to 1.19)0.2663Exceeds IOM recommendations0———— Physical activity Weight gain in pregnancy (kg)1437-39 42 43 45-48 50-541057−0.72* (−1.20 to −0.25)0.00330Birth weight (g)1437-40 42 44-50 52 531369−60* (−120 to −10)0.020Small for gestational age437 38 46 534091.28† (0.52 to 3.15)0.600Large for gestational age438 39 46 523550.52† (0.25 to 1.09)0.080Exceeds IOM recommendations146740.33† (0.11 to 0.98)0.05NA Mixed approach Weight gain in pregnancy (kg)107 56 59-63 65-671864−1.06* (−1.67 to −0.46)<0.00136Birth weight (g)757 59 61-63 65 66104810* (−50 to 70)0.860Small for gestational age458 63 65 668910.88† (0.53 to 1.44)0.600Large for gestational age957-59 61 62 63 65-6715001.05† (0.79 to 1.40)0.720Exceeds IOM recommendations461 63 65 668990.89† (0.71 to 1.13)0.3356 All interventions Weight gain in pregnancy (kg)345481−1.42* (−1.89 to −0.95)<0.00180Birth weight (g)315278−50* (−100 to 0)0.0857Small for gestational age1135521.00† (0.78 to 1.28)0.990Large for gestational age1842330.85† (0.66 to 1.09)0.2138Exceeds IOM recommendations58730.85† (0.66 to 1.11)0.2160\nIOM=Institute of Medicine; NA=not applicable.']	gestational	GO_BP_EXT	[13750]	[13761]	BMJ_2012_May_17_344_e2088_T65
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_67	[13710]	[15574]	['Caption (FIG)\n\nFig 3 Mean difference in gestational weight gain (kg) with dietary and lifestyle interventions in pregnancy\n\nCaption (TABLE-WRAP): TABLE 1 \n\nEffect of dietary and lifestyle interventions in pregnancy on primary outcomes (weight gain in pregnancy and birth weight) and secondary weight related outcomes ranked as critically important by Delphi survey (except for exceeding IOM recommendations)No of studiesNo of participantsSummary estimate (95% CI)P valueI2(%) Dietary intervention Weight gain in pregnancy (kg)1025-28 31-362560−3.84* (−5.22 to −2.45)<0.00192Birth weight (g)1026-28 30-362861−60* (−190 to 80)0.4184Small for gestational age328 30 3122521.02† (0.75 to 1.37)0.910Large for gestational age528 29 31 34 3523780.78† (0.51 to 1.19)0.2663Exceeds IOM recommendations0———— Physical activity Weight gain in pregnancy (kg)1437-39 42 43 45-48 50-541057−0.72* (−1.20 to −0.25)0.00330Birth weight (g)1437-40 42 44-50 52 531369−60* (−120 to −10)0.020Small for gestational age437 38 46 534091.28† (0.52 to 3.15)0.600Large for gestational age438 39 46 523550.52† (0.25 to 1.09)0.080Exceeds IOM recommendations146740.33† (0.11 to 0.98)0.05NA Mixed approach Weight gain in pregnancy (kg)107 56 59-63 65-671864−1.06* (−1.67 to −0.46)<0.00136Birth weight (g)757 59 61-63 65 66104810* (−50 to 70)0.860Small for gestational age458 63 65 668910.88† (0.53 to 1.44)0.600Large for gestational age957-59 61 62 63 65-6715001.05† (0.79 to 1.40)0.720Exceeds IOM recommendations461 63 65 668990.89† (0.71 to 1.13)0.3356 All interventions Weight gain in pregnancy (kg)345481−1.42* (−1.89 to −0.95)<0.00180Birth weight (g)315278−50* (−100 to 0)0.0857Small for gestational age1135521.00† (0.78 to 1.28)0.990Large for gestational age1842330.85† (0.66 to 1.09)0.2138Exceeds IOM recommendations58730.85† (0.66 to 1.11)0.2160\nIOM=Institute of Medicine; NA=not applicable.']	pregnancy	GO_BP_EXT	[13823]	[13832]	BMJ_2012_May_17_344_e2088_T66
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_67	[13710]	[15574]	['Caption (FIG)\n\nFig 3 Mean difference in gestational weight gain (kg) with dietary and lifestyle interventions in pregnancy\n\nCaption (TABLE-WRAP): TABLE 1 \n\nEffect of dietary and lifestyle interventions in pregnancy on primary outcomes (weight gain in pregnancy and birth weight) and secondary weight related outcomes ranked as critically important by Delphi survey (except for exceeding IOM recommendations)No of studiesNo of participantsSummary estimate (95% CI)P valueI2(%) Dietary intervention Weight gain in pregnancy (kg)1025-28 31-362560−3.84* (−5.22 to −2.45)<0.00192Birth weight (g)1026-28 30-362861−60* (−190 to 80)0.4184Small for gestational age328 30 3122521.02† (0.75 to 1.37)0.910Large for gestational age528 29 31 34 3523780.78† (0.51 to 1.19)0.2663Exceeds IOM recommendations0———— Physical activity Weight gain in pregnancy (kg)1437-39 42 43 45-48 50-541057−0.72* (−1.20 to −0.25)0.00330Birth weight (g)1437-40 42 44-50 52 531369−60* (−120 to −10)0.020Small for gestational age437 38 46 534091.28† (0.52 to 3.15)0.600Large for gestational age438 39 46 523550.52† (0.25 to 1.09)0.080Exceeds IOM recommendations146740.33† (0.11 to 0.98)0.05NA Mixed approach Weight gain in pregnancy (kg)107 56 59-63 65-671864−1.06* (−1.67 to −0.46)<0.00136Birth weight (g)757 59 61-63 65 66104810* (−50 to 70)0.860Small for gestational age458 63 65 668910.88† (0.53 to 1.44)0.600Large for gestational age957-59 61 62 63 65-6715001.05† (0.79 to 1.40)0.720Exceeds IOM recommendations461 63 65 668990.89† (0.71 to 1.13)0.3356 All interventions Weight gain in pregnancy (kg)345481−1.42* (−1.89 to −0.95)<0.00180Birth weight (g)315278−50* (−100 to 0)0.0857Small for gestational age1135521.00† (0.78 to 1.28)0.990Large for gestational age1842330.85† (0.66 to 1.09)0.2138Exceeds IOM recommendations58730.85† (0.66 to 1.11)0.2160\nIOM=Institute of Medicine; NA=not applicable.']	pregnancy	GO_BP_EXT	[13915]	[13924]	BMJ_2012_May_17_344_e2088_T67
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_67	[13710]	[15574]	['Caption (FIG)\n\nFig 3 Mean difference in gestational weight gain (kg) with dietary and lifestyle interventions in pregnancy\n\nCaption (TABLE-WRAP): TABLE 1 \n\nEffect of dietary and lifestyle interventions in pregnancy on primary outcomes (weight gain in pregnancy and birth weight) and secondary weight related outcomes ranked as critically important by Delphi survey (except for exceeding IOM recommendations)No of studiesNo of participantsSummary estimate (95% CI)P valueI2(%) Dietary intervention Weight gain in pregnancy (kg)1025-28 31-362560−3.84* (−5.22 to −2.45)<0.00192Birth weight (g)1026-28 30-362861−60* (−190 to 80)0.4184Small for gestational age328 30 3122521.02† (0.75 to 1.37)0.910Large for gestational age528 29 31 34 3523780.78† (0.51 to 1.19)0.2663Exceeds IOM recommendations0———— Physical activity Weight gain in pregnancy (kg)1437-39 42 43 45-48 50-541057−0.72* (−1.20 to −0.25)0.00330Birth weight (g)1437-40 42 44-50 52 531369−60* (−120 to −10)0.020Small for gestational age437 38 46 534091.28† (0.52 to 3.15)0.600Large for gestational age438 39 46 523550.52† (0.25 to 1.09)0.080Exceeds IOM recommendations146740.33† (0.11 to 0.98)0.05NA Mixed approach Weight gain in pregnancy (kg)107 56 59-63 65-671864−1.06* (−1.67 to −0.46)<0.00136Birth weight (g)757 59 61-63 65 66104810* (−50 to 70)0.860Small for gestational age458 63 65 668910.88† (0.53 to 1.44)0.600Large for gestational age957-59 61 62 63 65-6715001.05† (0.79 to 1.40)0.720Exceeds IOM recommendations461 63 65 668990.89† (0.71 to 1.13)0.3356 All interventions Weight gain in pregnancy (kg)345481−1.42* (−1.89 to −0.95)<0.00180Birth weight (g)315278−50* (−100 to 0)0.0857Small for gestational age1135521.00† (0.78 to 1.28)0.990Large for gestational age1842330.85† (0.66 to 1.09)0.2138Exceeds IOM recommendations58730.85† (0.66 to 1.11)0.2160\nIOM=Institute of Medicine; NA=not applicable.']	pregnancy	GO_BP_EXT	[13961]	[13970]	BMJ_2012_May_17_344_e2088_T68
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_67	[13710]	[15574]	['Caption (FIG)\n\nFig 3 Mean difference in gestational weight gain (kg) with dietary and lifestyle interventions in pregnancy\n\nCaption (TABLE-WRAP): TABLE 1 \n\nEffect of dietary and lifestyle interventions in pregnancy on primary outcomes (weight gain in pregnancy and birth weight) and secondary weight related outcomes ranked as critically important by Delphi survey (except for exceeding IOM recommendations)No of studiesNo of participantsSummary estimate (95% CI)P valueI2(%) Dietary intervention Weight gain in pregnancy (kg)1025-28 31-362560−3.84* (−5.22 to −2.45)<0.00192Birth weight (g)1026-28 30-362861−60* (−190 to 80)0.4184Small for gestational age328 30 3122521.02† (0.75 to 1.37)0.910Large for gestational age528 29 31 34 3523780.78† (0.51 to 1.19)0.2663Exceeds IOM recommendations0———— Physical activity Weight gain in pregnancy (kg)1437-39 42 43 45-48 50-541057−0.72* (−1.20 to −0.25)0.00330Birth weight (g)1437-40 42 44-50 52 531369−60* (−120 to −10)0.020Small for gestational age437 38 46 534091.28† (0.52 to 3.15)0.600Large for gestational age438 39 46 523550.52† (0.25 to 1.09)0.080Exceeds IOM recommendations146740.33† (0.11 to 0.98)0.05NA Mixed approach Weight gain in pregnancy (kg)107 56 59-63 65-671864−1.06* (−1.67 to −0.46)<0.00136Birth weight (g)757 59 61-63 65 66104810* (−50 to 70)0.860Small for gestational age458 63 65 668910.88† (0.53 to 1.44)0.600Large for gestational age957-59 61 62 63 65-6715001.05† (0.79 to 1.40)0.720Exceeds IOM recommendations461 63 65 668990.89† (0.71 to 1.13)0.3356 All interventions Weight gain in pregnancy (kg)345481−1.42* (−1.89 to −0.95)<0.00180Birth weight (g)315278−50* (−100 to 0)0.0857Small for gestational age1135521.00† (0.78 to 1.28)0.990Large for gestational age1842330.85† (0.66 to 1.09)0.2138Exceeds IOM recommendations58730.85† (0.66 to 1.11)0.2160\nIOM=Institute of Medicine; NA=not applicable.']	birth	GO_BP_EXT	[13975]	[13980]	BMJ_2012_May_17_344_e2088_T69
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_67	[13710]	[15574]	['Caption (FIG)\n\nFig 3 Mean difference in gestational weight gain (kg) with dietary and lifestyle interventions in pregnancy\n\nCaption (TABLE-WRAP): TABLE 1 \n\nEffect of dietary and lifestyle interventions in pregnancy on primary outcomes (weight gain in pregnancy and birth weight) and secondary weight related outcomes ranked as critically important by Delphi survey (except for exceeding IOM recommendations)No of studiesNo of participantsSummary estimate (95% CI)P valueI2(%) Dietary intervention Weight gain in pregnancy (kg)1025-28 31-362560−3.84* (−5.22 to −2.45)<0.00192Birth weight (g)1026-28 30-362861−60* (−190 to 80)0.4184Small for gestational age328 30 3122521.02† (0.75 to 1.37)0.910Large for gestational age528 29 31 34 3523780.78† (0.51 to 1.19)0.2663Exceeds IOM recommendations0———— Physical activity Weight gain in pregnancy (kg)1437-39 42 43 45-48 50-541057−0.72* (−1.20 to −0.25)0.00330Birth weight (g)1437-40 42 44-50 52 531369−60* (−120 to −10)0.020Small for gestational age437 38 46 534091.28† (0.52 to 3.15)0.600Large for gestational age438 39 46 523550.52† (0.25 to 1.09)0.080Exceeds IOM recommendations146740.33† (0.11 to 0.98)0.05NA Mixed approach Weight gain in pregnancy (kg)107 56 59-63 65-671864−1.06* (−1.67 to −0.46)<0.00136Birth weight (g)757 59 61-63 65 66104810* (−50 to 70)0.860Small for gestational age458 63 65 668910.88† (0.53 to 1.44)0.600Large for gestational age957-59 61 62 63 65-6715001.05† (0.79 to 1.40)0.720Exceeds IOM recommendations461 63 65 668990.89† (0.71 to 1.13)0.3356 All interventions Weight gain in pregnancy (kg)345481−1.42* (−1.89 to −0.95)<0.00180Birth weight (g)315278−50* (−100 to 0)0.0857Small for gestational age1135521.00† (0.78 to 1.28)0.990Large for gestational age1842330.85† (0.66 to 1.09)0.2138Exceeds IOM recommendations58730.85† (0.66 to 1.11)0.2160\nIOM=Institute of Medicine; NA=not applicable.']	pregnancy	GO_BP_EXT	[14222]	[14231]	BMJ_2012_May_17_344_e2088_T70
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_67	[13710]	[15574]	['Caption (FIG)\n\nFig 3 Mean difference in gestational weight gain (kg) with dietary and lifestyle interventions in pregnancy\n\nCaption (TABLE-WRAP): TABLE 1 \n\nEffect of dietary and lifestyle interventions in pregnancy on primary outcomes (weight gain in pregnancy and birth weight) and secondary weight related outcomes ranked as critically important by Delphi survey (except for exceeding IOM recommendations)No of studiesNo of participantsSummary estimate (95% CI)P valueI2(%) Dietary intervention Weight gain in pregnancy (kg)1025-28 31-362560−3.84* (−5.22 to −2.45)<0.00192Birth weight (g)1026-28 30-362861−60* (−190 to 80)0.4184Small for gestational age328 30 3122521.02† (0.75 to 1.37)0.910Large for gestational age528 29 31 34 3523780.78† (0.51 to 1.19)0.2663Exceeds IOM recommendations0———— Physical activity Weight gain in pregnancy (kg)1437-39 42 43 45-48 50-541057−0.72* (−1.20 to −0.25)0.00330Birth weight (g)1437-40 42 44-50 52 531369−60* (−120 to −10)0.020Small for gestational age437 38 46 534091.28† (0.52 to 3.15)0.600Large for gestational age438 39 46 523550.52† (0.25 to 1.09)0.080Exceeds IOM recommendations146740.33† (0.11 to 0.98)0.05NA Mixed approach Weight gain in pregnancy (kg)107 56 59-63 65-671864−1.06* (−1.67 to −0.46)<0.00136Birth weight (g)757 59 61-63 65 66104810* (−50 to 70)0.860Small for gestational age458 63 65 668910.88† (0.53 to 1.44)0.600Large for gestational age957-59 61 62 63 65-6715001.05† (0.79 to 1.40)0.720Exceeds IOM recommendations461 63 65 668990.89† (0.71 to 1.13)0.3356 All interventions Weight gain in pregnancy (kg)345481−1.42* (−1.89 to −0.95)<0.00180Birth weight (g)315278−50* (−100 to 0)0.0857Small for gestational age1135521.00† (0.78 to 1.28)0.990Large for gestational age1842330.85† (0.66 to 1.09)0.2138Exceeds IOM recommendations58730.85† (0.66 to 1.11)0.2160\nIOM=Institute of Medicine; NA=not applicable.']	gestational	GO_BP_EXT	[14350]	[14361]	BMJ_2012_May_17_344_e2088_T71
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_67	[13710]	[15574]	['Caption (FIG)\n\nFig 3 Mean difference in gestational weight gain (kg) with dietary and lifestyle interventions in pregnancy\n\nCaption (TABLE-WRAP): TABLE 1 \n\nEffect of dietary and lifestyle interventions in pregnancy on primary outcomes (weight gain in pregnancy and birth weight) and secondary weight related outcomes ranked as critically important by Delphi survey (except for exceeding IOM recommendations)No of studiesNo of participantsSummary estimate (95% CI)P valueI2(%) Dietary intervention Weight gain in pregnancy (kg)1025-28 31-362560−3.84* (−5.22 to −2.45)<0.00192Birth weight (g)1026-28 30-362861−60* (−190 to 80)0.4184Small for gestational age328 30 3122521.02† (0.75 to 1.37)0.910Large for gestational age528 29 31 34 3523780.78† (0.51 to 1.19)0.2663Exceeds IOM recommendations0———— Physical activity Weight gain in pregnancy (kg)1437-39 42 43 45-48 50-541057−0.72* (−1.20 to −0.25)0.00330Birth weight (g)1437-40 42 44-50 52 531369−60* (−120 to −10)0.020Small for gestational age437 38 46 534091.28† (0.52 to 3.15)0.600Large for gestational age438 39 46 523550.52† (0.25 to 1.09)0.080Exceeds IOM recommendations146740.33† (0.11 to 0.98)0.05NA Mixed approach Weight gain in pregnancy (kg)107 56 59-63 65-671864−1.06* (−1.67 to −0.46)<0.00136Birth weight (g)757 59 61-63 65 66104810* (−50 to 70)0.860Small for gestational age458 63 65 668910.88† (0.53 to 1.44)0.600Large for gestational age957-59 61 62 63 65-6715001.05† (0.79 to 1.40)0.720Exceeds IOM recommendations461 63 65 668990.89† (0.71 to 1.13)0.3356 All interventions Weight gain in pregnancy (kg)345481−1.42* (−1.89 to −0.95)<0.00180Birth weight (g)315278−50* (−100 to 0)0.0857Small for gestational age1135521.00† (0.78 to 1.28)0.990Large for gestational age1842330.85† (0.66 to 1.09)0.2138Exceeds IOM recommendations58730.85† (0.66 to 1.11)0.2160\nIOM=Institute of Medicine; NA=not applicable.']	gestational	GO_BP_EXT	[14413]	[14424]	BMJ_2012_May_17_344_e2088_T72
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_67	[13710]	[15574]	['Caption (FIG)\n\nFig 3 Mean difference in gestational weight gain (kg) with dietary and lifestyle interventions in pregnancy\n\nCaption (TABLE-WRAP): TABLE 1 \n\nEffect of dietary and lifestyle interventions in pregnancy on primary outcomes (weight gain in pregnancy and birth weight) and secondary weight related outcomes ranked as critically important by Delphi survey (except for exceeding IOM recommendations)No of studiesNo of participantsSummary estimate (95% CI)P valueI2(%) Dietary intervention Weight gain in pregnancy (kg)1025-28 31-362560−3.84* (−5.22 to −2.45)<0.00192Birth weight (g)1026-28 30-362861−60* (−190 to 80)0.4184Small for gestational age328 30 3122521.02† (0.75 to 1.37)0.910Large for gestational age528 29 31 34 3523780.78† (0.51 to 1.19)0.2663Exceeds IOM recommendations0———— Physical activity Weight gain in pregnancy (kg)1437-39 42 43 45-48 50-541057−0.72* (−1.20 to −0.25)0.00330Birth weight (g)1437-40 42 44-50 52 531369−60* (−120 to −10)0.020Small for gestational age437 38 46 534091.28† (0.52 to 3.15)0.600Large for gestational age438 39 46 523550.52† (0.25 to 1.09)0.080Exceeds IOM recommendations146740.33† (0.11 to 0.98)0.05NA Mixed approach Weight gain in pregnancy (kg)107 56 59-63 65-671864−1.06* (−1.67 to −0.46)<0.00136Birth weight (g)757 59 61-63 65 66104810* (−50 to 70)0.860Small for gestational age458 63 65 668910.88† (0.53 to 1.44)0.600Large for gestational age957-59 61 62 63 65-6715001.05† (0.79 to 1.40)0.720Exceeds IOM recommendations461 63 65 668990.89† (0.71 to 1.13)0.3356 All interventions Weight gain in pregnancy (kg)345481−1.42* (−1.89 to −0.95)<0.00180Birth weight (g)315278−50* (−100 to 0)0.0857Small for gestational age1135521.00† (0.78 to 1.28)0.990Large for gestational age1842330.85† (0.66 to 1.09)0.2138Exceeds IOM recommendations58730.85† (0.66 to 1.11)0.2160\nIOM=Institute of Medicine; NA=not applicable.']	pregnancy	GO_BP_EXT	[14539]	[14548]	BMJ_2012_May_17_344_e2088_T73
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_67	[13710]	[15574]	['Caption (FIG)\n\nFig 3 Mean difference in gestational weight gain (kg) with dietary and lifestyle interventions in pregnancy\n\nCaption (TABLE-WRAP): TABLE 1 \n\nEffect of dietary and lifestyle interventions in pregnancy on primary outcomes (weight gain in pregnancy and birth weight) and secondary weight related outcomes ranked as critically important by Delphi survey (except for exceeding IOM recommendations)No of studiesNo of participantsSummary estimate (95% CI)P valueI2(%) Dietary intervention Weight gain in pregnancy (kg)1025-28 31-362560−3.84* (−5.22 to −2.45)<0.00192Birth weight (g)1026-28 30-362861−60* (−190 to 80)0.4184Small for gestational age328 30 3122521.02† (0.75 to 1.37)0.910Large for gestational age528 29 31 34 3523780.78† (0.51 to 1.19)0.2663Exceeds IOM recommendations0———— Physical activity Weight gain in pregnancy (kg)1437-39 42 43 45-48 50-541057−0.72* (−1.20 to −0.25)0.00330Birth weight (g)1437-40 42 44-50 52 531369−60* (−120 to −10)0.020Small for gestational age437 38 46 534091.28† (0.52 to 3.15)0.600Large for gestational age438 39 46 523550.52† (0.25 to 1.09)0.080Exceeds IOM recommendations146740.33† (0.11 to 0.98)0.05NA Mixed approach Weight gain in pregnancy (kg)107 56 59-63 65-671864−1.06* (−1.67 to −0.46)<0.00136Birth weight (g)757 59 61-63 65 66104810* (−50 to 70)0.860Small for gestational age458 63 65 668910.88† (0.53 to 1.44)0.600Large for gestational age957-59 61 62 63 65-6715001.05† (0.79 to 1.40)0.720Exceeds IOM recommendations461 63 65 668990.89† (0.71 to 1.13)0.3356 All interventions Weight gain in pregnancy (kg)345481−1.42* (−1.89 to −0.95)<0.00180Birth weight (g)315278−50* (−100 to 0)0.0857Small for gestational age1135521.00† (0.78 to 1.28)0.990Large for gestational age1842330.85† (0.66 to 1.09)0.2138Exceeds IOM recommendations58730.85† (0.66 to 1.11)0.2160\nIOM=Institute of Medicine; NA=not applicable.']	gestational	GO_BP_EXT	[14687]	[14698]	BMJ_2012_May_17_344_e2088_T74
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_67	[13710]	[15574]	['Caption (FIG)\n\nFig 3 Mean difference in gestational weight gain (kg) with dietary and lifestyle interventions in pregnancy\n\nCaption (TABLE-WRAP): TABLE 1 \n\nEffect of dietary and lifestyle interventions in pregnancy on primary outcomes (weight gain in pregnancy and birth weight) and secondary weight related outcomes ranked as critically important by Delphi survey (except for exceeding IOM recommendations)No of studiesNo of participantsSummary estimate (95% CI)P valueI2(%) Dietary intervention Weight gain in pregnancy (kg)1025-28 31-362560−3.84* (−5.22 to −2.45)<0.00192Birth weight (g)1026-28 30-362861−60* (−190 to 80)0.4184Small for gestational age328 30 3122521.02† (0.75 to 1.37)0.910Large for gestational age528 29 31 34 3523780.78† (0.51 to 1.19)0.2663Exceeds IOM recommendations0———— Physical activity Weight gain in pregnancy (kg)1437-39 42 43 45-48 50-541057−0.72* (−1.20 to −0.25)0.00330Birth weight (g)1437-40 42 44-50 52 531369−60* (−120 to −10)0.020Small for gestational age437 38 46 534091.28† (0.52 to 3.15)0.600Large for gestational age438 39 46 523550.52† (0.25 to 1.09)0.080Exceeds IOM recommendations146740.33† (0.11 to 0.98)0.05NA Mixed approach Weight gain in pregnancy (kg)107 56 59-63 65-671864−1.06* (−1.67 to −0.46)<0.00136Birth weight (g)757 59 61-63 65 66104810* (−50 to 70)0.860Small for gestational age458 63 65 668910.88† (0.53 to 1.44)0.600Large for gestational age957-59 61 62 63 65-6715001.05† (0.79 to 1.40)0.720Exceeds IOM recommendations461 63 65 668990.89† (0.71 to 1.13)0.3356 All interventions Weight gain in pregnancy (kg)345481−1.42* (−1.89 to −0.95)<0.00180Birth weight (g)315278−50* (−100 to 0)0.0857Small for gestational age1135521.00† (0.78 to 1.28)0.990Large for gestational age1842330.85† (0.66 to 1.09)0.2138Exceeds IOM recommendations58730.85† (0.66 to 1.11)0.2160\nIOM=Institute of Medicine; NA=not applicable.']	gestational	GO_BP_EXT	[14752]	[14763]	BMJ_2012_May_17_344_e2088_T75
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_67	[13710]	[15574]	['Caption (FIG)\n\nFig 3 Mean difference in gestational weight gain (kg) with dietary and lifestyle interventions in pregnancy\n\nCaption (TABLE-WRAP): TABLE 1 \n\nEffect of dietary and lifestyle interventions in pregnancy on primary outcomes (weight gain in pregnancy and birth weight) and secondary weight related outcomes ranked as critically important by Delphi survey (except for exceeding IOM recommendations)No of studiesNo of participantsSummary estimate (95% CI)P valueI2(%) Dietary intervention Weight gain in pregnancy (kg)1025-28 31-362560−3.84* (−5.22 to −2.45)<0.00192Birth weight (g)1026-28 30-362861−60* (−190 to 80)0.4184Small for gestational age328 30 3122521.02† (0.75 to 1.37)0.910Large for gestational age528 29 31 34 3523780.78† (0.51 to 1.19)0.2663Exceeds IOM recommendations0———— Physical activity Weight gain in pregnancy (kg)1437-39 42 43 45-48 50-541057−0.72* (−1.20 to −0.25)0.00330Birth weight (g)1437-40 42 44-50 52 531369−60* (−120 to −10)0.020Small for gestational age437 38 46 534091.28† (0.52 to 3.15)0.600Large for gestational age438 39 46 523550.52† (0.25 to 1.09)0.080Exceeds IOM recommendations146740.33† (0.11 to 0.98)0.05NA Mixed approach Weight gain in pregnancy (kg)107 56 59-63 65-671864−1.06* (−1.67 to −0.46)<0.00136Birth weight (g)757 59 61-63 65 66104810* (−50 to 70)0.860Small for gestational age458 63 65 668910.88† (0.53 to 1.44)0.600Large for gestational age957-59 61 62 63 65-6715001.05† (0.79 to 1.40)0.720Exceeds IOM recommendations461 63 65 668990.89† (0.71 to 1.13)0.3356 All interventions Weight gain in pregnancy (kg)345481−1.42* (−1.89 to −0.95)<0.00180Birth weight (g)315278−50* (−100 to 0)0.0857Small for gestational age1135521.00† (0.78 to 1.28)0.990Large for gestational age1842330.85† (0.66 to 1.09)0.2138Exceeds IOM recommendations58730.85† (0.66 to 1.11)0.2160\nIOM=Institute of Medicine; NA=not applicable.']	pregnancy	GO_BP_EXT	[14896]	[14905]	BMJ_2012_May_17_344_e2088_T76
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_67	[13710]	[15574]	['Caption (FIG)\n\nFig 3 Mean difference in gestational weight gain (kg) with dietary and lifestyle interventions in pregnancy\n\nCaption (TABLE-WRAP): TABLE 1 \n\nEffect of dietary and lifestyle interventions in pregnancy on primary outcomes (weight gain in pregnancy and birth weight) and secondary weight related outcomes ranked as critically important by Delphi survey (except for exceeding IOM recommendations)No of studiesNo of participantsSummary estimate (95% CI)P valueI2(%) Dietary intervention Weight gain in pregnancy (kg)1025-28 31-362560−3.84* (−5.22 to −2.45)<0.00192Birth weight (g)1026-28 30-362861−60* (−190 to 80)0.4184Small for gestational age328 30 3122521.02† (0.75 to 1.37)0.910Large for gestational age528 29 31 34 3523780.78† (0.51 to 1.19)0.2663Exceeds IOM recommendations0———— Physical activity Weight gain in pregnancy (kg)1437-39 42 43 45-48 50-541057−0.72* (−1.20 to −0.25)0.00330Birth weight (g)1437-40 42 44-50 52 531369−60* (−120 to −10)0.020Small for gestational age437 38 46 534091.28† (0.52 to 3.15)0.600Large for gestational age438 39 46 523550.52† (0.25 to 1.09)0.080Exceeds IOM recommendations146740.33† (0.11 to 0.98)0.05NA Mixed approach Weight gain in pregnancy (kg)107 56 59-63 65-671864−1.06* (−1.67 to −0.46)<0.00136Birth weight (g)757 59 61-63 65 66104810* (−50 to 70)0.860Small for gestational age458 63 65 668910.88† (0.53 to 1.44)0.600Large for gestational age957-59 61 62 63 65-6715001.05† (0.79 to 1.40)0.720Exceeds IOM recommendations461 63 65 668990.89† (0.71 to 1.13)0.3356 All interventions Weight gain in pregnancy (kg)345481−1.42* (−1.89 to −0.95)<0.00180Birth weight (g)315278−50* (−100 to 0)0.0857Small for gestational age1135521.00† (0.78 to 1.28)0.990Large for gestational age1842330.85† (0.66 to 1.09)0.2138Exceeds IOM recommendations58730.85† (0.66 to 1.11)0.2160\nIOM=Institute of Medicine; NA=not applicable.']	gestational	GO_BP_EXT	[15031]	[15042]	BMJ_2012_May_17_344_e2088_T77
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_67	[13710]	[15574]	['Caption (FIG)\n\nFig 3 Mean difference in gestational weight gain (kg) with dietary and lifestyle interventions in pregnancy\n\nCaption (TABLE-WRAP): TABLE 1 \n\nEffect of dietary and lifestyle interventions in pregnancy on primary outcomes (weight gain in pregnancy and birth weight) and secondary weight related outcomes ranked as critically important by Delphi survey (except for exceeding IOM recommendations)No of studiesNo of participantsSummary estimate (95% CI)P valueI2(%) Dietary intervention Weight gain in pregnancy (kg)1025-28 31-362560−3.84* (−5.22 to −2.45)<0.00192Birth weight (g)1026-28 30-362861−60* (−190 to 80)0.4184Small for gestational age328 30 3122521.02† (0.75 to 1.37)0.910Large for gestational age528 29 31 34 3523780.78† (0.51 to 1.19)0.2663Exceeds IOM recommendations0———— Physical activity Weight gain in pregnancy (kg)1437-39 42 43 45-48 50-541057−0.72* (−1.20 to −0.25)0.00330Birth weight (g)1437-40 42 44-50 52 531369−60* (−120 to −10)0.020Small for gestational age437 38 46 534091.28† (0.52 to 3.15)0.600Large for gestational age438 39 46 523550.52† (0.25 to 1.09)0.080Exceeds IOM recommendations146740.33† (0.11 to 0.98)0.05NA Mixed approach Weight gain in pregnancy (kg)107 56 59-63 65-671864−1.06* (−1.67 to −0.46)<0.00136Birth weight (g)757 59 61-63 65 66104810* (−50 to 70)0.860Small for gestational age458 63 65 668910.88† (0.53 to 1.44)0.600Large for gestational age957-59 61 62 63 65-6715001.05† (0.79 to 1.40)0.720Exceeds IOM recommendations461 63 65 668990.89† (0.71 to 1.13)0.3356 All interventions Weight gain in pregnancy (kg)345481−1.42* (−1.89 to −0.95)<0.00180Birth weight (g)315278−50* (−100 to 0)0.0857Small for gestational age1135521.00† (0.78 to 1.28)0.990Large for gestational age1842330.85† (0.66 to 1.09)0.2138Exceeds IOM recommendations58730.85† (0.66 to 1.11)0.2160\nIOM=Institute of Medicine; NA=not applicable.']	gestational	GO_BP_EXT	[15096]	[15107]	BMJ_2012_May_17_344_e2088_T78
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_67	[13710]	[15574]	['Caption (FIG)\n\nFig 3 Mean difference in gestational weight gain (kg) with dietary and lifestyle interventions in pregnancy\n\nCaption (TABLE-WRAP): TABLE 1 \n\nEffect of dietary and lifestyle interventions in pregnancy on primary outcomes (weight gain in pregnancy and birth weight) and secondary weight related outcomes ranked as critically important by Delphi survey (except for exceeding IOM recommendations)No of studiesNo of participantsSummary estimate (95% CI)P valueI2(%) Dietary intervention Weight gain in pregnancy (kg)1025-28 31-362560−3.84* (−5.22 to −2.45)<0.00192Birth weight (g)1026-28 30-362861−60* (−190 to 80)0.4184Small for gestational age328 30 3122521.02† (0.75 to 1.37)0.910Large for gestational age528 29 31 34 3523780.78† (0.51 to 1.19)0.2663Exceeds IOM recommendations0———— Physical activity Weight gain in pregnancy (kg)1437-39 42 43 45-48 50-541057−0.72* (−1.20 to −0.25)0.00330Birth weight (g)1437-40 42 44-50 52 531369−60* (−120 to −10)0.020Small for gestational age437 38 46 534091.28† (0.52 to 3.15)0.600Large for gestational age438 39 46 523550.52† (0.25 to 1.09)0.080Exceeds IOM recommendations146740.33† (0.11 to 0.98)0.05NA Mixed approach Weight gain in pregnancy (kg)107 56 59-63 65-671864−1.06* (−1.67 to −0.46)<0.00136Birth weight (g)757 59 61-63 65 66104810* (−50 to 70)0.860Small for gestational age458 63 65 668910.88† (0.53 to 1.44)0.600Large for gestational age957-59 61 62 63 65-6715001.05† (0.79 to 1.40)0.720Exceeds IOM recommendations461 63 65 668990.89† (0.71 to 1.13)0.3356 All interventions Weight gain in pregnancy (kg)345481−1.42* (−1.89 to −0.95)<0.00180Birth weight (g)315278−50* (−100 to 0)0.0857Small for gestational age1135521.00† (0.78 to 1.28)0.990Large for gestational age1842330.85† (0.66 to 1.09)0.2138Exceeds IOM recommendations58730.85† (0.66 to 1.11)0.2160\nIOM=Institute of Medicine; NA=not applicable.']	pregnancy	GO_BP_EXT	[15263]	[15272]	BMJ_2012_May_17_344_e2088_T79
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_67	[13710]	[15574]	['Caption (FIG)\n\nFig 3 Mean difference in gestational weight gain (kg) with dietary and lifestyle interventions in pregnancy\n\nCaption (TABLE-WRAP): TABLE 1 \n\nEffect of dietary and lifestyle interventions in pregnancy on primary outcomes (weight gain in pregnancy and birth weight) and secondary weight related outcomes ranked as critically important by Delphi survey (except for exceeding IOM recommendations)No of studiesNo of participantsSummary estimate (95% CI)P valueI2(%) Dietary intervention Weight gain in pregnancy (kg)1025-28 31-362560−3.84* (−5.22 to −2.45)<0.00192Birth weight (g)1026-28 30-362861−60* (−190 to 80)0.4184Small for gestational age328 30 3122521.02† (0.75 to 1.37)0.910Large for gestational age528 29 31 34 3523780.78† (0.51 to 1.19)0.2663Exceeds IOM recommendations0———— Physical activity Weight gain in pregnancy (kg)1437-39 42 43 45-48 50-541057−0.72* (−1.20 to −0.25)0.00330Birth weight (g)1437-40 42 44-50 52 531369−60* (−120 to −10)0.020Small for gestational age437 38 46 534091.28† (0.52 to 3.15)0.600Large for gestational age438 39 46 523550.52† (0.25 to 1.09)0.080Exceeds IOM recommendations146740.33† (0.11 to 0.98)0.05NA Mixed approach Weight gain in pregnancy (kg)107 56 59-63 65-671864−1.06* (−1.67 to −0.46)<0.00136Birth weight (g)757 59 61-63 65 66104810* (−50 to 70)0.860Small for gestational age458 63 65 668910.88† (0.53 to 1.44)0.600Large for gestational age957-59 61 62 63 65-6715001.05† (0.79 to 1.40)0.720Exceeds IOM recommendations461 63 65 668990.89† (0.71 to 1.13)0.3356 All interventions Weight gain in pregnancy (kg)345481−1.42* (−1.89 to −0.95)<0.00180Birth weight (g)315278−50* (−100 to 0)0.0857Small for gestational age1135521.00† (0.78 to 1.28)0.990Large for gestational age1842330.85† (0.66 to 1.09)0.2138Exceeds IOM recommendations58730.85† (0.66 to 1.11)0.2160\nIOM=Institute of Medicine; NA=not applicable.']	gestational	GO_BP_EXT	[15368]	[15379]	BMJ_2012_May_17_344_e2088_T80
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_67	[13710]	[15574]	['Caption (FIG)\n\nFig 3 Mean difference in gestational weight gain (kg) with dietary and lifestyle interventions in pregnancy\n\nCaption (TABLE-WRAP): TABLE 1 \n\nEffect of dietary and lifestyle interventions in pregnancy on primary outcomes (weight gain in pregnancy and birth weight) and secondary weight related outcomes ranked as critically important by Delphi survey (except for exceeding IOM recommendations)No of studiesNo of participantsSummary estimate (95% CI)P valueI2(%) Dietary intervention Weight gain in pregnancy (kg)1025-28 31-362560−3.84* (−5.22 to −2.45)<0.00192Birth weight (g)1026-28 30-362861−60* (−190 to 80)0.4184Small for gestational age328 30 3122521.02† (0.75 to 1.37)0.910Large for gestational age528 29 31 34 3523780.78† (0.51 to 1.19)0.2663Exceeds IOM recommendations0———— Physical activity Weight gain in pregnancy (kg)1437-39 42 43 45-48 50-541057−0.72* (−1.20 to −0.25)0.00330Birth weight (g)1437-40 42 44-50 52 531369−60* (−120 to −10)0.020Small for gestational age437 38 46 534091.28† (0.52 to 3.15)0.600Large for gestational age438 39 46 523550.52† (0.25 to 1.09)0.080Exceeds IOM recommendations146740.33† (0.11 to 0.98)0.05NA Mixed approach Weight gain in pregnancy (kg)107 56 59-63 65-671864−1.06* (−1.67 to −0.46)<0.00136Birth weight (g)757 59 61-63 65 66104810* (−50 to 70)0.860Small for gestational age458 63 65 668910.88† (0.53 to 1.44)0.600Large for gestational age957-59 61 62 63 65-6715001.05† (0.79 to 1.40)0.720Exceeds IOM recommendations461 63 65 668990.89† (0.71 to 1.13)0.3356 All interventions Weight gain in pregnancy (kg)345481−1.42* (−1.89 to −0.95)<0.00180Birth weight (g)315278−50* (−100 to 0)0.0857Small for gestational age1135521.00† (0.78 to 1.28)0.990Large for gestational age1842330.85† (0.66 to 1.09)0.2138Exceeds IOM recommendations58730.85† (0.66 to 1.11)0.2160\nIOM=Institute of Medicine; NA=not applicable.']	gestational	GO_BP_EXT	[15424]	[15435]	BMJ_2012_May_17_344_e2088_T81
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_70	[15610]	[16011]	['Effect of intervention on fetal weight\nThirty one randomised trials (5278 newborns) evaluated the effect of the interventions on birth weight.26272830313233343536373839404244454647484950525357596162636566Compared with controls, there was minimal reduction in the birth weight that was not significant (mean difference −50 g, 95% confidence interval −100 to 0 g) for all interventions (table 1, fig 4).']	newborns	UBERON_EXT	[15684]	[15692]	BMJ_2012_May_17_344_e2088_T318
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_70	[15610]	[16011]	['Effect of intervention on fetal weight\nThirty one randomised trials (5278 newborns) evaluated the effect of the interventions on birth weight.26272830313233343536373839404244454647484950525357596162636566Compared with controls, there was minimal reduction in the birth weight that was not significant (mean difference −50 g, 95% confidence interval −100 to 0 g) for all interventions (table 1, fig 4).']	birth	GO_BP_EXT	[15739]	[15744]	BMJ_2012_May_17_344_e2088_T82
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_70	[15610]	[16011]	['Effect of intervention on fetal weight\nThirty one randomised trials (5278 newborns) evaluated the effect of the interventions on birth weight.26272830313233343536373839404244454647484950525357596162636566Compared with controls, there was minimal reduction in the birth weight that was not significant (mean difference −50 g, 95% confidence interval −100 to 0 g) for all interventions (table 1, fig 4).']	birth	GO_BP_EXT	[15873]	[15878]	BMJ_2012_May_17_344_e2088_T83
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_71	[16012]	[16216]	['There was a trend towards reduction in the risk of large for gestational age babies (defined as birth weight above the 90th centile or 4000 g) (relative risk 0.85, 0.66 to 1.09) with interventions (fig 5.']	gestational	GO_BP_EXT	[16073]	[16084]	BMJ_2012_May_17_344_e2088_T84
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_71	[16012]	[16216]	['There was a trend towards reduction in the risk of large for gestational age babies (defined as birth weight above the 90th centile or 4000 g) (relative risk 0.85, 0.66 to 1.09) with interventions (fig 5.']	babies	UBERON_EXT	[16089]	[16095]	BMJ_2012_May_17_344_e2088_T319
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_71	[16012]	[16216]	['There was a trend towards reduction in the risk of large for gestational age babies (defined as birth weight above the 90th centile or 4000 g) (relative risk 0.85, 0.66 to 1.09) with interventions (fig 5.']	birth	GO_BP_EXT	[16108]	[16113]	BMJ_2012_May_17_344_e2088_T85
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_72	[16217]	[16385]	['The risk of small for gestational age babies (defined as birth weight below the 10th centile or 2500 g) was not altered (1.00, 0.78 to 1.28) with interventions (fig 5).']	gestational	GO_BP_EXT	[16239]	[16250]	BMJ_2012_May_17_344_e2088_T86
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_72	[16217]	[16385]	['The risk of small for gestational age babies (defined as birth weight below the 10th centile or 2500 g) was not altered (1.00, 0.78 to 1.28) with interventions (fig 5).']	babies	UBERON_EXT	[16255]	[16261]	BMJ_2012_May_17_344_e2088_T320
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_72	[16217]	[16385]	['The risk of small for gestational age babies (defined as birth weight below the 10th centile or 2500 g) was not altered (1.00, 0.78 to 1.28) with interventions (fig 5).']	birth	GO_BP_EXT	[16274]	[16279]	BMJ_2012_May_17_344_e2088_T87
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_73	[16387]	[16958]	['Caption (FIG)\n\nFig 4 Mean difference in birth weight (g) with dietary and lifestyle interventions in pregnancy\n\nCaption (FIG)\n\nFig 5 Relative risk of effect on size for gestational age with dietary and lifestyle interventions in pregnancy\n\nEffect of intervention on obstetric maternal outcomes\nThirty six randomised trials (n=6543 women) studied the effect of interventions on obstetric maternal outcomes.242628293031323334353637383942444546474849505253545556575961626364656667Fig 5shows the summary of the effect of weight management interventions on pregnancy outcomes.']	birth	GO_BP_EXT	[16427]	[16432]	BMJ_2012_May_17_344_e2088_T88
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_73	[16387]	[16958]	['Caption (FIG)\n\nFig 4 Mean difference in birth weight (g) with dietary and lifestyle interventions in pregnancy\n\nCaption (FIG)\n\nFig 5 Relative risk of effect on size for gestational age with dietary and lifestyle interventions in pregnancy\n\nEffect of intervention on obstetric maternal outcomes\nThirty six randomised trials (n=6543 women) studied the effect of interventions on obstetric maternal outcomes.242628293031323334353637383942444546474849505253545556575961626364656667Fig 5shows the summary of the effect of weight management interventions on pregnancy outcomes.']	pregnancy	GO_BP_EXT	[16488]	[16497]	BMJ_2012_May_17_344_e2088_T89
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_73	[16387]	[16958]	['Caption (FIG)\n\nFig 4 Mean difference in birth weight (g) with dietary and lifestyle interventions in pregnancy\n\nCaption (FIG)\n\nFig 5 Relative risk of effect on size for gestational age with dietary and lifestyle interventions in pregnancy\n\nEffect of intervention on obstetric maternal outcomes\nThirty six randomised trials (n=6543 women) studied the effect of interventions on obstetric maternal outcomes.242628293031323334353637383942444546474849505253545556575961626364656667Fig 5shows the summary of the effect of weight management interventions on pregnancy outcomes.']	gestational	GO_BP_EXT	[16556]	[16567]	BMJ_2012_May_17_344_e2088_T90
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_73	[16387]	[16958]	['Caption (FIG)\n\nFig 4 Mean difference in birth weight (g) with dietary and lifestyle interventions in pregnancy\n\nCaption (FIG)\n\nFig 5 Relative risk of effect on size for gestational age with dietary and lifestyle interventions in pregnancy\n\nEffect of intervention on obstetric maternal outcomes\nThirty six randomised trials (n=6543 women) studied the effect of interventions on obstetric maternal outcomes.242628293031323334353637383942444546474849505253545556575961626364656667Fig 5shows the summary of the effect of weight management interventions on pregnancy outcomes.']	pregnancy	GO_BP_EXT	[16616]	[16625]	BMJ_2012_May_17_344_e2088_T91
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_73	[16387]	[16958]	['Caption (FIG)\n\nFig 4 Mean difference in birth weight (g) with dietary and lifestyle interventions in pregnancy\n\nCaption (FIG)\n\nFig 5 Relative risk of effect on size for gestational age with dietary and lifestyle interventions in pregnancy\n\nEffect of intervention on obstetric maternal outcomes\nThirty six randomised trials (n=6543 women) studied the effect of interventions on obstetric maternal outcomes.242628293031323334353637383942444546474849505253545556575961626364656667Fig 5shows the summary of the effect of weight management interventions on pregnancy outcomes.']	women	NCBITAXON_EXT	[16718]	[16723]	BMJ_2012_May_17_344_e2088_T256
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_73	[16387]	[16958]	['Caption (FIG)\n\nFig 4 Mean difference in birth weight (g) with dietary and lifestyle interventions in pregnancy\n\nCaption (FIG)\n\nFig 5 Relative risk of effect on size for gestational age with dietary and lifestyle interventions in pregnancy\n\nEffect of intervention on obstetric maternal outcomes\nThirty six randomised trials (n=6543 women) studied the effect of interventions on obstetric maternal outcomes.242628293031323334353637383942444546474849505253545556575961626364656667Fig 5shows the summary of the effect of weight management interventions on pregnancy outcomes.']	women	UBERON_EXT	[16718]	[16723]	BMJ_2012_May_17_344_e2088_T321
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_73	[16387]	[16958]	['Caption (FIG)\n\nFig 4 Mean difference in birth weight (g) with dietary and lifestyle interventions in pregnancy\n\nCaption (FIG)\n\nFig 5 Relative risk of effect on size for gestational age with dietary and lifestyle interventions in pregnancy\n\nEffect of intervention on obstetric maternal outcomes\nThirty six randomised trials (n=6543 women) studied the effect of interventions on obstetric maternal outcomes.242628293031323334353637383942444546474849505253545556575961626364656667Fig 5shows the summary of the effect of weight management interventions on pregnancy outcomes.']	pregnancy	GO_BP_EXT	[16939]	[16948]	BMJ_2012_May_17_344_e2088_T92
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_75	[17091]	[17322]	['The summary estimate of interventions showed trends towards reduction in gestational diabetes (0.78, 0.57 to 1.08), gestational hypertension (0.89, 0.64 to 1.25), and preterm delivery (0.78, 0.60 to 1.02) that were not significant.']	gestational	GO_BP_EXT	[17164]	[17175]	BMJ_2012_May_17_344_e2088_T93
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_75	[17091]	[17322]	['The summary estimate of interventions showed trends towards reduction in gestational diabetes (0.78, 0.57 to 1.08), gestational hypertension (0.89, 0.64 to 1.25), and preterm delivery (0.78, 0.60 to 1.02) that were not significant.']	gestational	GO_BP_EXT	[17207]	[17218]	BMJ_2012_May_17_344_e2088_T94
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_75	[17091]	[17322]	['The summary estimate of interventions showed trends towards reduction in gestational diabetes (0.78, 0.57 to 1.08), gestational hypertension (0.89, 0.64 to 1.25), and preterm delivery (0.78, 0.60 to 1.02) that were not significant.']	delivery	GO_BP_EXT	[17266]	[17274]	BMJ_2012_May_17_344_e2088_T95
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_76	[17323]	[17613]	['Meta-analysis of the studies showed no difference between the groups in gestational age at delivery (mean difference 0.02 weeks, −0.08 to 0.11 weeks) and rates of caesarean section (0.93, 0.85 to 1.01), induction of labour (1.12, 1 to 1.26), and postpartum haemorrhage (0.90, 0.57 to 1.42).']	gestational	GO_BP_EXT	[17395]	[17406]	BMJ_2012_May_17_344_e2088_T96
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_76	[17323]	[17613]	['Meta-analysis of the studies showed no difference between the groups in gestational age at delivery (mean difference 0.02 weeks, −0.08 to 0.11 weeks) and rates of caesarean section (0.93, 0.85 to 1.01), induction of labour (1.12, 1 to 1.26), and postpartum haemorrhage (0.90, 0.57 to 1.42).']	delivery	GO_BP_EXT	[17414]	[17422]	BMJ_2012_May_17_344_e2088_T97
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_76	[17323]	[17613]	['Meta-analysis of the studies showed no difference between the groups in gestational age at delivery (mean difference 0.02 weeks, −0.08 to 0.11 weeks) and rates of caesarean section (0.93, 0.85 to 1.01), induction of labour (1.12, 1 to 1.26), and postpartum haemorrhage (0.90, 0.57 to 1.42).']	labour	GO_BP_EXT	[17539]	[17545]	BMJ_2012_May_17_344_e2088_T98
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_76	[17323]	[17613]	['Meta-analysis of the studies showed no difference between the groups in gestational age at delivery (mean difference 0.02 weeks, −0.08 to 0.11 weeks) and rates of caesarean section (0.93, 0.85 to 1.01), induction of labour (1.12, 1 to 1.26), and postpartum haemorrhage (0.90, 0.57 to 1.42).']	postpartum	GO_BP_EXT	[17569]	[17579]	BMJ_2012_May_17_344_e2088_T99
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_77	[17615]	[17979]	['Caption (FIG)\n\nFig 6 Relative risk of effects of weight management interventions in pregnancy on maternal outcomes\nCompared with the control, dietary interventions in pregnancy were associated with a 33% reduced risk of pre-eclampsia (0.67, 0.53 to 0.85; P<0.001, I2=0%) and a 61% reduced risk of gestational diabetes (0.39, 0.23 to 0.69; P=0.001, I2=21%) (fig 6).']	pregnancy	GO_BP_EXT	[17699]	[17708]	BMJ_2012_May_17_344_e2088_T100
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_77	[17615]	[17979]	['Caption (FIG)\n\nFig 6 Relative risk of effects of weight management interventions in pregnancy on maternal outcomes\nCompared with the control, dietary interventions in pregnancy were associated with a 33% reduced risk of pre-eclampsia (0.67, 0.53 to 0.85; P<0.001, I2=0%) and a 61% reduced risk of gestational diabetes (0.39, 0.23 to 0.69; P=0.001, I2=21%) (fig 6).']	pregnancy	GO_BP_EXT	[17782]	[17791]	BMJ_2012_May_17_344_e2088_T101
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_77	[17615]	[17979]	['Caption (FIG)\n\nFig 6 Relative risk of effects of weight management interventions in pregnancy on maternal outcomes\nCompared with the control, dietary interventions in pregnancy were associated with a 33% reduced risk of pre-eclampsia (0.67, 0.53 to 0.85; P<0.001, I2=0%) and a 61% reduced risk of gestational diabetes (0.39, 0.23 to 0.69; P=0.001, I2=21%) (fig 6).']	gestational	GO_BP_EXT	[17912]	[17923]	BMJ_2012_May_17_344_e2088_T102
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_78	[17980]	[18167]	['They were also associated with a significant reduction in gestational hypertension (0.30, 0.10 to 0.88; P=0.03, I2=0%) and preterm delivery (0.68, 0.48 to 0.96; P=0.03, I2=35%) (table 2).']	gestational	GO_BP_EXT	[18038]	[18049]	BMJ_2012_May_17_344_e2088_T103
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_78	[17980]	[18167]	['They were also associated with a significant reduction in gestational hypertension (0.30, 0.10 to 0.88; P=0.03, I2=0%) and preterm delivery (0.68, 0.48 to 0.96; P=0.03, I2=35%) (table 2).']	delivery	GO_BP_EXT	[18111]	[18119]	BMJ_2012_May_17_344_e2088_T104
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_81	[18408]	[18567]	['There was some evidence for funnel asymmetry for pregnancy outcomes such as gestational diabetes (P=0.034) and caesarean section (P=0.002) and none for others.']	pregnancy	GO_BP_EXT	[18457]	[18466]	BMJ_2012_May_17_344_e2088_T105
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_81	[18408]	[18567]	['There was some evidence for funnel asymmetry for pregnancy outcomes such as gestational diabetes (P=0.034) and caesarean section (P=0.002) and none for others.']	gestational	GO_BP_EXT	[18484]	[18495]	BMJ_2012_May_17_344_e2088_T106
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_82	[18569]	[18798]	['Caption (TABLE-WRAP): TABLE 2\n\nEffect of dietary and lifestyle interventions in pregnancy on secondary maternal outcomes (ranked as critically important by Delphi survey, except for vaginal delivery and gestational age at birth).']	pregnancy	GO_BP_EXT	[18649]	[18658]	BMJ_2012_May_17_344_e2088_T107
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_82	[18569]	[18798]	['Caption (TABLE-WRAP): TABLE 2\n\nEffect of dietary and lifestyle interventions in pregnancy on secondary maternal outcomes (ranked as critically important by Delphi survey, except for vaginal delivery and gestational age at birth).']	vaginal	UBERON_EXT	[18751]	[18758]	BMJ_2012_May_17_344_e2088_T322
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_82	[18569]	[18798]	['Caption (TABLE-WRAP): TABLE 2\n\nEffect of dietary and lifestyle interventions in pregnancy on secondary maternal outcomes (ranked as critically important by Delphi survey, except for vaginal delivery and gestational age at birth).']	delivery	GO_BP_EXT	[18759]	[18767]	BMJ_2012_May_17_344_e2088_T108
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_82	[18569]	[18798]	['Caption (TABLE-WRAP): TABLE 2\n\nEffect of dietary and lifestyle interventions in pregnancy on secondary maternal outcomes (ranked as critically important by Delphi survey, except for vaginal delivery and gestational age at birth).']	gestational	GO_BP_EXT	[18772]	[18783]	BMJ_2012_May_17_344_e2088_T109
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_82	[18569]	[18798]	['Caption (TABLE-WRAP): TABLE 2\n\nEffect of dietary and lifestyle interventions in pregnancy on secondary maternal outcomes (ranked as critically important by Delphi survey, except for vaginal delivery and gestational age at birth).']	birth	GO_BP_EXT	[18791]	[18796]	BMJ_2012_May_17_344_e2088_T110
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_83	[18799]	[20927]	['Summary estimates are relative risks unless stated otherwiseNo of studiesNo of participantsSummary estimate (95% CI)P valueI2(%) Dietary intervention Gestational diabetes mellitus333 35 364090.39 (0.23 to 0.69)0.00121Pre-eclampsia628 30 31 34-3626240.67 (0.53 to 0.85)<0.0010Gestational hypertension235 362820.30 (0.10 to 0.88)0.030Preterm delivery426 30 31 3514740.68 (0.48 to 0.96)0.0335Caesarean section528 29 31 35 3622730.93 (0.84 to1.04)0.1949Vaginal delivery231 344720.97 0.89 to 1.07)0.560Induction of labour428 31 34 3522771.12 (0.99 to 1.27)0.0760Postpartum haemorrhage228 3512320.90 (0.57 to 1.42)0.640Gestational age at delivery (weeks)628 30-32 34 352625−0.05* (−0.18 to 0.08)0.4271 Physical activity Gestational diabetes mellitus0————Pre-eclampsia0————Gestational hypertension0————Preterm delivery537 38 46 52 534501.22 (0.51 to 2.90)0.650Caesarean section537 39 48-505420.88 (0.66 to 1.17)0.380Vaginal delivery337 39 494881.02 (0.93 to 1.11)0.700Induction of labour0————Postpartum haemorrhage0————Gestational age at delivery (weeks)1137-39 42 44-49 5412500.03* (−0.14 to 0.20)0.740 Mixed approach Gestational diabetes mellitus661 62 63 65-6712331.18 (0.78 to 1.77)0.440Pre-eclampsia459 63 65 667181.16 (0.70 to 1.90)0.5739Gestational hypertension459 63 65 667791.08 (0.75 to 1.55)0.6942Preterm delivery457 63 65 667280.90 (0.55 to 1.47)0.687Caesarean section856 57 59 61 63 65-6714070.94 (0.79 to 1.13)0.5310Vaginal delivery157341.25 (0.88 to 1.78)0.21NAInduction of labour159851.17 (0.78 to 1.75)0.44NAPostpartum haemorrhage0————Gestational age at delivery (weeks)657 59 61 62 65 668130.20* (−0.02 to 0.42)0.071 All interventions Gestational diabetes mellitus916420.78 (0.57 to 1.08)0.1329Pre-eclampsia1033420.74 (0.60 to 0.92)0.00631Gestational hypertension610610.89 (0.64 to 1.25)0.5150Preterm delivery1326520.78 (0.60 to 1.02)0.070Caesarean section1842220.93 (0.85 to 1.01)0.103Vaginal delivery69941.00 (0.94 to 1.07)0.910Induction of labour523621.12 (1.00 to 1.26)0.0547Postpartum haemorrhage212320.90 (0.57 to 1.42)0.640Gestational age at delivery (weeks)2346880.02* (−0.08 to 0.11)0.7233\nNA=not applicable.']	Gestational	GO_BP_EXT	[18949]	[18960]	BMJ_2012_May_17_344_e2088_T111
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_83	[18799]	[20927]	['Summary estimates are relative risks unless stated otherwiseNo of studiesNo of participantsSummary estimate (95% CI)P valueI2(%) Dietary intervention Gestational diabetes mellitus333 35 364090.39 (0.23 to 0.69)0.00121Pre-eclampsia628 30 31 34-3626240.67 (0.53 to 0.85)<0.0010Gestational hypertension235 362820.30 (0.10 to 0.88)0.030Preterm delivery426 30 31 3514740.68 (0.48 to 0.96)0.0335Caesarean section528 29 31 35 3622730.93 (0.84 to1.04)0.1949Vaginal delivery231 344720.97 0.89 to 1.07)0.560Induction of labour428 31 34 3522771.12 (0.99 to 1.27)0.0760Postpartum haemorrhage228 3512320.90 (0.57 to 1.42)0.640Gestational age at delivery (weeks)628 30-32 34 352625−0.05* (−0.18 to 0.08)0.4271 Physical activity Gestational diabetes mellitus0————Pre-eclampsia0————Gestational hypertension0————Preterm delivery537 38 46 52 534501.22 (0.51 to 2.90)0.650Caesarean section537 39 48-505420.88 (0.66 to 1.17)0.380Vaginal delivery337 39 494881.02 (0.93 to 1.11)0.700Induction of labour0————Postpartum haemorrhage0————Gestational age at delivery (weeks)1137-39 42 44-49 5412500.03* (−0.14 to 0.20)0.740 Mixed approach Gestational diabetes mellitus661 62 63 65-6712331.18 (0.78 to 1.77)0.440Pre-eclampsia459 63 65 667181.16 (0.70 to 1.90)0.5739Gestational hypertension459 63 65 667791.08 (0.75 to 1.55)0.6942Preterm delivery457 63 65 667280.90 (0.55 to 1.47)0.687Caesarean section856 57 59 61 63 65-6714070.94 (0.79 to 1.13)0.5310Vaginal delivery157341.25 (0.88 to 1.78)0.21NAInduction of labour159851.17 (0.78 to 1.75)0.44NAPostpartum haemorrhage0————Gestational age at delivery (weeks)657 59 61 62 65 668130.20* (−0.02 to 0.42)0.071 All interventions Gestational diabetes mellitus916420.78 (0.57 to 1.08)0.1329Pre-eclampsia1033420.74 (0.60 to 0.92)0.00631Gestational hypertension610610.89 (0.64 to 1.25)0.5150Preterm delivery1326520.78 (0.60 to 1.02)0.070Caesarean section1842220.93 (0.85 to 1.01)0.103Vaginal delivery69941.00 (0.94 to 1.07)0.910Induction of labour523621.12 (1.00 to 1.26)0.0547Postpartum haemorrhage212320.90 (0.57 to 1.42)0.640Gestational age at delivery (weeks)2346880.02* (−0.08 to 0.11)0.7233\nNA=not applicable.']	delivery426	GO_BP_EXT	[19139]	[19150]	BMJ_2012_May_17_344_e2088_T112
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_83	[18799]	[20927]	['Summary estimates are relative risks unless stated otherwiseNo of studiesNo of participantsSummary estimate (95% CI)P valueI2(%) Dietary intervention Gestational diabetes mellitus333 35 364090.39 (0.23 to 0.69)0.00121Pre-eclampsia628 30 31 34-3626240.67 (0.53 to 0.85)<0.0010Gestational hypertension235 362820.30 (0.10 to 0.88)0.030Preterm delivery426 30 31 3514740.68 (0.48 to 0.96)0.0335Caesarean section528 29 31 35 3622730.93 (0.84 to1.04)0.1949Vaginal delivery231 344720.97 0.89 to 1.07)0.560Induction of labour428 31 34 3522771.12 (0.99 to 1.27)0.0760Postpartum haemorrhage228 3512320.90 (0.57 to 1.42)0.640Gestational age at delivery (weeks)628 30-32 34 352625−0.05* (−0.18 to 0.08)0.4271 Physical activity Gestational diabetes mellitus0————Pre-eclampsia0————Gestational hypertension0————Preterm delivery537 38 46 52 534501.22 (0.51 to 2.90)0.650Caesarean section537 39 48-505420.88 (0.66 to 1.17)0.380Vaginal delivery337 39 494881.02 (0.93 to 1.11)0.700Induction of labour0————Postpartum haemorrhage0————Gestational age at delivery (weeks)1137-39 42 44-49 5412500.03* (−0.14 to 0.20)0.740 Mixed approach Gestational diabetes mellitus661 62 63 65-6712331.18 (0.78 to 1.77)0.440Pre-eclampsia459 63 65 667181.16 (0.70 to 1.90)0.5739Gestational hypertension459 63 65 667791.08 (0.75 to 1.55)0.6942Preterm delivery457 63 65 667280.90 (0.55 to 1.47)0.687Caesarean section856 57 59 61 63 65-6714070.94 (0.79 to 1.13)0.5310Vaginal delivery157341.25 (0.88 to 1.78)0.21NAInduction of labour159851.17 (0.78 to 1.75)0.44NAPostpartum haemorrhage0————Gestational age at delivery (weeks)657 59 61 62 65 668130.20* (−0.02 to 0.42)0.071 All interventions Gestational diabetes mellitus916420.78 (0.57 to 1.08)0.1329Pre-eclampsia1033420.74 (0.60 to 0.92)0.00631Gestational hypertension610610.89 (0.64 to 1.25)0.5150Preterm delivery1326520.78 (0.60 to 1.02)0.070Caesarean section1842220.93 (0.85 to 1.01)0.103Vaginal delivery69941.00 (0.94 to 1.07)0.910Induction of labour523621.12 (1.00 to 1.26)0.0547Postpartum haemorrhage212320.90 (0.57 to 1.42)0.640Gestational age at delivery (weeks)2346880.02* (−0.08 to 0.11)0.7233\nNA=not applicable.']	delivery231	GO_BP_EXT	[19256]	[19267]	BMJ_2012_May_17_344_e2088_T113
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_83	[18799]	[20927]	['Summary estimates are relative risks unless stated otherwiseNo of studiesNo of participantsSummary estimate (95% CI)P valueI2(%) Dietary intervention Gestational diabetes mellitus333 35 364090.39 (0.23 to 0.69)0.00121Pre-eclampsia628 30 31 34-3626240.67 (0.53 to 0.85)<0.0010Gestational hypertension235 362820.30 (0.10 to 0.88)0.030Preterm delivery426 30 31 3514740.68 (0.48 to 0.96)0.0335Caesarean section528 29 31 35 3622730.93 (0.84 to1.04)0.1949Vaginal delivery231 344720.97 0.89 to 1.07)0.560Induction of labour428 31 34 3522771.12 (0.99 to 1.27)0.0760Postpartum haemorrhage228 3512320.90 (0.57 to 1.42)0.640Gestational age at delivery (weeks)628 30-32 34 352625−0.05* (−0.18 to 0.08)0.4271 Physical activity Gestational diabetes mellitus0————Pre-eclampsia0————Gestational hypertension0————Preterm delivery537 38 46 52 534501.22 (0.51 to 2.90)0.650Caesarean section537 39 48-505420.88 (0.66 to 1.17)0.380Vaginal delivery337 39 494881.02 (0.93 to 1.11)0.700Induction of labour0————Postpartum haemorrhage0————Gestational age at delivery (weeks)1137-39 42 44-49 5412500.03* (−0.14 to 0.20)0.740 Mixed approach Gestational diabetes mellitus661 62 63 65-6712331.18 (0.78 to 1.77)0.440Pre-eclampsia459 63 65 667181.16 (0.70 to 1.90)0.5739Gestational hypertension459 63 65 667791.08 (0.75 to 1.55)0.6942Preterm delivery457 63 65 667280.90 (0.55 to 1.47)0.687Caesarean section856 57 59 61 63 65-6714070.94 (0.79 to 1.13)0.5310Vaginal delivery157341.25 (0.88 to 1.78)0.21NAInduction of labour159851.17 (0.78 to 1.75)0.44NAPostpartum haemorrhage0————Gestational age at delivery (weeks)657 59 61 62 65 668130.20* (−0.02 to 0.42)0.071 All interventions Gestational diabetes mellitus916420.78 (0.57 to 1.08)0.1329Pre-eclampsia1033420.74 (0.60 to 0.92)0.00631Gestational hypertension610610.89 (0.64 to 1.25)0.5150Preterm delivery1326520.78 (0.60 to 1.02)0.070Caesarean section1842220.93 (0.85 to 1.01)0.103Vaginal delivery69941.00 (0.94 to 1.07)0.910Induction of labour523621.12 (1.00 to 1.26)0.0547Postpartum haemorrhage212320.90 (0.57 to 1.42)0.640Gestational age at delivery (weeks)2346880.02* (−0.08 to 0.11)0.7233\nNA=not applicable.']	delivery	GO_BP_EXT	[19431]	[19439]	BMJ_2012_May_17_344_e2088_T114
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_83	[18799]	[20927]	['Summary estimates are relative risks unless stated otherwiseNo of studiesNo of participantsSummary estimate (95% CI)P valueI2(%) Dietary intervention Gestational diabetes mellitus333 35 364090.39 (0.23 to 0.69)0.00121Pre-eclampsia628 30 31 34-3626240.67 (0.53 to 0.85)<0.0010Gestational hypertension235 362820.30 (0.10 to 0.88)0.030Preterm delivery426 30 31 3514740.68 (0.48 to 0.96)0.0335Caesarean section528 29 31 35 3622730.93 (0.84 to1.04)0.1949Vaginal delivery231 344720.97 0.89 to 1.07)0.560Induction of labour428 31 34 3522771.12 (0.99 to 1.27)0.0760Postpartum haemorrhage228 3512320.90 (0.57 to 1.42)0.640Gestational age at delivery (weeks)628 30-32 34 352625−0.05* (−0.18 to 0.08)0.4271 Physical activity Gestational diabetes mellitus0————Pre-eclampsia0————Gestational hypertension0————Preterm delivery537 38 46 52 534501.22 (0.51 to 2.90)0.650Caesarean section537 39 48-505420.88 (0.66 to 1.17)0.380Vaginal delivery337 39 494881.02 (0.93 to 1.11)0.700Induction of labour0————Postpartum haemorrhage0————Gestational age at delivery (weeks)1137-39 42 44-49 5412500.03* (−0.14 to 0.20)0.740 Mixed approach Gestational diabetes mellitus661 62 63 65-6712331.18 (0.78 to 1.77)0.440Pre-eclampsia459 63 65 667181.16 (0.70 to 1.90)0.5739Gestational hypertension459 63 65 667791.08 (0.75 to 1.55)0.6942Preterm delivery457 63 65 667280.90 (0.55 to 1.47)0.687Caesarean section856 57 59 61 63 65-6714070.94 (0.79 to 1.13)0.5310Vaginal delivery157341.25 (0.88 to 1.78)0.21NAInduction of labour159851.17 (0.78 to 1.75)0.44NAPostpartum haemorrhage0————Gestational age at delivery (weeks)657 59 61 62 65 668130.20* (−0.02 to 0.42)0.071 All interventions Gestational diabetes mellitus916420.78 (0.57 to 1.08)0.1329Pre-eclampsia1033420.74 (0.60 to 0.92)0.00631Gestational hypertension610610.89 (0.64 to 1.25)0.5150Preterm delivery1326520.78 (0.60 to 1.02)0.070Caesarean section1842220.93 (0.85 to 1.01)0.103Vaginal delivery69941.00 (0.94 to 1.07)0.910Induction of labour523621.12 (1.00 to 1.26)0.0547Postpartum haemorrhage212320.90 (0.57 to 1.42)0.640Gestational age at delivery (weeks)2346880.02* (−0.08 to 0.11)0.7233\nNA=not applicable.']	Gestational	GO_BP_EXT	[19513]	[19524]	BMJ_2012_May_17_344_e2088_T115
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_83	[18799]	[20927]	['Summary estimates are relative risks unless stated otherwiseNo of studiesNo of participantsSummary estimate (95% CI)P valueI2(%) Dietary intervention Gestational diabetes mellitus333 35 364090.39 (0.23 to 0.69)0.00121Pre-eclampsia628 30 31 34-3626240.67 (0.53 to 0.85)<0.0010Gestational hypertension235 362820.30 (0.10 to 0.88)0.030Preterm delivery426 30 31 3514740.68 (0.48 to 0.96)0.0335Caesarean section528 29 31 35 3622730.93 (0.84 to1.04)0.1949Vaginal delivery231 344720.97 0.89 to 1.07)0.560Induction of labour428 31 34 3522771.12 (0.99 to 1.27)0.0760Postpartum haemorrhage228 3512320.90 (0.57 to 1.42)0.640Gestational age at delivery (weeks)628 30-32 34 352625−0.05* (−0.18 to 0.08)0.4271 Physical activity Gestational diabetes mellitus0————Pre-eclampsia0————Gestational hypertension0————Preterm delivery537 38 46 52 534501.22 (0.51 to 2.90)0.650Caesarean section537 39 48-505420.88 (0.66 to 1.17)0.380Vaginal delivery337 39 494881.02 (0.93 to 1.11)0.700Induction of labour0————Postpartum haemorrhage0————Gestational age at delivery (weeks)1137-39 42 44-49 5412500.03* (−0.14 to 0.20)0.740 Mixed approach Gestational diabetes mellitus661 62 63 65-6712331.18 (0.78 to 1.77)0.440Pre-eclampsia459 63 65 667181.16 (0.70 to 1.90)0.5739Gestational hypertension459 63 65 667791.08 (0.75 to 1.55)0.6942Preterm delivery457 63 65 667280.90 (0.55 to 1.47)0.687Caesarean section856 57 59 61 63 65-6714070.94 (0.79 to 1.13)0.5310Vaginal delivery157341.25 (0.88 to 1.78)0.21NAInduction of labour159851.17 (0.78 to 1.75)0.44NAPostpartum haemorrhage0————Gestational age at delivery (weeks)657 59 61 62 65 668130.20* (−0.02 to 0.42)0.071 All interventions Gestational diabetes mellitus916420.78 (0.57 to 1.08)0.1329Pre-eclampsia1033420.74 (0.60 to 0.92)0.00631Gestational hypertension610610.89 (0.64 to 1.25)0.5150Preterm delivery1326520.78 (0.60 to 1.02)0.070Caesarean section1842220.93 (0.85 to 1.01)0.103Vaginal delivery69941.00 (0.94 to 1.07)0.910Induction of labour523621.12 (1.00 to 1.26)0.0547Postpartum haemorrhage212320.90 (0.57 to 1.42)0.640Gestational age at delivery (weeks)2346880.02* (−0.08 to 0.11)0.7233\nNA=not applicable.']	Gestational	GO_BP_EXT	[19565]	[19576]	BMJ_2012_May_17_344_e2088_T116
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_83	[18799]	[20927]	['Summary estimates are relative risks unless stated otherwiseNo of studiesNo of participantsSummary estimate (95% CI)P valueI2(%) Dietary intervention Gestational diabetes mellitus333 35 364090.39 (0.23 to 0.69)0.00121Pre-eclampsia628 30 31 34-3626240.67 (0.53 to 0.85)<0.0010Gestational hypertension235 362820.30 (0.10 to 0.88)0.030Preterm delivery426 30 31 3514740.68 (0.48 to 0.96)0.0335Caesarean section528 29 31 35 3622730.93 (0.84 to1.04)0.1949Vaginal delivery231 344720.97 0.89 to 1.07)0.560Induction of labour428 31 34 3522771.12 (0.99 to 1.27)0.0760Postpartum haemorrhage228 3512320.90 (0.57 to 1.42)0.640Gestational age at delivery (weeks)628 30-32 34 352625−0.05* (−0.18 to 0.08)0.4271 Physical activity Gestational diabetes mellitus0————Pre-eclampsia0————Gestational hypertension0————Preterm delivery537 38 46 52 534501.22 (0.51 to 2.90)0.650Caesarean section537 39 48-505420.88 (0.66 to 1.17)0.380Vaginal delivery337 39 494881.02 (0.93 to 1.11)0.700Induction of labour0————Postpartum haemorrhage0————Gestational age at delivery (weeks)1137-39 42 44-49 5412500.03* (−0.14 to 0.20)0.740 Mixed approach Gestational diabetes mellitus661 62 63 65-6712331.18 (0.78 to 1.77)0.440Pre-eclampsia459 63 65 667181.16 (0.70 to 1.90)0.5739Gestational hypertension459 63 65 667791.08 (0.75 to 1.55)0.6942Preterm delivery457 63 65 667280.90 (0.55 to 1.47)0.687Caesarean section856 57 59 61 63 65-6714070.94 (0.79 to 1.13)0.5310Vaginal delivery157341.25 (0.88 to 1.78)0.21NAInduction of labour159851.17 (0.78 to 1.75)0.44NAPostpartum haemorrhage0————Gestational age at delivery (weeks)657 59 61 62 65 668130.20* (−0.02 to 0.42)0.071 All interventions Gestational diabetes mellitus916420.78 (0.57 to 1.08)0.1329Pre-eclampsia1033420.74 (0.60 to 0.92)0.00631Gestational hypertension610610.89 (0.64 to 1.25)0.5150Preterm delivery1326520.78 (0.60 to 1.02)0.070Caesarean section1842220.93 (0.85 to 1.01)0.103Vaginal delivery69941.00 (0.94 to 1.07)0.910Induction of labour523621.12 (1.00 to 1.26)0.0547Postpartum haemorrhage212320.90 (0.57 to 1.42)0.640Gestational age at delivery (weeks)2346880.02* (−0.08 to 0.11)0.7233\nNA=not applicable.']	delivery537	GO_BP_EXT	[19602]	[19613]	BMJ_2012_May_17_344_e2088_T117
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_83	[18799]	[20927]	['Summary estimates are relative risks unless stated otherwiseNo of studiesNo of participantsSummary estimate (95% CI)P valueI2(%) Dietary intervention Gestational diabetes mellitus333 35 364090.39 (0.23 to 0.69)0.00121Pre-eclampsia628 30 31 34-3626240.67 (0.53 to 0.85)<0.0010Gestational hypertension235 362820.30 (0.10 to 0.88)0.030Preterm delivery426 30 31 3514740.68 (0.48 to 0.96)0.0335Caesarean section528 29 31 35 3622730.93 (0.84 to1.04)0.1949Vaginal delivery231 344720.97 0.89 to 1.07)0.560Induction of labour428 31 34 3522771.12 (0.99 to 1.27)0.0760Postpartum haemorrhage228 3512320.90 (0.57 to 1.42)0.640Gestational age at delivery (weeks)628 30-32 34 352625−0.05* (−0.18 to 0.08)0.4271 Physical activity Gestational diabetes mellitus0————Pre-eclampsia0————Gestational hypertension0————Preterm delivery537 38 46 52 534501.22 (0.51 to 2.90)0.650Caesarean section537 39 48-505420.88 (0.66 to 1.17)0.380Vaginal delivery337 39 494881.02 (0.93 to 1.11)0.700Induction of labour0————Postpartum haemorrhage0————Gestational age at delivery (weeks)1137-39 42 44-49 5412500.03* (−0.14 to 0.20)0.740 Mixed approach Gestational diabetes mellitus661 62 63 65-6712331.18 (0.78 to 1.77)0.440Pre-eclampsia459 63 65 667181.16 (0.70 to 1.90)0.5739Gestational hypertension459 63 65 667791.08 (0.75 to 1.55)0.6942Preterm delivery457 63 65 667280.90 (0.55 to 1.47)0.687Caesarean section856 57 59 61 63 65-6714070.94 (0.79 to 1.13)0.5310Vaginal delivery157341.25 (0.88 to 1.78)0.21NAInduction of labour159851.17 (0.78 to 1.75)0.44NAPostpartum haemorrhage0————Gestational age at delivery (weeks)657 59 61 62 65 668130.20* (−0.02 to 0.42)0.071 All interventions Gestational diabetes mellitus916420.78 (0.57 to 1.08)0.1329Pre-eclampsia1033420.74 (0.60 to 0.92)0.00631Gestational hypertension610610.89 (0.64 to 1.25)0.5150Preterm delivery1326520.78 (0.60 to 1.02)0.070Caesarean section1842220.93 (0.85 to 1.01)0.103Vaginal delivery69941.00 (0.94 to 1.07)0.910Induction of labour523621.12 (1.00 to 1.26)0.0547Postpartum haemorrhage212320.90 (0.57 to 1.42)0.640Gestational age at delivery (weeks)2346880.02* (−0.08 to 0.11)0.7233\nNA=not applicable.']	delivery337	GO_BP_EXT	[19716]	[19727]	BMJ_2012_May_17_344_e2088_T118
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_83	[18799]	[20927]	['Summary estimates are relative risks unless stated otherwiseNo of studiesNo of participantsSummary estimate (95% CI)P valueI2(%) Dietary intervention Gestational diabetes mellitus333 35 364090.39 (0.23 to 0.69)0.00121Pre-eclampsia628 30 31 34-3626240.67 (0.53 to 0.85)<0.0010Gestational hypertension235 362820.30 (0.10 to 0.88)0.030Preterm delivery426 30 31 3514740.68 (0.48 to 0.96)0.0335Caesarean section528 29 31 35 3622730.93 (0.84 to1.04)0.1949Vaginal delivery231 344720.97 0.89 to 1.07)0.560Induction of labour428 31 34 3522771.12 (0.99 to 1.27)0.0760Postpartum haemorrhage228 3512320.90 (0.57 to 1.42)0.640Gestational age at delivery (weeks)628 30-32 34 352625−0.05* (−0.18 to 0.08)0.4271 Physical activity Gestational diabetes mellitus0————Pre-eclampsia0————Gestational hypertension0————Preterm delivery537 38 46 52 534501.22 (0.51 to 2.90)0.650Caesarean section537 39 48-505420.88 (0.66 to 1.17)0.380Vaginal delivery337 39 494881.02 (0.93 to 1.11)0.700Induction of labour0————Postpartum haemorrhage0————Gestational age at delivery (weeks)1137-39 42 44-49 5412500.03* (−0.14 to 0.20)0.740 Mixed approach Gestational diabetes mellitus661 62 63 65-6712331.18 (0.78 to 1.77)0.440Pre-eclampsia459 63 65 667181.16 (0.70 to 1.90)0.5739Gestational hypertension459 63 65 667791.08 (0.75 to 1.55)0.6942Preterm delivery457 63 65 667280.90 (0.55 to 1.47)0.687Caesarean section856 57 59 61 63 65-6714070.94 (0.79 to 1.13)0.5310Vaginal delivery157341.25 (0.88 to 1.78)0.21NAInduction of labour159851.17 (0.78 to 1.75)0.44NAPostpartum haemorrhage0————Gestational age at delivery (weeks)657 59 61 62 65 668130.20* (−0.02 to 0.42)0.071 All interventions Gestational diabetes mellitus916420.78 (0.57 to 1.08)0.1329Pre-eclampsia1033420.74 (0.60 to 0.92)0.00631Gestational hypertension610610.89 (0.64 to 1.25)0.5150Preterm delivery1326520.78 (0.60 to 1.02)0.070Caesarean section1842220.93 (0.85 to 1.01)0.103Vaginal delivery69941.00 (0.94 to 1.07)0.910Induction of labour523621.12 (1.00 to 1.26)0.0547Postpartum haemorrhage212320.90 (0.57 to 1.42)0.640Gestational age at delivery (weeks)2346880.02* (−0.08 to 0.11)0.7233\nNA=not applicable.']	Postpartum	GO_BP_EXT	[19784]	[19794]	BMJ_2012_May_17_344_e2088_T119
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_83	[18799]	[20927]	['Summary estimates are relative risks unless stated otherwiseNo of studiesNo of participantsSummary estimate (95% CI)P valueI2(%) Dietary intervention Gestational diabetes mellitus333 35 364090.39 (0.23 to 0.69)0.00121Pre-eclampsia628 30 31 34-3626240.67 (0.53 to 0.85)<0.0010Gestational hypertension235 362820.30 (0.10 to 0.88)0.030Preterm delivery426 30 31 3514740.68 (0.48 to 0.96)0.0335Caesarean section528 29 31 35 3622730.93 (0.84 to1.04)0.1949Vaginal delivery231 344720.97 0.89 to 1.07)0.560Induction of labour428 31 34 3522771.12 (0.99 to 1.27)0.0760Postpartum haemorrhage228 3512320.90 (0.57 to 1.42)0.640Gestational age at delivery (weeks)628 30-32 34 352625−0.05* (−0.18 to 0.08)0.4271 Physical activity Gestational diabetes mellitus0————Pre-eclampsia0————Gestational hypertension0————Preterm delivery537 38 46 52 534501.22 (0.51 to 2.90)0.650Caesarean section537 39 48-505420.88 (0.66 to 1.17)0.380Vaginal delivery337 39 494881.02 (0.93 to 1.11)0.700Induction of labour0————Postpartum haemorrhage0————Gestational age at delivery (weeks)1137-39 42 44-49 5412500.03* (−0.14 to 0.20)0.740 Mixed approach Gestational diabetes mellitus661 62 63 65-6712331.18 (0.78 to 1.77)0.440Pre-eclampsia459 63 65 667181.16 (0.70 to 1.90)0.5739Gestational hypertension459 63 65 667791.08 (0.75 to 1.55)0.6942Preterm delivery457 63 65 667280.90 (0.55 to 1.47)0.687Caesarean section856 57 59 61 63 65-6714070.94 (0.79 to 1.13)0.5310Vaginal delivery157341.25 (0.88 to 1.78)0.21NAInduction of labour159851.17 (0.78 to 1.75)0.44NAPostpartum haemorrhage0————Gestational age at delivery (weeks)657 59 61 62 65 668130.20* (−0.02 to 0.42)0.071 All interventions Gestational diabetes mellitus916420.78 (0.57 to 1.08)0.1329Pre-eclampsia1033420.74 (0.60 to 0.92)0.00631Gestational hypertension610610.89 (0.64 to 1.25)0.5150Preterm delivery1326520.78 (0.60 to 1.02)0.070Caesarean section1842220.93 (0.85 to 1.01)0.103Vaginal delivery69941.00 (0.94 to 1.07)0.910Induction of labour523621.12 (1.00 to 1.26)0.0547Postpartum haemorrhage212320.90 (0.57 to 1.42)0.640Gestational age at delivery (weeks)2346880.02* (−0.08 to 0.11)0.7233\nNA=not applicable.']	Gestational	GO_BP_EXT	[19811]	[19822]	BMJ_2012_May_17_344_e2088_T120
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_83	[18799]	[20927]	['Summary estimates are relative risks unless stated otherwiseNo of studiesNo of participantsSummary estimate (95% CI)P valueI2(%) Dietary intervention Gestational diabetes mellitus333 35 364090.39 (0.23 to 0.69)0.00121Pre-eclampsia628 30 31 34-3626240.67 (0.53 to 0.85)<0.0010Gestational hypertension235 362820.30 (0.10 to 0.88)0.030Preterm delivery426 30 31 3514740.68 (0.48 to 0.96)0.0335Caesarean section528 29 31 35 3622730.93 (0.84 to1.04)0.1949Vaginal delivery231 344720.97 0.89 to 1.07)0.560Induction of labour428 31 34 3522771.12 (0.99 to 1.27)0.0760Postpartum haemorrhage228 3512320.90 (0.57 to 1.42)0.640Gestational age at delivery (weeks)628 30-32 34 352625−0.05* (−0.18 to 0.08)0.4271 Physical activity Gestational diabetes mellitus0————Pre-eclampsia0————Gestational hypertension0————Preterm delivery537 38 46 52 534501.22 (0.51 to 2.90)0.650Caesarean section537 39 48-505420.88 (0.66 to 1.17)0.380Vaginal delivery337 39 494881.02 (0.93 to 1.11)0.700Induction of labour0————Postpartum haemorrhage0————Gestational age at delivery (weeks)1137-39 42 44-49 5412500.03* (−0.14 to 0.20)0.740 Mixed approach Gestational diabetes mellitus661 62 63 65-6712331.18 (0.78 to 1.77)0.440Pre-eclampsia459 63 65 667181.16 (0.70 to 1.90)0.5739Gestational hypertension459 63 65 667791.08 (0.75 to 1.55)0.6942Preterm delivery457 63 65 667280.90 (0.55 to 1.47)0.687Caesarean section856 57 59 61 63 65-6714070.94 (0.79 to 1.13)0.5310Vaginal delivery157341.25 (0.88 to 1.78)0.21NAInduction of labour159851.17 (0.78 to 1.75)0.44NAPostpartum haemorrhage0————Gestational age at delivery (weeks)657 59 61 62 65 668130.20* (−0.02 to 0.42)0.071 All interventions Gestational diabetes mellitus916420.78 (0.57 to 1.08)0.1329Pre-eclampsia1033420.74 (0.60 to 0.92)0.00631Gestational hypertension610610.89 (0.64 to 1.25)0.5150Preterm delivery1326520.78 (0.60 to 1.02)0.070Caesarean section1842220.93 (0.85 to 1.01)0.103Vaginal delivery69941.00 (0.94 to 1.07)0.910Induction of labour523621.12 (1.00 to 1.26)0.0547Postpartum haemorrhage212320.90 (0.57 to 1.42)0.640Gestational age at delivery (weeks)2346880.02* (−0.08 to 0.11)0.7233\nNA=not applicable.']	delivery	GO_BP_EXT	[19830]	[19838]	BMJ_2012_May_17_344_e2088_T121
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_83	[18799]	[20927]	['Summary estimates are relative risks unless stated otherwiseNo of studiesNo of participantsSummary estimate (95% CI)P valueI2(%) Dietary intervention Gestational diabetes mellitus333 35 364090.39 (0.23 to 0.69)0.00121Pre-eclampsia628 30 31 34-3626240.67 (0.53 to 0.85)<0.0010Gestational hypertension235 362820.30 (0.10 to 0.88)0.030Preterm delivery426 30 31 3514740.68 (0.48 to 0.96)0.0335Caesarean section528 29 31 35 3622730.93 (0.84 to1.04)0.1949Vaginal delivery231 344720.97 0.89 to 1.07)0.560Induction of labour428 31 34 3522771.12 (0.99 to 1.27)0.0760Postpartum haemorrhage228 3512320.90 (0.57 to 1.42)0.640Gestational age at delivery (weeks)628 30-32 34 352625−0.05* (−0.18 to 0.08)0.4271 Physical activity Gestational diabetes mellitus0————Pre-eclampsia0————Gestational hypertension0————Preterm delivery537 38 46 52 534501.22 (0.51 to 2.90)0.650Caesarean section537 39 48-505420.88 (0.66 to 1.17)0.380Vaginal delivery337 39 494881.02 (0.93 to 1.11)0.700Induction of labour0————Postpartum haemorrhage0————Gestational age at delivery (weeks)1137-39 42 44-49 5412500.03* (−0.14 to 0.20)0.740 Mixed approach Gestational diabetes mellitus661 62 63 65-6712331.18 (0.78 to 1.77)0.440Pre-eclampsia459 63 65 667181.16 (0.70 to 1.90)0.5739Gestational hypertension459 63 65 667791.08 (0.75 to 1.55)0.6942Preterm delivery457 63 65 667280.90 (0.55 to 1.47)0.687Caesarean section856 57 59 61 63 65-6714070.94 (0.79 to 1.13)0.5310Vaginal delivery157341.25 (0.88 to 1.78)0.21NAInduction of labour159851.17 (0.78 to 1.75)0.44NAPostpartum haemorrhage0————Gestational age at delivery (weeks)657 59 61 62 65 668130.20* (−0.02 to 0.42)0.071 All interventions Gestational diabetes mellitus916420.78 (0.57 to 1.08)0.1329Pre-eclampsia1033420.74 (0.60 to 0.92)0.00631Gestational hypertension610610.89 (0.64 to 1.25)0.5150Preterm delivery1326520.78 (0.60 to 1.02)0.070Caesarean section1842220.93 (0.85 to 1.01)0.103Vaginal delivery69941.00 (0.94 to 1.07)0.910Induction of labour523621.12 (1.00 to 1.26)0.0547Postpartum haemorrhage212320.90 (0.57 to 1.42)0.640Gestational age at delivery (weeks)2346880.02* (−0.08 to 0.11)0.7233\nNA=not applicable.']	Gestational	GO_BP_EXT	[19911]	[19922]	BMJ_2012_May_17_344_e2088_T122
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_83	[18799]	[20927]	['Summary estimates are relative risks unless stated otherwiseNo of studiesNo of participantsSummary estimate (95% CI)P valueI2(%) Dietary intervention Gestational diabetes mellitus333 35 364090.39 (0.23 to 0.69)0.00121Pre-eclampsia628 30 31 34-3626240.67 (0.53 to 0.85)<0.0010Gestational hypertension235 362820.30 (0.10 to 0.88)0.030Preterm delivery426 30 31 3514740.68 (0.48 to 0.96)0.0335Caesarean section528 29 31 35 3622730.93 (0.84 to1.04)0.1949Vaginal delivery231 344720.97 0.89 to 1.07)0.560Induction of labour428 31 34 3522771.12 (0.99 to 1.27)0.0760Postpartum haemorrhage228 3512320.90 (0.57 to 1.42)0.640Gestational age at delivery (weeks)628 30-32 34 352625−0.05* (−0.18 to 0.08)0.4271 Physical activity Gestational diabetes mellitus0————Pre-eclampsia0————Gestational hypertension0————Preterm delivery537 38 46 52 534501.22 (0.51 to 2.90)0.650Caesarean section537 39 48-505420.88 (0.66 to 1.17)0.380Vaginal delivery337 39 494881.02 (0.93 to 1.11)0.700Induction of labour0————Postpartum haemorrhage0————Gestational age at delivery (weeks)1137-39 42 44-49 5412500.03* (−0.14 to 0.20)0.740 Mixed approach Gestational diabetes mellitus661 62 63 65-6712331.18 (0.78 to 1.77)0.440Pre-eclampsia459 63 65 667181.16 (0.70 to 1.90)0.5739Gestational hypertension459 63 65 667791.08 (0.75 to 1.55)0.6942Preterm delivery457 63 65 667280.90 (0.55 to 1.47)0.687Caesarean section856 57 59 61 63 65-6714070.94 (0.79 to 1.13)0.5310Vaginal delivery157341.25 (0.88 to 1.78)0.21NAInduction of labour159851.17 (0.78 to 1.75)0.44NAPostpartum haemorrhage0————Gestational age at delivery (weeks)657 59 61 62 65 668130.20* (−0.02 to 0.42)0.071 All interventions Gestational diabetes mellitus916420.78 (0.57 to 1.08)0.1329Pre-eclampsia1033420.74 (0.60 to 0.92)0.00631Gestational hypertension610610.89 (0.64 to 1.25)0.5150Preterm delivery1326520.78 (0.60 to 1.02)0.070Caesarean section1842220.93 (0.85 to 1.01)0.103Vaginal delivery69941.00 (0.94 to 1.07)0.910Induction of labour523621.12 (1.00 to 1.26)0.0547Postpartum haemorrhage212320.90 (0.57 to 1.42)0.640Gestational age at delivery (weeks)2346880.02* (−0.08 to 0.11)0.7233\nNA=not applicable.']	delivery157341	GO_BP_EXT	[20230]	[20244]	BMJ_2012_May_17_344_e2088_T123
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_83	[18799]	[20927]	['Summary estimates are relative risks unless stated otherwiseNo of studiesNo of participantsSummary estimate (95% CI)P valueI2(%) Dietary intervention Gestational diabetes mellitus333 35 364090.39 (0.23 to 0.69)0.00121Pre-eclampsia628 30 31 34-3626240.67 (0.53 to 0.85)<0.0010Gestational hypertension235 362820.30 (0.10 to 0.88)0.030Preterm delivery426 30 31 3514740.68 (0.48 to 0.96)0.0335Caesarean section528 29 31 35 3622730.93 (0.84 to1.04)0.1949Vaginal delivery231 344720.97 0.89 to 1.07)0.560Induction of labour428 31 34 3522771.12 (0.99 to 1.27)0.0760Postpartum haemorrhage228 3512320.90 (0.57 to 1.42)0.640Gestational age at delivery (weeks)628 30-32 34 352625−0.05* (−0.18 to 0.08)0.4271 Physical activity Gestational diabetes mellitus0————Pre-eclampsia0————Gestational hypertension0————Preterm delivery537 38 46 52 534501.22 (0.51 to 2.90)0.650Caesarean section537 39 48-505420.88 (0.66 to 1.17)0.380Vaginal delivery337 39 494881.02 (0.93 to 1.11)0.700Induction of labour0————Postpartum haemorrhage0————Gestational age at delivery (weeks)1137-39 42 44-49 5412500.03* (−0.14 to 0.20)0.740 Mixed approach Gestational diabetes mellitus661 62 63 65-6712331.18 (0.78 to 1.77)0.440Pre-eclampsia459 63 65 667181.16 (0.70 to 1.90)0.5739Gestational hypertension459 63 65 667791.08 (0.75 to 1.55)0.6942Preterm delivery457 63 65 667280.90 (0.55 to 1.47)0.687Caesarean section856 57 59 61 63 65-6714070.94 (0.79 to 1.13)0.5310Vaginal delivery157341.25 (0.88 to 1.78)0.21NAInduction of labour159851.17 (0.78 to 1.75)0.44NAPostpartum haemorrhage0————Gestational age at delivery (weeks)657 59 61 62 65 668130.20* (−0.02 to 0.42)0.071 All interventions Gestational diabetes mellitus916420.78 (0.57 to 1.08)0.1329Pre-eclampsia1033420.74 (0.60 to 0.92)0.00631Gestational hypertension610610.89 (0.64 to 1.25)0.5150Preterm delivery1326520.78 (0.60 to 1.02)0.070Caesarean section1842220.93 (0.85 to 1.01)0.103Vaginal delivery69941.00 (0.94 to 1.07)0.910Induction of labour523621.12 (1.00 to 1.26)0.0547Postpartum haemorrhage212320.90 (0.57 to 1.42)0.640Gestational age at delivery (weeks)2346880.02* (−0.08 to 0.11)0.7233\nNA=not applicable.']	labour159851	GO_BP_EXT	[20281]	[20293]	BMJ_2012_May_17_344_e2088_T124
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_83	[18799]	[20927]	['Summary estimates are relative risks unless stated otherwiseNo of studiesNo of participantsSummary estimate (95% CI)P valueI2(%) Dietary intervention Gestational diabetes mellitus333 35 364090.39 (0.23 to 0.69)0.00121Pre-eclampsia628 30 31 34-3626240.67 (0.53 to 0.85)<0.0010Gestational hypertension235 362820.30 (0.10 to 0.88)0.030Preterm delivery426 30 31 3514740.68 (0.48 to 0.96)0.0335Caesarean section528 29 31 35 3622730.93 (0.84 to1.04)0.1949Vaginal delivery231 344720.97 0.89 to 1.07)0.560Induction of labour428 31 34 3522771.12 (0.99 to 1.27)0.0760Postpartum haemorrhage228 3512320.90 (0.57 to 1.42)0.640Gestational age at delivery (weeks)628 30-32 34 352625−0.05* (−0.18 to 0.08)0.4271 Physical activity Gestational diabetes mellitus0————Pre-eclampsia0————Gestational hypertension0————Preterm delivery537 38 46 52 534501.22 (0.51 to 2.90)0.650Caesarean section537 39 48-505420.88 (0.66 to 1.17)0.380Vaginal delivery337 39 494881.02 (0.93 to 1.11)0.700Induction of labour0————Postpartum haemorrhage0————Gestational age at delivery (weeks)1137-39 42 44-49 5412500.03* (−0.14 to 0.20)0.740 Mixed approach Gestational diabetes mellitus661 62 63 65-6712331.18 (0.78 to 1.77)0.440Pre-eclampsia459 63 65 667181.16 (0.70 to 1.90)0.5739Gestational hypertension459 63 65 667791.08 (0.75 to 1.55)0.6942Preterm delivery457 63 65 667280.90 (0.55 to 1.47)0.687Caesarean section856 57 59 61 63 65-6714070.94 (0.79 to 1.13)0.5310Vaginal delivery157341.25 (0.88 to 1.78)0.21NAInduction of labour159851.17 (0.78 to 1.75)0.44NAPostpartum haemorrhage0————Gestational age at delivery (weeks)657 59 61 62 65 668130.20* (−0.02 to 0.42)0.071 All interventions Gestational diabetes mellitus916420.78 (0.57 to 1.08)0.1329Pre-eclampsia1033420.74 (0.60 to 0.92)0.00631Gestational hypertension610610.89 (0.64 to 1.25)0.5150Preterm delivery1326520.78 (0.60 to 1.02)0.070Caesarean section1842220.93 (0.85 to 1.01)0.103Vaginal delivery69941.00 (0.94 to 1.07)0.910Induction of labour523621.12 (1.00 to 1.26)0.0547Postpartum haemorrhage212320.90 (0.57 to 1.42)0.640Gestational age at delivery (weeks)2346880.02* (−0.08 to 0.11)0.7233\nNA=not applicable.']	Gestational	GO_BP_EXT	[20344]	[20355]	BMJ_2012_May_17_344_e2088_T125
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_83	[18799]	[20927]	['Summary estimates are relative risks unless stated otherwiseNo of studiesNo of participantsSummary estimate (95% CI)P valueI2(%) Dietary intervention Gestational diabetes mellitus333 35 364090.39 (0.23 to 0.69)0.00121Pre-eclampsia628 30 31 34-3626240.67 (0.53 to 0.85)<0.0010Gestational hypertension235 362820.30 (0.10 to 0.88)0.030Preterm delivery426 30 31 3514740.68 (0.48 to 0.96)0.0335Caesarean section528 29 31 35 3622730.93 (0.84 to1.04)0.1949Vaginal delivery231 344720.97 0.89 to 1.07)0.560Induction of labour428 31 34 3522771.12 (0.99 to 1.27)0.0760Postpartum haemorrhage228 3512320.90 (0.57 to 1.42)0.640Gestational age at delivery (weeks)628 30-32 34 352625−0.05* (−0.18 to 0.08)0.4271 Physical activity Gestational diabetes mellitus0————Pre-eclampsia0————Gestational hypertension0————Preterm delivery537 38 46 52 534501.22 (0.51 to 2.90)0.650Caesarean section537 39 48-505420.88 (0.66 to 1.17)0.380Vaginal delivery337 39 494881.02 (0.93 to 1.11)0.700Induction of labour0————Postpartum haemorrhage0————Gestational age at delivery (weeks)1137-39 42 44-49 5412500.03* (−0.14 to 0.20)0.740 Mixed approach Gestational diabetes mellitus661 62 63 65-6712331.18 (0.78 to 1.77)0.440Pre-eclampsia459 63 65 667181.16 (0.70 to 1.90)0.5739Gestational hypertension459 63 65 667791.08 (0.75 to 1.55)0.6942Preterm delivery457 63 65 667280.90 (0.55 to 1.47)0.687Caesarean section856 57 59 61 63 65-6714070.94 (0.79 to 1.13)0.5310Vaginal delivery157341.25 (0.88 to 1.78)0.21NAInduction of labour159851.17 (0.78 to 1.75)0.44NAPostpartum haemorrhage0————Gestational age at delivery (weeks)657 59 61 62 65 668130.20* (−0.02 to 0.42)0.071 All interventions Gestational diabetes mellitus916420.78 (0.57 to 1.08)0.1329Pre-eclampsia1033420.74 (0.60 to 0.92)0.00631Gestational hypertension610610.89 (0.64 to 1.25)0.5150Preterm delivery1326520.78 (0.60 to 1.02)0.070Caesarean section1842220.93 (0.85 to 1.01)0.103Vaginal delivery69941.00 (0.94 to 1.07)0.910Induction of labour523621.12 (1.00 to 1.26)0.0547Postpartum haemorrhage212320.90 (0.57 to 1.42)0.640Gestational age at delivery (weeks)2346880.02* (−0.08 to 0.11)0.7233\nNA=not applicable.']	delivery	GO_BP_EXT	[20363]	[20371]	BMJ_2012_May_17_344_e2088_T126
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_83	[18799]	[20927]	['Summary estimates are relative risks unless stated otherwiseNo of studiesNo of participantsSummary estimate (95% CI)P valueI2(%) Dietary intervention Gestational diabetes mellitus333 35 364090.39 (0.23 to 0.69)0.00121Pre-eclampsia628 30 31 34-3626240.67 (0.53 to 0.85)<0.0010Gestational hypertension235 362820.30 (0.10 to 0.88)0.030Preterm delivery426 30 31 3514740.68 (0.48 to 0.96)0.0335Caesarean section528 29 31 35 3622730.93 (0.84 to1.04)0.1949Vaginal delivery231 344720.97 0.89 to 1.07)0.560Induction of labour428 31 34 3522771.12 (0.99 to 1.27)0.0760Postpartum haemorrhage228 3512320.90 (0.57 to 1.42)0.640Gestational age at delivery (weeks)628 30-32 34 352625−0.05* (−0.18 to 0.08)0.4271 Physical activity Gestational diabetes mellitus0————Pre-eclampsia0————Gestational hypertension0————Preterm delivery537 38 46 52 534501.22 (0.51 to 2.90)0.650Caesarean section537 39 48-505420.88 (0.66 to 1.17)0.380Vaginal delivery337 39 494881.02 (0.93 to 1.11)0.700Induction of labour0————Postpartum haemorrhage0————Gestational age at delivery (weeks)1137-39 42 44-49 5412500.03* (−0.14 to 0.20)0.740 Mixed approach Gestational diabetes mellitus661 62 63 65-6712331.18 (0.78 to 1.77)0.440Pre-eclampsia459 63 65 667181.16 (0.70 to 1.90)0.5739Gestational hypertension459 63 65 667791.08 (0.75 to 1.55)0.6942Preterm delivery457 63 65 667280.90 (0.55 to 1.47)0.687Caesarean section856 57 59 61 63 65-6714070.94 (0.79 to 1.13)0.5310Vaginal delivery157341.25 (0.88 to 1.78)0.21NAInduction of labour159851.17 (0.78 to 1.75)0.44NAPostpartum haemorrhage0————Gestational age at delivery (weeks)657 59 61 62 65 668130.20* (−0.02 to 0.42)0.071 All interventions Gestational diabetes mellitus916420.78 (0.57 to 1.08)0.1329Pre-eclampsia1033420.74 (0.60 to 0.92)0.00631Gestational hypertension610610.89 (0.64 to 1.25)0.5150Preterm delivery1326520.78 (0.60 to 1.02)0.070Caesarean section1842220.93 (0.85 to 1.01)0.103Vaginal delivery69941.00 (0.94 to 1.07)0.910Induction of labour523621.12 (1.00 to 1.26)0.0547Postpartum haemorrhage212320.90 (0.57 to 1.42)0.640Gestational age at delivery (weeks)2346880.02* (−0.08 to 0.11)0.7233\nNA=not applicable.']	Gestational	GO_BP_EXT	[20445]	[20456]	BMJ_2012_May_17_344_e2088_T127
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_83	[18799]	[20927]	['Summary estimates are relative risks unless stated otherwiseNo of studiesNo of participantsSummary estimate (95% CI)P valueI2(%) Dietary intervention Gestational diabetes mellitus333 35 364090.39 (0.23 to 0.69)0.00121Pre-eclampsia628 30 31 34-3626240.67 (0.53 to 0.85)<0.0010Gestational hypertension235 362820.30 (0.10 to 0.88)0.030Preterm delivery426 30 31 3514740.68 (0.48 to 0.96)0.0335Caesarean section528 29 31 35 3622730.93 (0.84 to1.04)0.1949Vaginal delivery231 344720.97 0.89 to 1.07)0.560Induction of labour428 31 34 3522771.12 (0.99 to 1.27)0.0760Postpartum haemorrhage228 3512320.90 (0.57 to 1.42)0.640Gestational age at delivery (weeks)628 30-32 34 352625−0.05* (−0.18 to 0.08)0.4271 Physical activity Gestational diabetes mellitus0————Pre-eclampsia0————Gestational hypertension0————Preterm delivery537 38 46 52 534501.22 (0.51 to 2.90)0.650Caesarean section537 39 48-505420.88 (0.66 to 1.17)0.380Vaginal delivery337 39 494881.02 (0.93 to 1.11)0.700Induction of labour0————Postpartum haemorrhage0————Gestational age at delivery (weeks)1137-39 42 44-49 5412500.03* (−0.14 to 0.20)0.740 Mixed approach Gestational diabetes mellitus661 62 63 65-6712331.18 (0.78 to 1.77)0.440Pre-eclampsia459 63 65 667181.16 (0.70 to 1.90)0.5739Gestational hypertension459 63 65 667791.08 (0.75 to 1.55)0.6942Preterm delivery457 63 65 667280.90 (0.55 to 1.47)0.687Caesarean section856 57 59 61 63 65-6714070.94 (0.79 to 1.13)0.5310Vaginal delivery157341.25 (0.88 to 1.78)0.21NAInduction of labour159851.17 (0.78 to 1.75)0.44NAPostpartum haemorrhage0————Gestational age at delivery (weeks)657 59 61 62 65 668130.20* (−0.02 to 0.42)0.071 All interventions Gestational diabetes mellitus916420.78 (0.57 to 1.08)0.1329Pre-eclampsia1033420.74 (0.60 to 0.92)0.00631Gestational hypertension610610.89 (0.64 to 1.25)0.5150Preterm delivery1326520.78 (0.60 to 1.02)0.070Caesarean section1842220.93 (0.85 to 1.01)0.103Vaginal delivery69941.00 (0.94 to 1.07)0.910Induction of labour523621.12 (1.00 to 1.26)0.0547Postpartum haemorrhage212320.90 (0.57 to 1.42)0.640Gestational age at delivery (weeks)2346880.02* (−0.08 to 0.11)0.7233\nNA=not applicable.']	delivery1326520	GO_BP_EXT	[20611]	[20626]	BMJ_2012_May_17_344_e2088_T128
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_83	[18799]	[20927]	['Summary estimates are relative risks unless stated otherwiseNo of studiesNo of participantsSummary estimate (95% CI)P valueI2(%) Dietary intervention Gestational diabetes mellitus333 35 364090.39 (0.23 to 0.69)0.00121Pre-eclampsia628 30 31 34-3626240.67 (0.53 to 0.85)<0.0010Gestational hypertension235 362820.30 (0.10 to 0.88)0.030Preterm delivery426 30 31 3514740.68 (0.48 to 0.96)0.0335Caesarean section528 29 31 35 3622730.93 (0.84 to1.04)0.1949Vaginal delivery231 344720.97 0.89 to 1.07)0.560Induction of labour428 31 34 3522771.12 (0.99 to 1.27)0.0760Postpartum haemorrhage228 3512320.90 (0.57 to 1.42)0.640Gestational age at delivery (weeks)628 30-32 34 352625−0.05* (−0.18 to 0.08)0.4271 Physical activity Gestational diabetes mellitus0————Pre-eclampsia0————Gestational hypertension0————Preterm delivery537 38 46 52 534501.22 (0.51 to 2.90)0.650Caesarean section537 39 48-505420.88 (0.66 to 1.17)0.380Vaginal delivery337 39 494881.02 (0.93 to 1.11)0.700Induction of labour0————Postpartum haemorrhage0————Gestational age at delivery (weeks)1137-39 42 44-49 5412500.03* (−0.14 to 0.20)0.740 Mixed approach Gestational diabetes mellitus661 62 63 65-6712331.18 (0.78 to 1.77)0.440Pre-eclampsia459 63 65 667181.16 (0.70 to 1.90)0.5739Gestational hypertension459 63 65 667791.08 (0.75 to 1.55)0.6942Preterm delivery457 63 65 667280.90 (0.55 to 1.47)0.687Caesarean section856 57 59 61 63 65-6714070.94 (0.79 to 1.13)0.5310Vaginal delivery157341.25 (0.88 to 1.78)0.21NAInduction of labour159851.17 (0.78 to 1.75)0.44NAPostpartum haemorrhage0————Gestational age at delivery (weeks)657 59 61 62 65 668130.20* (−0.02 to 0.42)0.071 All interventions Gestational diabetes mellitus916420.78 (0.57 to 1.08)0.1329Pre-eclampsia1033420.74 (0.60 to 0.92)0.00631Gestational hypertension610610.89 (0.64 to 1.25)0.5150Preterm delivery1326520.78 (0.60 to 1.02)0.070Caesarean section1842220.93 (0.85 to 1.01)0.103Vaginal delivery69941.00 (0.94 to 1.07)0.910Induction of labour523621.12 (1.00 to 1.26)0.0547Postpartum haemorrhage212320.90 (0.57 to 1.42)0.640Gestational age at delivery (weeks)2346880.02* (−0.08 to 0.11)0.7233\nNA=not applicable.']	delivery69941	GO_BP_EXT	[20704]	[20717]	BMJ_2012_May_17_344_e2088_T129
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_83	[18799]	[20927]	['Summary estimates are relative risks unless stated otherwiseNo of studiesNo of participantsSummary estimate (95% CI)P valueI2(%) Dietary intervention Gestational diabetes mellitus333 35 364090.39 (0.23 to 0.69)0.00121Pre-eclampsia628 30 31 34-3626240.67 (0.53 to 0.85)<0.0010Gestational hypertension235 362820.30 (0.10 to 0.88)0.030Preterm delivery426 30 31 3514740.68 (0.48 to 0.96)0.0335Caesarean section528 29 31 35 3622730.93 (0.84 to1.04)0.1949Vaginal delivery231 344720.97 0.89 to 1.07)0.560Induction of labour428 31 34 3522771.12 (0.99 to 1.27)0.0760Postpartum haemorrhage228 3512320.90 (0.57 to 1.42)0.640Gestational age at delivery (weeks)628 30-32 34 352625−0.05* (−0.18 to 0.08)0.4271 Physical activity Gestational diabetes mellitus0————Pre-eclampsia0————Gestational hypertension0————Preterm delivery537 38 46 52 534501.22 (0.51 to 2.90)0.650Caesarean section537 39 48-505420.88 (0.66 to 1.17)0.380Vaginal delivery337 39 494881.02 (0.93 to 1.11)0.700Induction of labour0————Postpartum haemorrhage0————Gestational age at delivery (weeks)1137-39 42 44-49 5412500.03* (−0.14 to 0.20)0.740 Mixed approach Gestational diabetes mellitus661 62 63 65-6712331.18 (0.78 to 1.77)0.440Pre-eclampsia459 63 65 667181.16 (0.70 to 1.90)0.5739Gestational hypertension459 63 65 667791.08 (0.75 to 1.55)0.6942Preterm delivery457 63 65 667280.90 (0.55 to 1.47)0.687Caesarean section856 57 59 61 63 65-6714070.94 (0.79 to 1.13)0.5310Vaginal delivery157341.25 (0.88 to 1.78)0.21NAInduction of labour159851.17 (0.78 to 1.75)0.44NAPostpartum haemorrhage0————Gestational age at delivery (weeks)657 59 61 62 65 668130.20* (−0.02 to 0.42)0.071 All interventions Gestational diabetes mellitus916420.78 (0.57 to 1.08)0.1329Pre-eclampsia1033420.74 (0.60 to 0.92)0.00631Gestational hypertension610610.89 (0.64 to 1.25)0.5150Preterm delivery1326520.78 (0.60 to 1.02)0.070Caesarean section1842220.93 (0.85 to 1.01)0.103Vaginal delivery69941.00 (0.94 to 1.07)0.910Induction of labour523621.12 (1.00 to 1.26)0.0547Postpartum haemorrhage212320.90 (0.57 to 1.42)0.640Gestational age at delivery (weeks)2346880.02* (−0.08 to 0.11)0.7233\nNA=not applicable.']	labour523621	GO_BP_EXT	[20753]	[20765]	BMJ_2012_May_17_344_e2088_T130
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_83	[18799]	[20927]	['Summary estimates are relative risks unless stated otherwiseNo of studiesNo of participantsSummary estimate (95% CI)P valueI2(%) Dietary intervention Gestational diabetes mellitus333 35 364090.39 (0.23 to 0.69)0.00121Pre-eclampsia628 30 31 34-3626240.67 (0.53 to 0.85)<0.0010Gestational hypertension235 362820.30 (0.10 to 0.88)0.030Preterm delivery426 30 31 3514740.68 (0.48 to 0.96)0.0335Caesarean section528 29 31 35 3622730.93 (0.84 to1.04)0.1949Vaginal delivery231 344720.97 0.89 to 1.07)0.560Induction of labour428 31 34 3522771.12 (0.99 to 1.27)0.0760Postpartum haemorrhage228 3512320.90 (0.57 to 1.42)0.640Gestational age at delivery (weeks)628 30-32 34 352625−0.05* (−0.18 to 0.08)0.4271 Physical activity Gestational diabetes mellitus0————Pre-eclampsia0————Gestational hypertension0————Preterm delivery537 38 46 52 534501.22 (0.51 to 2.90)0.650Caesarean section537 39 48-505420.88 (0.66 to 1.17)0.380Vaginal delivery337 39 494881.02 (0.93 to 1.11)0.700Induction of labour0————Postpartum haemorrhage0————Gestational age at delivery (weeks)1137-39 42 44-49 5412500.03* (−0.14 to 0.20)0.740 Mixed approach Gestational diabetes mellitus661 62 63 65-6712331.18 (0.78 to 1.77)0.440Pre-eclampsia459 63 65 667181.16 (0.70 to 1.90)0.5739Gestational hypertension459 63 65 667791.08 (0.75 to 1.55)0.6942Preterm delivery457 63 65 667280.90 (0.55 to 1.47)0.687Caesarean section856 57 59 61 63 65-6714070.94 (0.79 to 1.13)0.5310Vaginal delivery157341.25 (0.88 to 1.78)0.21NAInduction of labour159851.17 (0.78 to 1.75)0.44NAPostpartum haemorrhage0————Gestational age at delivery (weeks)657 59 61 62 65 668130.20* (−0.02 to 0.42)0.071 All interventions Gestational diabetes mellitus916420.78 (0.57 to 1.08)0.1329Pre-eclampsia1033420.74 (0.60 to 0.92)0.00631Gestational hypertension610610.89 (0.64 to 1.25)0.5150Preterm delivery1326520.78 (0.60 to 1.02)0.070Caesarean section1842220.93 (0.85 to 1.01)0.103Vaginal delivery69941.00 (0.94 to 1.07)0.910Induction of labour523621.12 (1.00 to 1.26)0.0547Postpartum haemorrhage212320.90 (0.57 to 1.42)0.640Gestational age at delivery (weeks)2346880.02* (−0.08 to 0.11)0.7233\nNA=not applicable.']	delivery	GO_BP_EXT	[20859]	[20867]	BMJ_2012_May_17_344_e2088_T131
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_85	[20947]	[21413]	['Effect of interventions on fetal and neonatal outcomes\nFifteen randomised trials (n=3905 newborns) studied the effect of interventions on fetal and neonatal morbidity and mortality outcomes.282930313435373839465053576367Meta-analysis of the effect of interventions showed trends towards reduction in intrauterine death (relative risk 0.15, 0.02 to 1.20, I2=0%), birth trauma (0.36, 0.11 to 1.23, I2=0%) (fig 7), and hyperbilirubinaemia (0.84, 0.64 to 1.10; table 3).']	neonatal	UBERON_EXT	[20984]	[20992]	BMJ_2012_May_17_344_e2088_T323
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_85	[20947]	[21413]	['Effect of interventions on fetal and neonatal outcomes\nFifteen randomised trials (n=3905 newborns) studied the effect of interventions on fetal and neonatal morbidity and mortality outcomes.282930313435373839465053576367Meta-analysis of the effect of interventions showed trends towards reduction in intrauterine death (relative risk 0.15, 0.02 to 1.20, I2=0%), birth trauma (0.36, 0.11 to 1.23, I2=0%) (fig 7), and hyperbilirubinaemia (0.84, 0.64 to 1.10; table 3).']	newborns	UBERON_EXT	[21036]	[21044]	BMJ_2012_May_17_344_e2088_T324
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_85	[20947]	[21413]	['Effect of interventions on fetal and neonatal outcomes\nFifteen randomised trials (n=3905 newborns) studied the effect of interventions on fetal and neonatal morbidity and mortality outcomes.282930313435373839465053576367Meta-analysis of the effect of interventions showed trends towards reduction in intrauterine death (relative risk 0.15, 0.02 to 1.20, I2=0%), birth trauma (0.36, 0.11 to 1.23, I2=0%) (fig 7), and hyperbilirubinaemia (0.84, 0.64 to 1.10; table 3).']	neonatal	UBERON_EXT	[21095]	[21103]	BMJ_2012_May_17_344_e2088_T325
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_85	[20947]	[21413]	['Effect of interventions on fetal and neonatal outcomes\nFifteen randomised trials (n=3905 newborns) studied the effect of interventions on fetal and neonatal morbidity and mortality outcomes.282930313435373839465053576367Meta-analysis of the effect of interventions showed trends towards reduction in intrauterine death (relative risk 0.15, 0.02 to 1.20, I2=0%), birth trauma (0.36, 0.11 to 1.23, I2=0%) (fig 7), and hyperbilirubinaemia (0.84, 0.64 to 1.10; table 3).']	intrauterine	UBERON_EXT	[21247]	[21259]	BMJ_2012_May_17_344_e2088_T326
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_85	[20947]	[21413]	['Effect of interventions on fetal and neonatal outcomes\nFifteen randomised trials (n=3905 newborns) studied the effect of interventions on fetal and neonatal morbidity and mortality outcomes.282930313435373839465053576367Meta-analysis of the effect of interventions showed trends towards reduction in intrauterine death (relative risk 0.15, 0.02 to 1.20, I2=0%), birth trauma (0.36, 0.11 to 1.23, I2=0%) (fig 7), and hyperbilirubinaemia (0.84, 0.64 to 1.10; table 3).']	death	GO_BP_EXT	[21260]	[21265]	BMJ_2012_May_17_344_e2088_T132
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_85	[20947]	[21413]	['Effect of interventions on fetal and neonatal outcomes\nFifteen randomised trials (n=3905 newborns) studied the effect of interventions on fetal and neonatal morbidity and mortality outcomes.282930313435373839465053576367Meta-analysis of the effect of interventions showed trends towards reduction in intrauterine death (relative risk 0.15, 0.02 to 1.20, I2=0%), birth trauma (0.36, 0.11 to 1.23, I2=0%) (fig 7), and hyperbilirubinaemia (0.84, 0.64 to 1.10; table 3).']	birth	GO_BP_EXT	[21309]	[21314]	BMJ_2012_May_17_344_e2088_T133
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_86	[21414]	[21572]	['The overall risk of shoulder dystocia was reduced by 61% with all interventions compared with the control group (0.39, 0.22 to 0.70; P=0.002, I2=0%; table 3).']	shoulder	UBERON_EXT	[21434]	[21442]	BMJ_2012_May_17_344_e2088_T327
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_87	[21573]	[21786]	['There were no differences between the groups for respiratory distress syndrome (1.05, 0.48 to 2.28), admission to neonatal intensive care (1.00, 0.75 to 1.33), or infant hypoglycaemia (1.07, 0.85 to 1.35) (fig 7).']	respiratory	UBERON_EXT	[21622]	[21633]	BMJ_2012_May_17_344_e2088_T328
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_87	[21573]	[21786]	['There were no differences between the groups for respiratory distress syndrome (1.05, 0.48 to 2.28), admission to neonatal intensive care (1.00, 0.75 to 1.33), or infant hypoglycaemia (1.07, 0.85 to 1.35) (fig 7).']	neonatal	UBERON_EXT	[21687]	[21695]	BMJ_2012_May_17_344_e2088_T329
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_87	[21573]	[21786]	['There were no differences between the groups for respiratory distress syndrome (1.05, 0.48 to 2.28), admission to neonatal intensive care (1.00, 0.75 to 1.33), or infant hypoglycaemia (1.07, 0.85 to 1.35) (fig 7).']	infant	UBERON_EXT	[21736]	[21742]	BMJ_2012_May_17_344_e2088_T330
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_88	[21788]	[22135]	['Caption (FIG)\n\nFig 7 Relative risk of effects of weight management interventions in pregnancy on fetal and neonatal outcomes\n\nCaption (TABLE-WRAP): TABLE 3\n\nEffect of dietary and lifestyle interventions in pregnancy* on secondary fetal and neonatal outcomes (ranked as critically important by Delphi survey, except for infant hyperbilirubinaemia).']	pregnancy	GO_BP_EXT	[21872]	[21881]	BMJ_2012_May_17_344_e2088_T134
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_88	[21788]	[22135]	['Caption (FIG)\n\nFig 7 Relative risk of effects of weight management interventions in pregnancy on fetal and neonatal outcomes\n\nCaption (TABLE-WRAP): TABLE 3\n\nEffect of dietary and lifestyle interventions in pregnancy* on secondary fetal and neonatal outcomes (ranked as critically important by Delphi survey, except for infant hyperbilirubinaemia).']	fetal	UBERON_EXT	[21885]	[21890]	BMJ_2012_May_17_344_e2088_T331
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_88	[21788]	[22135]	['Caption (FIG)\n\nFig 7 Relative risk of effects of weight management interventions in pregnancy on fetal and neonatal outcomes\n\nCaption (TABLE-WRAP): TABLE 3\n\nEffect of dietary and lifestyle interventions in pregnancy* on secondary fetal and neonatal outcomes (ranked as critically important by Delphi survey, except for infant hyperbilirubinaemia).']	neonatal	UBERON_EXT	[21895]	[21903]	BMJ_2012_May_17_344_e2088_T332
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_88	[21788]	[22135]	['Caption (FIG)\n\nFig 7 Relative risk of effects of weight management interventions in pregnancy on fetal and neonatal outcomes\n\nCaption (TABLE-WRAP): TABLE 3\n\nEffect of dietary and lifestyle interventions in pregnancy* on secondary fetal and neonatal outcomes (ranked as critically important by Delphi survey, except for infant hyperbilirubinaemia).']	pregnancy	GO_BP_EXT	[21994]	[22003]	BMJ_2012_May_17_344_e2088_T135
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_88	[21788]	[22135]	['Caption (FIG)\n\nFig 7 Relative risk of effects of weight management interventions in pregnancy on fetal and neonatal outcomes\n\nCaption (TABLE-WRAP): TABLE 3\n\nEffect of dietary and lifestyle interventions in pregnancy* on secondary fetal and neonatal outcomes (ranked as critically important by Delphi survey, except for infant hyperbilirubinaemia).']	neonatal	UBERON_EXT	[22028]	[22036]	BMJ_2012_May_17_344_e2088_T333
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_88	[21788]	[22135]	['Caption (FIG)\n\nFig 7 Relative risk of effects of weight management interventions in pregnancy on fetal and neonatal outcomes\n\nCaption (TABLE-WRAP): TABLE 3\n\nEffect of dietary and lifestyle interventions in pregnancy* on secondary fetal and neonatal outcomes (ranked as critically important by Delphi survey, except for infant hyperbilirubinaemia).']	infant	UBERON_EXT	[22107]	[22113]	BMJ_2012_May_17_344_e2088_T334
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_89	[22136]	[23459]	['Summary estimates are relative risks unless stated otherwiseNo of studiesNo of participantsRelative risk (95% CI)P valueI2(%) Dietary intervention Intrauterine death228 3013200.15 (0.02 to 1.20)0.070Admission to neonatal intensive care unit228 3119620.98 (0.66 to 1.47)0.9377Shoulder dystocia328 31 3420820.38 (0.21 to 0.69)0.0010Birth trauma228 3119610.36 (0.11 to 1.23)0.100Respiratory distress syndrome228 3119621.05 (0.48 to 2.28)0.9158Infant hypoglycaemia328 31 3418771.05 (0.83 to 1.33)0.6941Infant hyperbilirubinaemia228 3118980.84 (0.64 to 1.10)0.190 Mixed approach Intrauterine death0————Admission to neonatal intensive care unit1673040.98 (0.56 to 1.71)0.94NAShoulder dystocia1632350.90 (0.06 to 14.14)0.94NABirth trauma0————Respiratory distress syndrome0————Infant hypoglycaemia257 632692.35 (0.47 to 11.76)0.30Infant hyperbilirubinaemia0———— All interventions Intrauterine death213200.15 (0.02 to 1.20)0.070Admission to neonatal intensive care unit322661.00 (0.75 to 1.33)1.0058Shoulder dystocia423170.39 (0.22 to 0.70)0.0020Birth trauma219610.36 (0.11 to 1.23)0.100Respiratory distress syndrome219621.05 (0.48 to 2.28)0.9158Infant hypoglycaemia521461.07 (0.85 to 1.35)0.5510Infant hyperbilirubinaemia218980.84 (0.64 to 1.10)0.190\n*No randomised studies evaluated effect of physical activity for above outcomes.']	Intrauterine	UBERON_EXT	[22283]	[22295]	BMJ_2012_May_17_344_e2088_T335
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_89	[22136]	[23459]	['Summary estimates are relative risks unless stated otherwiseNo of studiesNo of participantsRelative risk (95% CI)P valueI2(%) Dietary intervention Intrauterine death228 3013200.15 (0.02 to 1.20)0.070Admission to neonatal intensive care unit228 3119620.98 (0.66 to 1.47)0.9377Shoulder dystocia328 31 3420820.38 (0.21 to 0.69)0.0010Birth trauma228 3119610.36 (0.11 to 1.23)0.100Respiratory distress syndrome228 3119621.05 (0.48 to 2.28)0.9158Infant hypoglycaemia328 31 3418771.05 (0.83 to 1.33)0.6941Infant hyperbilirubinaemia228 3118980.84 (0.64 to 1.10)0.190 Mixed approach Intrauterine death0————Admission to neonatal intensive care unit1673040.98 (0.56 to 1.71)0.94NAShoulder dystocia1632350.90 (0.06 to 14.14)0.94NABirth trauma0————Respiratory distress syndrome0————Infant hypoglycaemia257 632692.35 (0.47 to 11.76)0.30Infant hyperbilirubinaemia0———— All interventions Intrauterine death213200.15 (0.02 to 1.20)0.070Admission to neonatal intensive care unit322661.00 (0.75 to 1.33)1.0058Shoulder dystocia423170.39 (0.22 to 0.70)0.0020Birth trauma219610.36 (0.11 to 1.23)0.100Respiratory distress syndrome219621.05 (0.48 to 2.28)0.9158Infant hypoglycaemia521461.07 (0.85 to 1.35)0.5510Infant hyperbilirubinaemia218980.84 (0.64 to 1.10)0.190\n*No randomised studies evaluated effect of physical activity for above outcomes.']	death228	GO_BP_EXT	[22296]	[22304]	BMJ_2012_May_17_344_e2088_T136
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_89	[22136]	[23459]	['Summary estimates are relative risks unless stated otherwiseNo of studiesNo of participantsRelative risk (95% CI)P valueI2(%) Dietary intervention Intrauterine death228 3013200.15 (0.02 to 1.20)0.070Admission to neonatal intensive care unit228 3119620.98 (0.66 to 1.47)0.9377Shoulder dystocia328 31 3420820.38 (0.21 to 0.69)0.0010Birth trauma228 3119610.36 (0.11 to 1.23)0.100Respiratory distress syndrome228 3119621.05 (0.48 to 2.28)0.9158Infant hypoglycaemia328 31 3418771.05 (0.83 to 1.33)0.6941Infant hyperbilirubinaemia228 3118980.84 (0.64 to 1.10)0.190 Mixed approach Intrauterine death0————Admission to neonatal intensive care unit1673040.98 (0.56 to 1.71)0.94NAShoulder dystocia1632350.90 (0.06 to 14.14)0.94NABirth trauma0————Respiratory distress syndrome0————Infant hypoglycaemia257 632692.35 (0.47 to 11.76)0.30Infant hyperbilirubinaemia0———— All interventions Intrauterine death213200.15 (0.02 to 1.20)0.070Admission to neonatal intensive care unit322661.00 (0.75 to 1.33)1.0058Shoulder dystocia423170.39 (0.22 to 0.70)0.0020Birth trauma219610.36 (0.11 to 1.23)0.100Respiratory distress syndrome219621.05 (0.48 to 2.28)0.9158Infant hypoglycaemia521461.07 (0.85 to 1.35)0.5510Infant hyperbilirubinaemia218980.84 (0.64 to 1.10)0.190\n*No randomised studies evaluated effect of physical activity for above outcomes.']	neonatal	UBERON_EXT	[22348]	[22356]	BMJ_2012_May_17_344_e2088_T336
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_89	[22136]	[23459]	['Summary estimates are relative risks unless stated otherwiseNo of studiesNo of participantsRelative risk (95% CI)P valueI2(%) Dietary intervention Intrauterine death228 3013200.15 (0.02 to 1.20)0.070Admission to neonatal intensive care unit228 3119620.98 (0.66 to 1.47)0.9377Shoulder dystocia328 31 3420820.38 (0.21 to 0.69)0.0010Birth trauma228 3119610.36 (0.11 to 1.23)0.100Respiratory distress syndrome228 3119621.05 (0.48 to 2.28)0.9158Infant hypoglycaemia328 31 3418771.05 (0.83 to 1.33)0.6941Infant hyperbilirubinaemia228 3118980.84 (0.64 to 1.10)0.190 Mixed approach Intrauterine death0————Admission to neonatal intensive care unit1673040.98 (0.56 to 1.71)0.94NAShoulder dystocia1632350.90 (0.06 to 14.14)0.94NABirth trauma0————Respiratory distress syndrome0————Infant hypoglycaemia257 632692.35 (0.47 to 11.76)0.30Infant hyperbilirubinaemia0———— All interventions Intrauterine death213200.15 (0.02 to 1.20)0.070Admission to neonatal intensive care unit322661.00 (0.75 to 1.33)1.0058Shoulder dystocia423170.39 (0.22 to 0.70)0.0020Birth trauma219610.36 (0.11 to 1.23)0.100Respiratory distress syndrome219621.05 (0.48 to 2.28)0.9158Infant hypoglycaemia521461.07 (0.85 to 1.35)0.5510Infant hyperbilirubinaemia218980.84 (0.64 to 1.10)0.190\n*No randomised studies evaluated effect of physical activity for above outcomes.']	intensive care unit228	UBERON_EXT	[22357]	[22379]	BMJ_2012_May_17_344_e2088_T337
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_89	[22136]	[23459]	['Summary estimates are relative risks unless stated otherwiseNo of studiesNo of participantsRelative risk (95% CI)P valueI2(%) Dietary intervention Intrauterine death228 3013200.15 (0.02 to 1.20)0.070Admission to neonatal intensive care unit228 3119620.98 (0.66 to 1.47)0.9377Shoulder dystocia328 31 3420820.38 (0.21 to 0.69)0.0010Birth trauma228 3119610.36 (0.11 to 1.23)0.100Respiratory distress syndrome228 3119621.05 (0.48 to 2.28)0.9158Infant hypoglycaemia328 31 3418771.05 (0.83 to 1.33)0.6941Infant hyperbilirubinaemia228 3118980.84 (0.64 to 1.10)0.190 Mixed approach Intrauterine death0————Admission to neonatal intensive care unit1673040.98 (0.56 to 1.71)0.94NAShoulder dystocia1632350.90 (0.06 to 14.14)0.94NABirth trauma0————Respiratory distress syndrome0————Infant hypoglycaemia257 632692.35 (0.47 to 11.76)0.30Infant hyperbilirubinaemia0———— All interventions Intrauterine death213200.15 (0.02 to 1.20)0.070Admission to neonatal intensive care unit322661.00 (0.75 to 1.33)1.0058Shoulder dystocia423170.39 (0.22 to 0.70)0.0020Birth trauma219610.36 (0.11 to 1.23)0.100Respiratory distress syndrome219621.05 (0.48 to 2.28)0.9158Infant hypoglycaemia521461.07 (0.85 to 1.35)0.5510Infant hyperbilirubinaemia218980.84 (0.64 to 1.10)0.190\n*No randomised studies evaluated effect of physical activity for above outcomes.']	Intrauterine	UBERON_EXT	[22710]	[22722]	BMJ_2012_May_17_344_e2088_T338
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_89	[22136]	[23459]	['Summary estimates are relative risks unless stated otherwiseNo of studiesNo of participantsRelative risk (95% CI)P valueI2(%) Dietary intervention Intrauterine death228 3013200.15 (0.02 to 1.20)0.070Admission to neonatal intensive care unit228 3119620.98 (0.66 to 1.47)0.9377Shoulder dystocia328 31 3420820.38 (0.21 to 0.69)0.0010Birth trauma228 3119610.36 (0.11 to 1.23)0.100Respiratory distress syndrome228 3119621.05 (0.48 to 2.28)0.9158Infant hypoglycaemia328 31 3418771.05 (0.83 to 1.33)0.6941Infant hyperbilirubinaemia228 3118980.84 (0.64 to 1.10)0.190 Mixed approach Intrauterine death0————Admission to neonatal intensive care unit1673040.98 (0.56 to 1.71)0.94NAShoulder dystocia1632350.90 (0.06 to 14.14)0.94NABirth trauma0————Respiratory distress syndrome0————Infant hypoglycaemia257 632692.35 (0.47 to 11.76)0.30Infant hyperbilirubinaemia0———— All interventions Intrauterine death213200.15 (0.02 to 1.20)0.070Admission to neonatal intensive care unit322661.00 (0.75 to 1.33)1.0058Shoulder dystocia423170.39 (0.22 to 0.70)0.0020Birth trauma219610.36 (0.11 to 1.23)0.100Respiratory distress syndrome219621.05 (0.48 to 2.28)0.9158Infant hypoglycaemia521461.07 (0.85 to 1.35)0.5510Infant hyperbilirubinaemia218980.84 (0.64 to 1.10)0.190\n*No randomised studies evaluated effect of physical activity for above outcomes.']	death0	GO_BP_EXT	[22723]	[22729]	BMJ_2012_May_17_344_e2088_T137
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_89	[22136]	[23459]	['Summary estimates are relative risks unless stated otherwiseNo of studiesNo of participantsRelative risk (95% CI)P valueI2(%) Dietary intervention Intrauterine death228 3013200.15 (0.02 to 1.20)0.070Admission to neonatal intensive care unit228 3119620.98 (0.66 to 1.47)0.9377Shoulder dystocia328 31 3420820.38 (0.21 to 0.69)0.0010Birth trauma228 3119610.36 (0.11 to 1.23)0.100Respiratory distress syndrome228 3119621.05 (0.48 to 2.28)0.9158Infant hypoglycaemia328 31 3418771.05 (0.83 to 1.33)0.6941Infant hyperbilirubinaemia228 3118980.84 (0.64 to 1.10)0.190 Mixed approach Intrauterine death0————Admission to neonatal intensive care unit1673040.98 (0.56 to 1.71)0.94NAShoulder dystocia1632350.90 (0.06 to 14.14)0.94NABirth trauma0————Respiratory distress syndrome0————Infant hypoglycaemia257 632692.35 (0.47 to 11.76)0.30Infant hyperbilirubinaemia0———— All interventions Intrauterine death213200.15 (0.02 to 1.20)0.070Admission to neonatal intensive care unit322661.00 (0.75 to 1.33)1.0058Shoulder dystocia423170.39 (0.22 to 0.70)0.0020Birth trauma219610.36 (0.11 to 1.23)0.100Respiratory distress syndrome219621.05 (0.48 to 2.28)0.9158Infant hypoglycaemia521461.07 (0.85 to 1.35)0.5510Infant hyperbilirubinaemia218980.84 (0.64 to 1.10)0.190\n*No randomised studies evaluated effect of physical activity for above outcomes.']	neonatal	UBERON_EXT	[22746]	[22754]	BMJ_2012_May_17_344_e2088_T339
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_89	[22136]	[23459]	['Summary estimates are relative risks unless stated otherwiseNo of studiesNo of participantsRelative risk (95% CI)P valueI2(%) Dietary intervention Intrauterine death228 3013200.15 (0.02 to 1.20)0.070Admission to neonatal intensive care unit228 3119620.98 (0.66 to 1.47)0.9377Shoulder dystocia328 31 3420820.38 (0.21 to 0.69)0.0010Birth trauma228 3119610.36 (0.11 to 1.23)0.100Respiratory distress syndrome228 3119621.05 (0.48 to 2.28)0.9158Infant hypoglycaemia328 31 3418771.05 (0.83 to 1.33)0.6941Infant hyperbilirubinaemia228 3118980.84 (0.64 to 1.10)0.190 Mixed approach Intrauterine death0————Admission to neonatal intensive care unit1673040.98 (0.56 to 1.71)0.94NAShoulder dystocia1632350.90 (0.06 to 14.14)0.94NABirth trauma0————Respiratory distress syndrome0————Infant hypoglycaemia257 632692.35 (0.47 to 11.76)0.30Infant hyperbilirubinaemia0———— All interventions Intrauterine death213200.15 (0.02 to 1.20)0.070Admission to neonatal intensive care unit322661.00 (0.75 to 1.33)1.0058Shoulder dystocia423170.39 (0.22 to 0.70)0.0020Birth trauma219610.36 (0.11 to 1.23)0.100Respiratory distress syndrome219621.05 (0.48 to 2.28)0.9158Infant hypoglycaemia521461.07 (0.85 to 1.35)0.5510Infant hyperbilirubinaemia218980.84 (0.64 to 1.10)0.190\n*No randomised studies evaluated effect of physical activity for above outcomes.']	care	UBERON_EXT	[22765]	[22769]	BMJ_2012_May_17_344_e2088_T340
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_89	[22136]	[23459]	['Summary estimates are relative risks unless stated otherwiseNo of studiesNo of participantsRelative risk (95% CI)P valueI2(%) Dietary intervention Intrauterine death228 3013200.15 (0.02 to 1.20)0.070Admission to neonatal intensive care unit228 3119620.98 (0.66 to 1.47)0.9377Shoulder dystocia328 31 3420820.38 (0.21 to 0.69)0.0010Birth trauma228 3119610.36 (0.11 to 1.23)0.100Respiratory distress syndrome228 3119621.05 (0.48 to 2.28)0.9158Infant hypoglycaemia328 31 3418771.05 (0.83 to 1.33)0.6941Infant hyperbilirubinaemia228 3118980.84 (0.64 to 1.10)0.190 Mixed approach Intrauterine death0————Admission to neonatal intensive care unit1673040.98 (0.56 to 1.71)0.94NAShoulder dystocia1632350.90 (0.06 to 14.14)0.94NABirth trauma0————Respiratory distress syndrome0————Infant hypoglycaemia257 632692.35 (0.47 to 11.76)0.30Infant hyperbilirubinaemia0———— All interventions Intrauterine death213200.15 (0.02 to 1.20)0.070Admission to neonatal intensive care unit322661.00 (0.75 to 1.33)1.0058Shoulder dystocia423170.39 (0.22 to 0.70)0.0020Birth trauma219610.36 (0.11 to 1.23)0.100Respiratory distress syndrome219621.05 (0.48 to 2.28)0.9158Infant hypoglycaemia521461.07 (0.85 to 1.35)0.5510Infant hyperbilirubinaemia218980.84 (0.64 to 1.10)0.190\n*No randomised studies evaluated effect of physical activity for above outcomes.']	Intrauterine	UBERON_EXT	[23008]	[23020]	BMJ_2012_May_17_344_e2088_T341
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_89	[22136]	[23459]	['Summary estimates are relative risks unless stated otherwiseNo of studiesNo of participantsRelative risk (95% CI)P valueI2(%) Dietary intervention Intrauterine death228 3013200.15 (0.02 to 1.20)0.070Admission to neonatal intensive care unit228 3119620.98 (0.66 to 1.47)0.9377Shoulder dystocia328 31 3420820.38 (0.21 to 0.69)0.0010Birth trauma228 3119610.36 (0.11 to 1.23)0.100Respiratory distress syndrome228 3119621.05 (0.48 to 2.28)0.9158Infant hypoglycaemia328 31 3418771.05 (0.83 to 1.33)0.6941Infant hyperbilirubinaemia228 3118980.84 (0.64 to 1.10)0.190 Mixed approach Intrauterine death0————Admission to neonatal intensive care unit1673040.98 (0.56 to 1.71)0.94NAShoulder dystocia1632350.90 (0.06 to 14.14)0.94NABirth trauma0————Respiratory distress syndrome0————Infant hypoglycaemia257 632692.35 (0.47 to 11.76)0.30Infant hyperbilirubinaemia0———— All interventions Intrauterine death213200.15 (0.02 to 1.20)0.070Admission to neonatal intensive care unit322661.00 (0.75 to 1.33)1.0058Shoulder dystocia423170.39 (0.22 to 0.70)0.0020Birth trauma219610.36 (0.11 to 1.23)0.100Respiratory distress syndrome219621.05 (0.48 to 2.28)0.9158Infant hypoglycaemia521461.07 (0.85 to 1.35)0.5510Infant hyperbilirubinaemia218980.84 (0.64 to 1.10)0.190\n*No randomised studies evaluated effect of physical activity for above outcomes.']	death213200	GO_BP_EXT	[23021]	[23032]	BMJ_2012_May_17_344_e2088_T138
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_89	[22136]	[23459]	['Summary estimates are relative risks unless stated otherwiseNo of studiesNo of participantsRelative risk (95% CI)P valueI2(%) Dietary intervention Intrauterine death228 3013200.15 (0.02 to 1.20)0.070Admission to neonatal intensive care unit228 3119620.98 (0.66 to 1.47)0.9377Shoulder dystocia328 31 3420820.38 (0.21 to 0.69)0.0010Birth trauma228 3119610.36 (0.11 to 1.23)0.100Respiratory distress syndrome228 3119621.05 (0.48 to 2.28)0.9158Infant hypoglycaemia328 31 3418771.05 (0.83 to 1.33)0.6941Infant hyperbilirubinaemia228 3118980.84 (0.64 to 1.10)0.190 Mixed approach Intrauterine death0————Admission to neonatal intensive care unit1673040.98 (0.56 to 1.71)0.94NAShoulder dystocia1632350.90 (0.06 to 14.14)0.94NABirth trauma0————Respiratory distress syndrome0————Infant hypoglycaemia257 632692.35 (0.47 to 11.76)0.30Infant hyperbilirubinaemia0———— All interventions Intrauterine death213200.15 (0.02 to 1.20)0.070Admission to neonatal intensive care unit322661.00 (0.75 to 1.33)1.0058Shoulder dystocia423170.39 (0.22 to 0.70)0.0020Birth trauma219610.36 (0.11 to 1.23)0.100Respiratory distress syndrome219621.05 (0.48 to 2.28)0.9158Infant hypoglycaemia521461.07 (0.85 to 1.35)0.5510Infant hyperbilirubinaemia218980.84 (0.64 to 1.10)0.190\n*No randomised studies evaluated effect of physical activity for above outcomes.']	neonatal	UBERON_EXT	[23068]	[23076]	BMJ_2012_May_17_344_e2088_T342
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_89	[22136]	[23459]	['Summary estimates are relative risks unless stated otherwiseNo of studiesNo of participantsRelative risk (95% CI)P valueI2(%) Dietary intervention Intrauterine death228 3013200.15 (0.02 to 1.20)0.070Admission to neonatal intensive care unit228 3119620.98 (0.66 to 1.47)0.9377Shoulder dystocia328 31 3420820.38 (0.21 to 0.69)0.0010Birth trauma228 3119610.36 (0.11 to 1.23)0.100Respiratory distress syndrome228 3119621.05 (0.48 to 2.28)0.9158Infant hypoglycaemia328 31 3418771.05 (0.83 to 1.33)0.6941Infant hyperbilirubinaemia228 3118980.84 (0.64 to 1.10)0.190 Mixed approach Intrauterine death0————Admission to neonatal intensive care unit1673040.98 (0.56 to 1.71)0.94NAShoulder dystocia1632350.90 (0.06 to 14.14)0.94NABirth trauma0————Respiratory distress syndrome0————Infant hypoglycaemia257 632692.35 (0.47 to 11.76)0.30Infant hyperbilirubinaemia0———— All interventions Intrauterine death213200.15 (0.02 to 1.20)0.070Admission to neonatal intensive care unit322661.00 (0.75 to 1.33)1.0058Shoulder dystocia423170.39 (0.22 to 0.70)0.0020Birth trauma219610.36 (0.11 to 1.23)0.100Respiratory distress syndrome219621.05 (0.48 to 2.28)0.9158Infant hypoglycaemia521461.07 (0.85 to 1.35)0.5510Infant hyperbilirubinaemia218980.84 (0.64 to 1.10)0.190\n*No randomised studies evaluated effect of physical activity for above outcomes.']	care	UBERON_EXT	[23087]	[23091]	BMJ_2012_May_17_344_e2088_T343
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_92	[23666]	[23795]	['There was a significant difference between the subgroups for gestational weight gain based on the type of intervention (P<0.001).']	gestational	GO_BP_EXT	[23727]	[23738]	BMJ_2012_May_17_344_e2088_T139
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_93	[23796]	[24019]	['The responders, defined as women with significantly reduced gestational weight gain with intervention, showed a difference in reduction in pre-eclampsia (P=0.009) and birth weight (P=0.002) compared with the non-responders.']	women	NCBITAXON_EXT	[23823]	[23828]	BMJ_2012_May_17_344_e2088_T257
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_93	[23796]	[24019]	['The responders, defined as women with significantly reduced gestational weight gain with intervention, showed a difference in reduction in pre-eclampsia (P=0.009) and birth weight (P=0.002) compared with the non-responders.']	gestational	GO_BP_EXT	[23856]	[23867]	BMJ_2012_May_17_344_e2088_T140
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_94	[24020]	[24172]	['There were no significant differences between the subgroups based on the BMI, diabetic status in pregnancy, and risk of bias for allocation concealment.']	pregnancy	GO_BP_EXT	[24117]	[24126]	BMJ_2012_May_17_344_e2088_T141
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_95	[24174]	[25350]	['Caption (TABLE-WRAP): TABLE 4\n\nSubgroup analyses for trial methods and clinical characteristics for maternal outcomes in evaluation of dietary and lifestyle interventions in pregnancySubgroupGestational weight gain (kg)Pre-eclampsiaNo of studiesMean difference (95% CI)P value for interactionNo of studiesRelative risk (95% CI)P value for interactionIntervention type:\u2003Diet10−3.84 (−5.22 to −2.45)<0.00160.67 (0.53 to 0.85)0.05\u2003Physical activity14−0.72 (−1.20 to −0.25)0—\u2003Mixed10−1.06 (−1.67 to −0.46)41.16 (0.70 to 1.90)Diabetic status:\u2003Women with diabetes4−1.85 (−2.44 to −1.26)0.3330.65 (0.50 to 0.84)0.06\u2003Normal women30−1.4 (−2.09 to −0.71)71.01 (0.68 to 1.50)BMI:\u2003Obese and overweight11*†−2.41 (−4.04 to -0.77)0.057†0.81 (0.58 to 1.14)0.49\u2003Any weight25*†−0.63 (−1.24 to -0.02)4†0.70 (0.53 to 0.92)Maternal weight change with intervention:\u2003Significantly reduced———40.61 (0.47 to 0.79)0.009\u2003No significant change——61.12 (0.77 to 1.61)Risk of bias (allocation concealment):\u2003High risk28−0.89 (−1.61 to −0.17)0.0770.73 (0.56 to 0.93)0.76\u2003Low risk6−2.14 (−3.28 to −1.01)30.78 (0.53 to 1.16)\n*Polley et al66data presented separately for normal weight women and overweight women.']	pregnancySubgroupGestational	GO_BP_EXT	[24348]	[24376]	BMJ_2012_May_17_344_e2088_T142
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_95	[24174]	[25350]	['Caption (TABLE-WRAP): TABLE 4\n\nSubgroup analyses for trial methods and clinical characteristics for maternal outcomes in evaluation of dietary and lifestyle interventions in pregnancySubgroupGestational weight gain (kg)Pre-eclampsiaNo of studiesMean difference (95% CI)P value for interactionNo of studiesRelative risk (95% CI)P value for interactionIntervention type:\u2003Diet10−3.84 (−5.22 to −2.45)<0.00160.67 (0.53 to 0.85)0.05\u2003Physical activity14−0.72 (−1.20 to −0.25)0—\u2003Mixed10−1.06 (−1.67 to −0.46)41.16 (0.70 to 1.90)Diabetic status:\u2003Women with diabetes4−1.85 (−2.44 to −1.26)0.3330.65 (0.50 to 0.84)0.06\u2003Normal women30−1.4 (−2.09 to −0.71)71.01 (0.68 to 1.50)BMI:\u2003Obese and overweight11*†−2.41 (−4.04 to -0.77)0.057†0.81 (0.58 to 1.14)0.49\u2003Any weight25*†−0.63 (−1.24 to -0.02)4†0.70 (0.53 to 0.92)Maternal weight change with intervention:\u2003Significantly reduced———40.61 (0.47 to 0.79)0.009\u2003No significant change——61.12 (0.77 to 1.61)Risk of bias (allocation concealment):\u2003High risk28−0.89 (−1.61 to −0.17)0.0770.73 (0.56 to 0.93)0.76\u2003Low risk6−2.14 (−3.28 to −1.01)30.78 (0.53 to 1.16)\n*Polley et al66data presented separately for normal weight women and overweight women.']	Women	NCBITAXON_EXT	[24712]	[24717]	BMJ_2012_May_17_344_e2088_T258
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_95	[24174]	[25350]	['Caption (TABLE-WRAP): TABLE 4\n\nSubgroup analyses for trial methods and clinical characteristics for maternal outcomes in evaluation of dietary and lifestyle interventions in pregnancySubgroupGestational weight gain (kg)Pre-eclampsiaNo of studiesMean difference (95% CI)P value for interactionNo of studiesRelative risk (95% CI)P value for interactionIntervention type:\u2003Diet10−3.84 (−5.22 to −2.45)<0.00160.67 (0.53 to 0.85)0.05\u2003Physical activity14−0.72 (−1.20 to −0.25)0—\u2003Mixed10−1.06 (−1.67 to −0.46)41.16 (0.70 to 1.90)Diabetic status:\u2003Women with diabetes4−1.85 (−2.44 to −1.26)0.3330.65 (0.50 to 0.84)0.06\u2003Normal women30−1.4 (−2.09 to −0.71)71.01 (0.68 to 1.50)BMI:\u2003Obese and overweight11*†−2.41 (−4.04 to -0.77)0.057†0.81 (0.58 to 1.14)0.49\u2003Any weight25*†−0.63 (−1.24 to -0.02)4†0.70 (0.53 to 0.92)Maternal weight change with intervention:\u2003Significantly reduced———40.61 (0.47 to 0.79)0.009\u2003No significant change——61.12 (0.77 to 1.61)Risk of bias (allocation concealment):\u2003High risk28−0.89 (−1.61 to −0.17)0.0770.73 (0.56 to 0.93)0.76\u2003Low risk6−2.14 (−3.28 to −1.01)30.78 (0.53 to 1.16)\n*Polley et al66data presented separately for normal weight women and overweight women.']	Women	UBERON_EXT	[24712]	[24717]	BMJ_2012_May_17_344_e2088_T344
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_95	[24174]	[25350]	['Caption (TABLE-WRAP): TABLE 4\n\nSubgroup analyses for trial methods and clinical characteristics for maternal outcomes in evaluation of dietary and lifestyle interventions in pregnancySubgroupGestational weight gain (kg)Pre-eclampsiaNo of studiesMean difference (95% CI)P value for interactionNo of studiesRelative risk (95% CI)P value for interactionIntervention type:\u2003Diet10−3.84 (−5.22 to −2.45)<0.00160.67 (0.53 to 0.85)0.05\u2003Physical activity14−0.72 (−1.20 to −0.25)0—\u2003Mixed10−1.06 (−1.67 to −0.46)41.16 (0.70 to 1.90)Diabetic status:\u2003Women with diabetes4−1.85 (−2.44 to −1.26)0.3330.65 (0.50 to 0.84)0.06\u2003Normal women30−1.4 (−2.09 to −0.71)71.01 (0.68 to 1.50)BMI:\u2003Obese and overweight11*†−2.41 (−4.04 to -0.77)0.057†0.81 (0.58 to 1.14)0.49\u2003Any weight25*†−0.63 (−1.24 to -0.02)4†0.70 (0.53 to 0.92)Maternal weight change with intervention:\u2003Significantly reduced———40.61 (0.47 to 0.79)0.009\u2003No significant change——61.12 (0.77 to 1.61)Risk of bias (allocation concealment):\u2003High risk28−0.89 (−1.61 to −0.17)0.0770.73 (0.56 to 0.93)0.76\u2003Low risk6−2.14 (−3.28 to −1.01)30.78 (0.53 to 1.16)\n*Polley et al66data presented separately for normal weight women and overweight women.']	women30	NCBITAXON_EXT	[24790]	[24797]	BMJ_2012_May_17_344_e2088_T259
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_95	[24174]	[25350]	['Caption (TABLE-WRAP): TABLE 4\n\nSubgroup analyses for trial methods and clinical characteristics for maternal outcomes in evaluation of dietary and lifestyle interventions in pregnancySubgroupGestational weight gain (kg)Pre-eclampsiaNo of studiesMean difference (95% CI)P value for interactionNo of studiesRelative risk (95% CI)P value for interactionIntervention type:\u2003Diet10−3.84 (−5.22 to −2.45)<0.00160.67 (0.53 to 0.85)0.05\u2003Physical activity14−0.72 (−1.20 to −0.25)0—\u2003Mixed10−1.06 (−1.67 to −0.46)41.16 (0.70 to 1.90)Diabetic status:\u2003Women with diabetes4−1.85 (−2.44 to −1.26)0.3330.65 (0.50 to 0.84)0.06\u2003Normal women30−1.4 (−2.09 to −0.71)71.01 (0.68 to 1.50)BMI:\u2003Obese and overweight11*†−2.41 (−4.04 to -0.77)0.057†0.81 (0.58 to 1.14)0.49\u2003Any weight25*†−0.63 (−1.24 to -0.02)4†0.70 (0.53 to 0.92)Maternal weight change with intervention:\u2003Significantly reduced———40.61 (0.47 to 0.79)0.009\u2003No significant change——61.12 (0.77 to 1.61)Risk of bias (allocation concealment):\u2003High risk28−0.89 (−1.61 to −0.17)0.0770.73 (0.56 to 0.93)0.76\u2003Low risk6−2.14 (−3.28 to −1.01)30.78 (0.53 to 1.16)\n*Polley et al66data presented separately for normal weight women and overweight women.']	women30	UBERON_EXT	[24790]	[24797]	BMJ_2012_May_17_344_e2088_T345
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_95	[24174]	[25350]	['Caption (TABLE-WRAP): TABLE 4\n\nSubgroup analyses for trial methods and clinical characteristics for maternal outcomes in evaluation of dietary and lifestyle interventions in pregnancySubgroupGestational weight gain (kg)Pre-eclampsiaNo of studiesMean difference (95% CI)P value for interactionNo of studiesRelative risk (95% CI)P value for interactionIntervention type:\u2003Diet10−3.84 (−5.22 to −2.45)<0.00160.67 (0.53 to 0.85)0.05\u2003Physical activity14−0.72 (−1.20 to −0.25)0—\u2003Mixed10−1.06 (−1.67 to −0.46)41.16 (0.70 to 1.90)Diabetic status:\u2003Women with diabetes4−1.85 (−2.44 to −1.26)0.3330.65 (0.50 to 0.84)0.06\u2003Normal women30−1.4 (−2.09 to −0.71)71.01 (0.68 to 1.50)BMI:\u2003Obese and overweight11*†−2.41 (−4.04 to -0.77)0.057†0.81 (0.58 to 1.14)0.49\u2003Any weight25*†−0.63 (−1.24 to -0.02)4†0.70 (0.53 to 0.92)Maternal weight change with intervention:\u2003Significantly reduced———40.61 (0.47 to 0.79)0.009\u2003No significant change——61.12 (0.77 to 1.61)Risk of bias (allocation concealment):\u2003High risk28−0.89 (−1.61 to −0.17)0.0770.73 (0.56 to 0.93)0.76\u2003Low risk6−2.14 (−3.28 to −1.01)30.78 (0.53 to 1.16)\n*Polley et al66data presented separately for normal weight women and overweight women.']	women	NCBITAXON_EXT	[25323]	[25328]	BMJ_2012_May_17_344_e2088_T260
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_95	[24174]	[25350]	['Caption (TABLE-WRAP): TABLE 4\n\nSubgroup analyses for trial methods and clinical characteristics for maternal outcomes in evaluation of dietary and lifestyle interventions in pregnancySubgroupGestational weight gain (kg)Pre-eclampsiaNo of studiesMean difference (95% CI)P value for interactionNo of studiesRelative risk (95% CI)P value for interactionIntervention type:\u2003Diet10−3.84 (−5.22 to −2.45)<0.00160.67 (0.53 to 0.85)0.05\u2003Physical activity14−0.72 (−1.20 to −0.25)0—\u2003Mixed10−1.06 (−1.67 to −0.46)41.16 (0.70 to 1.90)Diabetic status:\u2003Women with diabetes4−1.85 (−2.44 to −1.26)0.3330.65 (0.50 to 0.84)0.06\u2003Normal women30−1.4 (−2.09 to −0.71)71.01 (0.68 to 1.50)BMI:\u2003Obese and overweight11*†−2.41 (−4.04 to -0.77)0.057†0.81 (0.58 to 1.14)0.49\u2003Any weight25*†−0.63 (−1.24 to -0.02)4†0.70 (0.53 to 0.92)Maternal weight change with intervention:\u2003Significantly reduced———40.61 (0.47 to 0.79)0.009\u2003No significant change——61.12 (0.77 to 1.61)Risk of bias (allocation concealment):\u2003High risk28−0.89 (−1.61 to −0.17)0.0770.73 (0.56 to 0.93)0.76\u2003Low risk6−2.14 (−3.28 to −1.01)30.78 (0.53 to 1.16)\n*Polley et al66data presented separately for normal weight women and overweight women.']	women	NCBITAXON_EXT	[25344]	[25349]	BMJ_2012_May_17_344_e2088_T261
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_96	[25351]	[25442]	['†Phelan 2011 et al65data presented separately for normal weight women and overweight women.']	women	NCBITAXON_EXT	[25415]	[25420]	BMJ_2012_May_17_344_e2088_T262
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_96	[25351]	[25442]	['†Phelan 2011 et al65data presented separately for normal weight women and overweight women.']	women	UBERON_EXT	[25415]	[25420]	BMJ_2012_May_17_344_e2088_T346
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_96	[25351]	[25442]	['†Phelan 2011 et al65data presented separately for normal weight women and overweight women.']	women	NCBITAXON_EXT	[25436]	[25441]	BMJ_2012_May_17_344_e2088_T263
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_96	[25351]	[25442]	['†Phelan 2011 et al65data presented separately for normal weight women and overweight women.']	women	UBERON_EXT	[25436]	[25441]	BMJ_2012_May_17_344_e2088_T347
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_97	[25444]	[26940]	['Caption (TABLE-WRAP): TABLE 5\n\nSubgroup analyses for trial methods and clinical characteristics for fetal outcomes in evaluation of dietary and lifestyle interventions in pregnancySubgroupBirth weight (g)Large for gestational ageSmall for gestational ageNo of studiesMean difference (95% CI)P value for interactionNo of studiesRelative risk (95% CI)P value for interactionNo of studiesRelative risk (95% CI)P value for interactionIntervention type:\u2003Diet10−60 (−190 to 80)0.2250.78 (0.51 to 1.19)0.1631.02 (0.75 to 1.37)0.76\u2003Physical activity14−60 (−120 to −10)40.52 (0.25 to 1.09)41.28 (0.52 to 3.15)\u2003Mixed710 (−50 to 70)91.05 (0.79 to 1.40)40.88 (0.53 to 1.44)Diabetic status:\u2003Women with diabetes5−60 (−170 to 50)0.80130.97(0.73 to 1.27)0.3431.03 (0.75 to 1.41)0.77\u2003Normal women26−40 (−100 to 10)50.76 (0.50 to 1.15)80.95 (0.64 to 1.42)BMI:\u2003Obese and overweight9*−20 (−90 to 50)0.437†1.05 (0.68 to 1.63)0.134*†1.17 (0.77 to 1.80)0.35\u2003Any weight23*−60 (−130 to 10)12†0.71 (0.55 to 0.91)9*†0.92 (0.68 to 1.24)Maternal weight change with intervention:\u2003Significantly reduced7−170 (−300 to −40)0.0025‡0.79 (0.50 to 1.25)0.702‡1.03 (0.74 to 1.42)0.78\u2003No significant change24−10 (−50 to −30)12‡0.88 (0.66 to 1.17)8‡0.95 (0.64 to 1.42)Risk of bias (allocation concealment):\u2003High risk26−60 (−120 to 0)0.33150.82 (0.63 to 1.08)0.6670.89 (0.63 to 1.25)0.35\u2003Low risk50 (−90 to 80)30.96 (0.51 to 1.80)41.13 (0.79 to 1.62)\n*Polley et al66data presented separately for normal weight women and overweight women.']	pregnancySubgroupBirth	GO_BP_EXT	[25615]	[25637]	BMJ_2012_May_17_344_e2088_T143
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_97	[25444]	[26940]	['Caption (TABLE-WRAP): TABLE 5\n\nSubgroup analyses for trial methods and clinical characteristics for fetal outcomes in evaluation of dietary and lifestyle interventions in pregnancySubgroupBirth weight (g)Large for gestational ageSmall for gestational ageNo of studiesMean difference (95% CI)P value for interactionNo of studiesRelative risk (95% CI)P value for interactionNo of studiesRelative risk (95% CI)P value for interactionIntervention type:\u2003Diet10−60 (−190 to 80)0.2250.78 (0.51 to 1.19)0.1631.02 (0.75 to 1.37)0.76\u2003Physical activity14−60 (−120 to −10)40.52 (0.25 to 1.09)41.28 (0.52 to 3.15)\u2003Mixed710 (−50 to 70)91.05 (0.79 to 1.40)40.88 (0.53 to 1.44)Diabetic status:\u2003Women with diabetes5−60 (−170 to 50)0.80130.97(0.73 to 1.27)0.3431.03 (0.75 to 1.41)0.77\u2003Normal women26−40 (−100 to 10)50.76 (0.50 to 1.15)80.95 (0.64 to 1.42)BMI:\u2003Obese and overweight9*−20 (−90 to 50)0.437†1.05 (0.68 to 1.63)0.134*†1.17 (0.77 to 1.80)0.35\u2003Any weight23*−60 (−130 to 10)12†0.71 (0.55 to 0.91)9*†0.92 (0.68 to 1.24)Maternal weight change with intervention:\u2003Significantly reduced7−170 (−300 to −40)0.0025‡0.79 (0.50 to 1.25)0.702‡1.03 (0.74 to 1.42)0.78\u2003No significant change24−10 (−50 to −30)12‡0.88 (0.66 to 1.17)8‡0.95 (0.64 to 1.42)Risk of bias (allocation concealment):\u2003High risk26−60 (−120 to 0)0.33150.82 (0.63 to 1.08)0.6670.89 (0.63 to 1.25)0.35\u2003Low risk50 (−90 to 80)30.96 (0.51 to 1.80)41.13 (0.79 to 1.62)\n*Polley et al66data presented separately for normal weight women and overweight women.']	gestational	GO_BP_EXT	[25658]	[25669]	BMJ_2012_May_17_344_e2088_T144
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_97	[25444]	[26940]	['Caption (TABLE-WRAP): TABLE 5\n\nSubgroup analyses for trial methods and clinical characteristics for fetal outcomes in evaluation of dietary and lifestyle interventions in pregnancySubgroupBirth weight (g)Large for gestational ageSmall for gestational ageNo of studiesMean difference (95% CI)P value for interactionNo of studiesRelative risk (95% CI)P value for interactionNo of studiesRelative risk (95% CI)P value for interactionIntervention type:\u2003Diet10−60 (−190 to 80)0.2250.78 (0.51 to 1.19)0.1631.02 (0.75 to 1.37)0.76\u2003Physical activity14−60 (−120 to −10)40.52 (0.25 to 1.09)41.28 (0.52 to 3.15)\u2003Mixed710 (−50 to 70)91.05 (0.79 to 1.40)40.88 (0.53 to 1.44)Diabetic status:\u2003Women with diabetes5−60 (−170 to 50)0.80130.97(0.73 to 1.27)0.3431.03 (0.75 to 1.41)0.77\u2003Normal women26−40 (−100 to 10)50.76 (0.50 to 1.15)80.95 (0.64 to 1.42)BMI:\u2003Obese and overweight9*−20 (−90 to 50)0.437†1.05 (0.68 to 1.63)0.134*†1.17 (0.77 to 1.80)0.35\u2003Any weight23*−60 (−130 to 10)12†0.71 (0.55 to 0.91)9*†0.92 (0.68 to 1.24)Maternal weight change with intervention:\u2003Significantly reduced7−170 (−300 to −40)0.0025‡0.79 (0.50 to 1.25)0.702‡1.03 (0.74 to 1.42)0.78\u2003No significant change24−10 (−50 to −30)12‡0.88 (0.66 to 1.17)8‡0.95 (0.64 to 1.42)Risk of bias (allocation concealment):\u2003High risk26−60 (−120 to 0)0.33150.82 (0.63 to 1.08)0.6670.89 (0.63 to 1.25)0.35\u2003Low risk50 (−90 to 80)30.96 (0.51 to 1.80)41.13 (0.79 to 1.62)\n*Polley et al66data presented separately for normal weight women and overweight women.']	gestational	GO_BP_EXT	[25683]	[25694]	BMJ_2012_May_17_344_e2088_T145
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_97	[25444]	[26940]	['Caption (TABLE-WRAP): TABLE 5\n\nSubgroup analyses for trial methods and clinical characteristics for fetal outcomes in evaluation of dietary and lifestyle interventions in pregnancySubgroupBirth weight (g)Large for gestational ageSmall for gestational ageNo of studiesMean difference (95% CI)P value for interactionNo of studiesRelative risk (95% CI)P value for interactionNo of studiesRelative risk (95% CI)P value for interactionIntervention type:\u2003Diet10−60 (−190 to 80)0.2250.78 (0.51 to 1.19)0.1631.02 (0.75 to 1.37)0.76\u2003Physical activity14−60 (−120 to −10)40.52 (0.25 to 1.09)41.28 (0.52 to 3.15)\u2003Mixed710 (−50 to 70)91.05 (0.79 to 1.40)40.88 (0.53 to 1.44)Diabetic status:\u2003Women with diabetes5−60 (−170 to 50)0.80130.97(0.73 to 1.27)0.3431.03 (0.75 to 1.41)0.77\u2003Normal women26−40 (−100 to 10)50.76 (0.50 to 1.15)80.95 (0.64 to 1.42)BMI:\u2003Obese and overweight9*−20 (−90 to 50)0.437†1.05 (0.68 to 1.63)0.134*†1.17 (0.77 to 1.80)0.35\u2003Any weight23*−60 (−130 to 10)12†0.71 (0.55 to 0.91)9*†0.92 (0.68 to 1.24)Maternal weight change with intervention:\u2003Significantly reduced7−170 (−300 to −40)0.0025‡0.79 (0.50 to 1.25)0.702‡1.03 (0.74 to 1.42)0.78\u2003No significant change24−10 (−50 to −30)12‡0.88 (0.66 to 1.17)8‡0.95 (0.64 to 1.42)Risk of bias (allocation concealment):\u2003High risk26−60 (−120 to 0)0.33150.82 (0.63 to 1.08)0.6670.89 (0.63 to 1.25)0.35\u2003Low risk50 (−90 to 80)30.96 (0.51 to 1.80)41.13 (0.79 to 1.62)\n*Polley et al66data presented separately for normal weight women and overweight women.']	Women	NCBITAXON_EXT	[26122]	[26127]	BMJ_2012_May_17_344_e2088_T264
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_97	[25444]	[26940]	['Caption (TABLE-WRAP): TABLE 5\n\nSubgroup analyses for trial methods and clinical characteristics for fetal outcomes in evaluation of dietary and lifestyle interventions in pregnancySubgroupBirth weight (g)Large for gestational ageSmall for gestational ageNo of studiesMean difference (95% CI)P value for interactionNo of studiesRelative risk (95% CI)P value for interactionNo of studiesRelative risk (95% CI)P value for interactionIntervention type:\u2003Diet10−60 (−190 to 80)0.2250.78 (0.51 to 1.19)0.1631.02 (0.75 to 1.37)0.76\u2003Physical activity14−60 (−120 to −10)40.52 (0.25 to 1.09)41.28 (0.52 to 3.15)\u2003Mixed710 (−50 to 70)91.05 (0.79 to 1.40)40.88 (0.53 to 1.44)Diabetic status:\u2003Women with diabetes5−60 (−170 to 50)0.80130.97(0.73 to 1.27)0.3431.03 (0.75 to 1.41)0.77\u2003Normal women26−40 (−100 to 10)50.76 (0.50 to 1.15)80.95 (0.64 to 1.42)BMI:\u2003Obese and overweight9*−20 (−90 to 50)0.437†1.05 (0.68 to 1.63)0.134*†1.17 (0.77 to 1.80)0.35\u2003Any weight23*−60 (−130 to 10)12†0.71 (0.55 to 0.91)9*†0.92 (0.68 to 1.24)Maternal weight change with intervention:\u2003Significantly reduced7−170 (−300 to −40)0.0025‡0.79 (0.50 to 1.25)0.702‡1.03 (0.74 to 1.42)0.78\u2003No significant change24−10 (−50 to −30)12‡0.88 (0.66 to 1.17)8‡0.95 (0.64 to 1.42)Risk of bias (allocation concealment):\u2003High risk26−60 (−120 to 0)0.33150.82 (0.63 to 1.08)0.6670.89 (0.63 to 1.25)0.35\u2003Low risk50 (−90 to 80)30.96 (0.51 to 1.80)41.13 (0.79 to 1.62)\n*Polley et al66data presented separately for normal weight women and overweight women.']	Women	UBERON_EXT	[26122]	[26127]	BMJ_2012_May_17_344_e2088_T348
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_97	[25444]	[26940]	['Caption (TABLE-WRAP): TABLE 5\n\nSubgroup analyses for trial methods and clinical characteristics for fetal outcomes in evaluation of dietary and lifestyle interventions in pregnancySubgroupBirth weight (g)Large for gestational ageSmall for gestational ageNo of studiesMean difference (95% CI)P value for interactionNo of studiesRelative risk (95% CI)P value for interactionNo of studiesRelative risk (95% CI)P value for interactionIntervention type:\u2003Diet10−60 (−190 to 80)0.2250.78 (0.51 to 1.19)0.1631.02 (0.75 to 1.37)0.76\u2003Physical activity14−60 (−120 to −10)40.52 (0.25 to 1.09)41.28 (0.52 to 3.15)\u2003Mixed710 (−50 to 70)91.05 (0.79 to 1.40)40.88 (0.53 to 1.44)Diabetic status:\u2003Women with diabetes5−60 (−170 to 50)0.80130.97(0.73 to 1.27)0.3431.03 (0.75 to 1.41)0.77\u2003Normal women26−40 (−100 to 10)50.76 (0.50 to 1.15)80.95 (0.64 to 1.42)BMI:\u2003Obese and overweight9*−20 (−90 to 50)0.437†1.05 (0.68 to 1.63)0.134*†1.17 (0.77 to 1.80)0.35\u2003Any weight23*−60 (−130 to 10)12†0.71 (0.55 to 0.91)9*†0.92 (0.68 to 1.24)Maternal weight change with intervention:\u2003Significantly reduced7−170 (−300 to −40)0.0025‡0.79 (0.50 to 1.25)0.702‡1.03 (0.74 to 1.42)0.78\u2003No significant change24−10 (−50 to −30)12‡0.88 (0.66 to 1.17)8‡0.95 (0.64 to 1.42)Risk of bias (allocation concealment):\u2003High risk26−60 (−120 to 0)0.33150.82 (0.63 to 1.08)0.6670.89 (0.63 to 1.25)0.35\u2003Low risk50 (−90 to 80)30.96 (0.51 to 1.80)41.13 (0.79 to 1.62)\n*Polley et al66data presented separately for normal weight women and overweight women.']	women26	NCBITAXON_EXT	[26218]	[26225]	BMJ_2012_May_17_344_e2088_T265
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_97	[25444]	[26940]	['Caption (TABLE-WRAP): TABLE 5\n\nSubgroup analyses for trial methods and clinical characteristics for fetal outcomes in evaluation of dietary and lifestyle interventions in pregnancySubgroupBirth weight (g)Large for gestational ageSmall for gestational ageNo of studiesMean difference (95% CI)P value for interactionNo of studiesRelative risk (95% CI)P value for interactionNo of studiesRelative risk (95% CI)P value for interactionIntervention type:\u2003Diet10−60 (−190 to 80)0.2250.78 (0.51 to 1.19)0.1631.02 (0.75 to 1.37)0.76\u2003Physical activity14−60 (−120 to −10)40.52 (0.25 to 1.09)41.28 (0.52 to 3.15)\u2003Mixed710 (−50 to 70)91.05 (0.79 to 1.40)40.88 (0.53 to 1.44)Diabetic status:\u2003Women with diabetes5−60 (−170 to 50)0.80130.97(0.73 to 1.27)0.3431.03 (0.75 to 1.41)0.77\u2003Normal women26−40 (−100 to 10)50.76 (0.50 to 1.15)80.95 (0.64 to 1.42)BMI:\u2003Obese and overweight9*−20 (−90 to 50)0.437†1.05 (0.68 to 1.63)0.134*†1.17 (0.77 to 1.80)0.35\u2003Any weight23*−60 (−130 to 10)12†0.71 (0.55 to 0.91)9*†0.92 (0.68 to 1.24)Maternal weight change with intervention:\u2003Significantly reduced7−170 (−300 to −40)0.0025‡0.79 (0.50 to 1.25)0.702‡1.03 (0.74 to 1.42)0.78\u2003No significant change24−10 (−50 to −30)12‡0.88 (0.66 to 1.17)8‡0.95 (0.64 to 1.42)Risk of bias (allocation concealment):\u2003High risk26−60 (−120 to 0)0.33150.82 (0.63 to 1.08)0.6670.89 (0.63 to 1.25)0.35\u2003Low risk50 (−90 to 80)30.96 (0.51 to 1.80)41.13 (0.79 to 1.62)\n*Polley et al66data presented separately for normal weight women and overweight women.']	women26	UBERON_EXT	[26218]	[26225]	BMJ_2012_May_17_344_e2088_T349
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_97	[25444]	[26940]	['Caption (TABLE-WRAP): TABLE 5\n\nSubgroup analyses for trial methods and clinical characteristics for fetal outcomes in evaluation of dietary and lifestyle interventions in pregnancySubgroupBirth weight (g)Large for gestational ageSmall for gestational ageNo of studiesMean difference (95% CI)P value for interactionNo of studiesRelative risk (95% CI)P value for interactionNo of studiesRelative risk (95% CI)P value for interactionIntervention type:\u2003Diet10−60 (−190 to 80)0.2250.78 (0.51 to 1.19)0.1631.02 (0.75 to 1.37)0.76\u2003Physical activity14−60 (−120 to −10)40.52 (0.25 to 1.09)41.28 (0.52 to 3.15)\u2003Mixed710 (−50 to 70)91.05 (0.79 to 1.40)40.88 (0.53 to 1.44)Diabetic status:\u2003Women with diabetes5−60 (−170 to 50)0.80130.97(0.73 to 1.27)0.3431.03 (0.75 to 1.41)0.77\u2003Normal women26−40 (−100 to 10)50.76 (0.50 to 1.15)80.95 (0.64 to 1.42)BMI:\u2003Obese and overweight9*−20 (−90 to 50)0.437†1.05 (0.68 to 1.63)0.134*†1.17 (0.77 to 1.80)0.35\u2003Any weight23*−60 (−130 to 10)12†0.71 (0.55 to 0.91)9*†0.92 (0.68 to 1.24)Maternal weight change with intervention:\u2003Significantly reduced7−170 (−300 to −40)0.0025‡0.79 (0.50 to 1.25)0.702‡1.03 (0.74 to 1.42)0.78\u2003No significant change24−10 (−50 to −30)12‡0.88 (0.66 to 1.17)8‡0.95 (0.64 to 1.42)Risk of bias (allocation concealment):\u2003High risk26−60 (−120 to 0)0.33150.82 (0.63 to 1.08)0.6670.89 (0.63 to 1.25)0.35\u2003Low risk50 (−90 to 80)30.96 (0.51 to 1.80)41.13 (0.79 to 1.62)\n*Polley et al66data presented separately for normal weight women and overweight women.']	women	NCBITAXON_EXT	[26913]	[26918]	BMJ_2012_May_17_344_e2088_T266
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_97	[25444]	[26940]	['Caption (TABLE-WRAP): TABLE 5\n\nSubgroup analyses for trial methods and clinical characteristics for fetal outcomes in evaluation of dietary and lifestyle interventions in pregnancySubgroupBirth weight (g)Large for gestational ageSmall for gestational ageNo of studiesMean difference (95% CI)P value for interactionNo of studiesRelative risk (95% CI)P value for interactionNo of studiesRelative risk (95% CI)P value for interactionIntervention type:\u2003Diet10−60 (−190 to 80)0.2250.78 (0.51 to 1.19)0.1631.02 (0.75 to 1.37)0.76\u2003Physical activity14−60 (−120 to −10)40.52 (0.25 to 1.09)41.28 (0.52 to 3.15)\u2003Mixed710 (−50 to 70)91.05 (0.79 to 1.40)40.88 (0.53 to 1.44)Diabetic status:\u2003Women with diabetes5−60 (−170 to 50)0.80130.97(0.73 to 1.27)0.3431.03 (0.75 to 1.41)0.77\u2003Normal women26−40 (−100 to 10)50.76 (0.50 to 1.15)80.95 (0.64 to 1.42)BMI:\u2003Obese and overweight9*−20 (−90 to 50)0.437†1.05 (0.68 to 1.63)0.134*†1.17 (0.77 to 1.80)0.35\u2003Any weight23*−60 (−130 to 10)12†0.71 (0.55 to 0.91)9*†0.92 (0.68 to 1.24)Maternal weight change with intervention:\u2003Significantly reduced7−170 (−300 to −40)0.0025‡0.79 (0.50 to 1.25)0.702‡1.03 (0.74 to 1.42)0.78\u2003No significant change24−10 (−50 to −30)12‡0.88 (0.66 to 1.17)8‡0.95 (0.64 to 1.42)Risk of bias (allocation concealment):\u2003High risk26−60 (−120 to 0)0.33150.82 (0.63 to 1.08)0.6670.89 (0.63 to 1.25)0.35\u2003Low risk50 (−90 to 80)30.96 (0.51 to 1.80)41.13 (0.79 to 1.62)\n*Polley et al66data presented separately for normal weight women and overweight women.']	women	UBERON_EXT	[26913]	[26918]	BMJ_2012_May_17_344_e2088_T350
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_97	[25444]	[26940]	['Caption (TABLE-WRAP): TABLE 5\n\nSubgroup analyses for trial methods and clinical characteristics for fetal outcomes in evaluation of dietary and lifestyle interventions in pregnancySubgroupBirth weight (g)Large for gestational ageSmall for gestational ageNo of studiesMean difference (95% CI)P value for interactionNo of studiesRelative risk (95% CI)P value for interactionNo of studiesRelative risk (95% CI)P value for interactionIntervention type:\u2003Diet10−60 (−190 to 80)0.2250.78 (0.51 to 1.19)0.1631.02 (0.75 to 1.37)0.76\u2003Physical activity14−60 (−120 to −10)40.52 (0.25 to 1.09)41.28 (0.52 to 3.15)\u2003Mixed710 (−50 to 70)91.05 (0.79 to 1.40)40.88 (0.53 to 1.44)Diabetic status:\u2003Women with diabetes5−60 (−170 to 50)0.80130.97(0.73 to 1.27)0.3431.03 (0.75 to 1.41)0.77\u2003Normal women26−40 (−100 to 10)50.76 (0.50 to 1.15)80.95 (0.64 to 1.42)BMI:\u2003Obese and overweight9*−20 (−90 to 50)0.437†1.05 (0.68 to 1.63)0.134*†1.17 (0.77 to 1.80)0.35\u2003Any weight23*−60 (−130 to 10)12†0.71 (0.55 to 0.91)9*†0.92 (0.68 to 1.24)Maternal weight change with intervention:\u2003Significantly reduced7−170 (−300 to −40)0.0025‡0.79 (0.50 to 1.25)0.702‡1.03 (0.74 to 1.42)0.78\u2003No significant change24−10 (−50 to −30)12‡0.88 (0.66 to 1.17)8‡0.95 (0.64 to 1.42)Risk of bias (allocation concealment):\u2003High risk26−60 (−120 to 0)0.33150.82 (0.63 to 1.08)0.6670.89 (0.63 to 1.25)0.35\u2003Low risk50 (−90 to 80)30.96 (0.51 to 1.80)41.13 (0.79 to 1.62)\n*Polley et al66data presented separately for normal weight women and overweight women.']	women	NCBITAXON_EXT	[26934]	[26939]	BMJ_2012_May_17_344_e2088_T267
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_97	[25444]	[26940]	['Caption (TABLE-WRAP): TABLE 5\n\nSubgroup analyses for trial methods and clinical characteristics for fetal outcomes in evaluation of dietary and lifestyle interventions in pregnancySubgroupBirth weight (g)Large for gestational ageSmall for gestational ageNo of studiesMean difference (95% CI)P value for interactionNo of studiesRelative risk (95% CI)P value for interactionNo of studiesRelative risk (95% CI)P value for interactionIntervention type:\u2003Diet10−60 (−190 to 80)0.2250.78 (0.51 to 1.19)0.1631.02 (0.75 to 1.37)0.76\u2003Physical activity14−60 (−120 to −10)40.52 (0.25 to 1.09)41.28 (0.52 to 3.15)\u2003Mixed710 (−50 to 70)91.05 (0.79 to 1.40)40.88 (0.53 to 1.44)Diabetic status:\u2003Women with diabetes5−60 (−170 to 50)0.80130.97(0.73 to 1.27)0.3431.03 (0.75 to 1.41)0.77\u2003Normal women26−40 (−100 to 10)50.76 (0.50 to 1.15)80.95 (0.64 to 1.42)BMI:\u2003Obese and overweight9*−20 (−90 to 50)0.437†1.05 (0.68 to 1.63)0.134*†1.17 (0.77 to 1.80)0.35\u2003Any weight23*−60 (−130 to 10)12†0.71 (0.55 to 0.91)9*†0.92 (0.68 to 1.24)Maternal weight change with intervention:\u2003Significantly reduced7−170 (−300 to −40)0.0025‡0.79 (0.50 to 1.25)0.702‡1.03 (0.74 to 1.42)0.78\u2003No significant change24−10 (−50 to −30)12‡0.88 (0.66 to 1.17)8‡0.95 (0.64 to 1.42)Risk of bias (allocation concealment):\u2003High risk26−60 (−120 to 0)0.33150.82 (0.63 to 1.08)0.6670.89 (0.63 to 1.25)0.35\u2003Low risk50 (−90 to 80)30.96 (0.51 to 1.80)41.13 (0.79 to 1.62)\n*Polley et al66data presented separately for normal weight women and overweight women.']	women	UBERON_EXT	[26934]	[26939]	BMJ_2012_May_17_344_e2088_T351
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_98	[26941]	[27032]	['†Phelan 2011 et al65data presented separately for normal weight women and overweight women.']	women	NCBITAXON_EXT	[27005]	[27010]	BMJ_2012_May_17_344_e2088_T268
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_98	[26941]	[27032]	['†Phelan 2011 et al65data presented separately for normal weight women and overweight women.']	women	UBERON_EXT	[27005]	[27010]	BMJ_2012_May_17_344_e2088_T352
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_98	[26941]	[27032]	['†Phelan 2011 et al65data presented separately for normal weight women and overweight women.']	women	NCBITAXON_EXT	[27026]	[27031]	BMJ_2012_May_17_344_e2088_T269
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_98	[26941]	[27032]	['†Phelan 2011 et al65data presented separately for normal weight women and overweight women.']	women	UBERON_EXT	[27026]	[27031]	BMJ_2012_May_17_344_e2088_T353
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_99	[27033]	[27103]	['‡Ferrara 2011 et al58did not provide data for gestational weight gain.']	gestational	GO_BP_EXT	[27079]	[27090]	BMJ_2012_May_17_344_e2088_T146
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_100	[27104]	[27536]	['When we excluded studies on women with diabetes in pregnancy283132345758the sensitivity analysis consistently showed a overall reduction in gestational weight gain with interventions (mean difference −1.4 kg, 95% confidence interval −2.09 to −0.71 kg, P<0.001), including diet (−5.53 kg, −8.54 to −2.53 kg; P<0.001), physical activity (−0.72 kg, −1.2 to −0.25 kg, P=0.003), and mixed approach (−1.06 kg, −1.67 to −0.46 kg; P<0.001).']	women	NCBITAXON_EXT	[27132]	[27137]	BMJ_2012_May_17_344_e2088_T270
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_100	[27104]	[27536]	['When we excluded studies on women with diabetes in pregnancy283132345758the sensitivity analysis consistently showed a overall reduction in gestational weight gain with interventions (mean difference −1.4 kg, 95% confidence interval −2.09 to −0.71 kg, P<0.001), including diet (−5.53 kg, −8.54 to −2.53 kg; P<0.001), physical activity (−0.72 kg, −1.2 to −0.25 kg, P=0.003), and mixed approach (−1.06 kg, −1.67 to −0.46 kg; P<0.001).']	women	UBERON_EXT	[27132]	[27137]	BMJ_2012_May_17_344_e2088_T354
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_100	[27104]	[27536]	['When we excluded studies on women with diabetes in pregnancy283132345758the sensitivity analysis consistently showed a overall reduction in gestational weight gain with interventions (mean difference −1.4 kg, 95% confidence interval −2.09 to −0.71 kg, P<0.001), including diet (−5.53 kg, −8.54 to −2.53 kg; P<0.001), physical activity (−0.72 kg, −1.2 to −0.25 kg, P=0.003), and mixed approach (−1.06 kg, −1.67 to −0.46 kg; P<0.001).']	pregnancy283132345758the	GO_BP_EXT	[27155]	[27179]	BMJ_2012_May_17_344_e2088_T147
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_100	[27104]	[27536]	['When we excluded studies on women with diabetes in pregnancy283132345758the sensitivity analysis consistently showed a overall reduction in gestational weight gain with interventions (mean difference −1.4 kg, 95% confidence interval −2.09 to −0.71 kg, P<0.001), including diet (−5.53 kg, −8.54 to −2.53 kg; P<0.001), physical activity (−0.72 kg, −1.2 to −0.25 kg, P=0.003), and mixed approach (−1.06 kg, −1.67 to −0.46 kg; P<0.001).']	gestational	GO_BP_EXT	[27244]	[27255]	BMJ_2012_May_17_344_e2088_T148
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_101	[27537]	[27866]	['There was no significant reduction in birth weight with intervention (−40 g, −100 to 10 g).2627303335363738394042444546474849505253596162636566There were no differences between the groups in the incidence of babies who were small or large for gestational age or those with shoulder dystocia after we excluded women with diabetes.']	birth	GO_BP_EXT	[27575]	[27580]	BMJ_2012_May_17_344_e2088_T149
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_101	[27537]	[27866]	['There was no significant reduction in birth weight with intervention (−40 g, −100 to 10 g).2627303335363738394042444546474849505253596162636566There were no differences between the groups in the incidence of babies who were small or large for gestational age or those with shoulder dystocia after we excluded women with diabetes.']	gestational	GO_BP_EXT	[27780]	[27791]	BMJ_2012_May_17_344_e2088_T150
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_101	[27537]	[27866]	['There was no significant reduction in birth weight with intervention (−40 g, −100 to 10 g).2627303335363738394042444546474849505253596162636566There were no differences between the groups in the incidence of babies who were small or large for gestational age or those with shoulder dystocia after we excluded women with diabetes.']	shoulder	UBERON_EXT	[27810]	[27818]	BMJ_2012_May_17_344_e2088_T355
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_101	[27537]	[27866]	['There was no significant reduction in birth weight with intervention (−40 g, −100 to 10 g).2627303335363738394042444546474849505253596162636566There were no differences between the groups in the incidence of babies who were small or large for gestational age or those with shoulder dystocia after we excluded women with diabetes.']	women	NCBITAXON_EXT	[27846]	[27851]	BMJ_2012_May_17_344_e2088_T271
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_101	[27537]	[27866]	['There was no significant reduction in birth weight with intervention (−40 g, −100 to 10 g).2627303335363738394042444546474849505253596162636566There were no differences between the groups in the incidence of babies who were small or large for gestational age or those with shoulder dystocia after we excluded women with diabetes.']	women	UBERON_EXT	[27846]	[27851]	BMJ_2012_May_17_344_e2088_T356
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_102	[27867]	[28056]	['Dietary interventions in women without diabetes resulted in a significant reduction in preterm delivery (relative risk 0.26, 0.09 to 0.74) and gestational hypertension (0.30, 0.10 to 0.88).']	women	NCBITAXON_EXT	[27892]	[27897]	BMJ_2012_May_17_344_e2088_T272
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_102	[27867]	[28056]	['Dietary interventions in women without diabetes resulted in a significant reduction in preterm delivery (relative risk 0.26, 0.09 to 0.74) and gestational hypertension (0.30, 0.10 to 0.88).']	women	UBERON_EXT	[27892]	[27897]	BMJ_2012_May_17_344_e2088_T357
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_102	[27867]	[28056]	['Dietary interventions in women without diabetes resulted in a significant reduction in preterm delivery (relative risk 0.26, 0.09 to 0.74) and gestational hypertension (0.30, 0.10 to 0.88).']	delivery	GO_BP_EXT	[27962]	[27970]	BMJ_2012_May_17_344_e2088_T151
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_102	[27867]	[28056]	['Dietary interventions in women without diabetes resulted in a significant reduction in preterm delivery (relative risk 0.26, 0.09 to 0.74) and gestational hypertension (0.30, 0.10 to 0.88).']	gestational	GO_BP_EXT	[28010]	[28021]	BMJ_2012_May_17_344_e2088_T152
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_103	[28057]	[28183]	['There was a trend towards a reduction in pre-eclampsia (0.82, 0.43 to 1.42) in these women with diet that was not significant.']	women	NCBITAXON_EXT	[28142]	[28147]	BMJ_2012_May_17_344_e2088_T273
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_103	[28057]	[28183]	['There was a trend towards a reduction in pre-eclampsia (0.82, 0.43 to 1.42) in these women with diet that was not significant.']	women	UBERON_EXT	[28142]	[28147]	BMJ_2012_May_17_344_e2088_T358
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_104	[28184]	[28345]	['Interventions in obese and overweight pregnant women showed a reduction in gestational weight gain (mean difference −2.1 kg, −3.46 to −0.75 kg; P<0.002, I2=88%).']	pregnant	GO_BP_EXT	[28222]	[28230]	BMJ_2012_May_17_344_e2088_T153
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_104	[28184]	[28345]	['Interventions in obese and overweight pregnant women showed a reduction in gestational weight gain (mean difference −2.1 kg, −3.46 to −0.75 kg; P<0.002, I2=88%).']	women	NCBITAXON_EXT	[28231]	[28236]	BMJ_2012_May_17_344_e2088_T274
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_104	[28184]	[28345]	['Interventions in obese and overweight pregnant women showed a reduction in gestational weight gain (mean difference −2.1 kg, −3.46 to −0.75 kg; P<0.002, I2=88%).']	gestational	GO_BP_EXT	[28259]	[28270]	BMJ_2012_May_17_344_e2088_T154
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_106	[28425]	[28653]	['Dietary intervention in obese and overweight women significantly reduced the risk of pre-eclampsia (relative risk 0.63, 0.42 to 0.96), gestational diabetes (0.39, 0.23 to 0.69), and gestational hypertension (0.30, 0.10 to 0.88).']	women	NCBITAXON_EXT	[28470]	[28475]	BMJ_2012_May_17_344_e2088_T275
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_106	[28425]	[28653]	['Dietary intervention in obese and overweight women significantly reduced the risk of pre-eclampsia (relative risk 0.63, 0.42 to 0.96), gestational diabetes (0.39, 0.23 to 0.69), and gestational hypertension (0.30, 0.10 to 0.88).']	women	UBERON_EXT	[28470]	[28475]	BMJ_2012_May_17_344_e2088_T359
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_106	[28425]	[28653]	['Dietary intervention in obese and overweight women significantly reduced the risk of pre-eclampsia (relative risk 0.63, 0.42 to 0.96), gestational diabetes (0.39, 0.23 to 0.69), and gestational hypertension (0.30, 0.10 to 0.88).']	gestational	GO_BP_EXT	[28560]	[28571]	BMJ_2012_May_17_344_e2088_T155
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_106	[28425]	[28653]	['Dietary intervention in obese and overweight women significantly reduced the risk of pre-eclampsia (relative risk 0.63, 0.42 to 0.96), gestational diabetes (0.39, 0.23 to 0.69), and gestational hypertension (0.30, 0.10 to 0.88).']	gestational	GO_BP_EXT	[28607]	[28618]	BMJ_2012_May_17_344_e2088_T156
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_108	[28732]	[28977]	['After we excluded women with diabetes, the beneficial effect observed with diet persisted for gestational weight gain (mean difference −7.73 kg, −6.05 to −9.40 kg; P<0.001, I2=41%) and gestational hypertension (relative risk 0.30, 0.10 to 0.88).']	women	NCBITAXON_EXT	[28750]	[28755]	BMJ_2012_May_17_344_e2088_T276
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_108	[28732]	[28977]	['After we excluded women with diabetes, the beneficial effect observed with diet persisted for gestational weight gain (mean difference −7.73 kg, −6.05 to −9.40 kg; P<0.001, I2=41%) and gestational hypertension (relative risk 0.30, 0.10 to 0.88).']	women	UBERON_EXT	[28750]	[28755]	BMJ_2012_May_17_344_e2088_T360
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_108	[28732]	[28977]	['After we excluded women with diabetes, the beneficial effect observed with diet persisted for gestational weight gain (mean difference −7.73 kg, −6.05 to −9.40 kg; P<0.001, I2=41%) and gestational hypertension (relative risk 0.30, 0.10 to 0.88).']	gestational	GO_BP_EXT	[28826]	[28837]	BMJ_2012_May_17_344_e2088_T157
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_108	[28732]	[28977]	['After we excluded women with diabetes, the beneficial effect observed with diet persisted for gestational weight gain (mean difference −7.73 kg, −6.05 to −9.40 kg; P<0.001, I2=41%) and gestational hypertension (relative risk 0.30, 0.10 to 0.88).']	gestational	GO_BP_EXT	[28917]	[28928]	BMJ_2012_May_17_344_e2088_T158
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_109	[28978]	[29120]	['There was no increase in the risk of small for gestational age babies, and there was no effect on any of the other maternal or fetal outcomes.']	gestational	GO_BP_EXT	[29025]	[29036]	BMJ_2012_May_17_344_e2088_T159
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_110	[29122]	[29358]	['Rating the evidence\nThe Delphi survey of practicing clinicians determined the importance of the maternal and fetal outcomes.15The overall evidence rating was moderate for reduction in gestational weight gain (see appendix 2 on bmj.com).']	gestational	GO_BP_EXT	[29306]	[29317]	BMJ_2012_May_17_344_e2088_T160
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_111	[29359]	[29494]	['The rating was moderate for evidence of no effect observed with interventions on the risk of babies who were small for gestational age.']	babies	UBERON_EXT	[29452]	[29458]	BMJ_2012_May_17_344_e2088_T361
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_111	[29359]	[29494]	['The rating was moderate for evidence of no effect observed with interventions on the risk of babies who were small for gestational age.']	gestational	GO_BP_EXT	[29478]	[29489]	BMJ_2012_May_17_344_e2088_T161
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_112	[29495]	[29692]	['The rating for clinical outcomes such as pre-eclampsia, gestational diabetes, preterm delivery, gestational hypertension, admission to neonatal unit, and neonatal hypoglycaemia was low to very low.']	gestational	GO_BP_EXT	[29551]	[29562]	BMJ_2012_May_17_344_e2088_T162
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_112	[29495]	[29692]	['The rating for clinical outcomes such as pre-eclampsia, gestational diabetes, preterm delivery, gestational hypertension, admission to neonatal unit, and neonatal hypoglycaemia was low to very low.']	delivery	GO_BP_EXT	[29581]	[29589]	BMJ_2012_May_17_344_e2088_T163
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_112	[29495]	[29692]	['The rating for clinical outcomes such as pre-eclampsia, gestational diabetes, preterm delivery, gestational hypertension, admission to neonatal unit, and neonatal hypoglycaemia was low to very low.']	gestational	GO_BP_EXT	[29591]	[29602]	BMJ_2012_May_17_344_e2088_T164
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_112	[29495]	[29692]	['The rating for clinical outcomes such as pre-eclampsia, gestational diabetes, preterm delivery, gestational hypertension, admission to neonatal unit, and neonatal hypoglycaemia was low to very low.']	neonatal unit	UBERON_EXT	[29630]	[29643]	BMJ_2012_May_17_344_e2088_T362
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_112	[29495]	[29692]	['The rating for clinical outcomes such as pre-eclampsia, gestational diabetes, preterm delivery, gestational hypertension, admission to neonatal unit, and neonatal hypoglycaemia was low to very low.']	neonatal	UBERON_EXT	[29649]	[29657]	BMJ_2012_May_17_344_e2088_T363
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_113	[29693]	[29875]	['The evidence rating for the beneficial effect of diet was high for gestational hypertension, moderate for gestational diabetes, low for pre-eclampsia, and very low for preterm birth.']	gestational	GO_BP_EXT	[29760]	[29771]	BMJ_2012_May_17_344_e2088_T165
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_113	[29693]	[29875]	['The evidence rating for the beneficial effect of diet was high for gestational hypertension, moderate for gestational diabetes, low for pre-eclampsia, and very low for preterm birth.']	gestational	GO_BP_EXT	[29799]	[29810]	BMJ_2012_May_17_344_e2088_T166
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_113	[29693]	[29875]	['The evidence rating for the beneficial effect of diet was high for gestational hypertension, moderate for gestational diabetes, low for pre-eclampsia, and very low for preterm birth.']	preterm	GO_BP_EXT	[29861]	[29868]	BMJ_2012_May_17_344_e2088_T167
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_113	[29693]	[29875]	['The evidence rating for the beneficial effect of diet was high for gestational hypertension, moderate for gestational diabetes, low for pre-eclampsia, and very low for preterm birth.']	birth	GO_BP_EXT	[29869]	[29874]	BMJ_2012_May_17_344_e2088_T168
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_114	[29876]	[30256]	['Although clinicians judged thromboembolism, maternal admission to high dependency or intensive care unit, and long term neurological sequelae to the fetus as critically important outcomes, we did not identify evidence for these outcomes.15\n\nSafety of the interventions\nWe included 26 studies after reviewing 14\u2009832 citations to assess the safety of the interventions in pregnancy.']	thromboembolism	GO_BP_EXT	[29903]	[29918]	BMJ_2012_May_17_344_e2088_T169
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_114	[29876]	[30256]	['Although clinicians judged thromboembolism, maternal admission to high dependency or intensive care unit, and long term neurological sequelae to the fetus as critically important outcomes, we did not identify evidence for these outcomes.15\n\nSafety of the interventions\nWe included 26 studies after reviewing 14\u2009832 citations to assess the safety of the interventions in pregnancy.']	care	UBERON_EXT	[29971]	[29975]	BMJ_2012_May_17_344_e2088_T364
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_114	[29876]	[30256]	['Although clinicians judged thromboembolism, maternal admission to high dependency or intensive care unit, and long term neurological sequelae to the fetus as critically important outcomes, we did not identify evidence for these outcomes.15\n\nSafety of the interventions\nWe included 26 studies after reviewing 14\u2009832 citations to assess the safety of the interventions in pregnancy.']	neurological	UBERON_EXT	[29996]	[30008]	BMJ_2012_May_17_344_e2088_T365
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_114	[29876]	[30256]	['Although clinicians judged thromboembolism, maternal admission to high dependency or intensive care unit, and long term neurological sequelae to the fetus as critically important outcomes, we did not identify evidence for these outcomes.15\n\nSafety of the interventions\nWe included 26 studies after reviewing 14\u2009832 citations to assess the safety of the interventions in pregnancy.']	pregnancy	GO_BP_EXT	[30246]	[30255]	BMJ_2012_May_17_344_e2088_T170
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_115	[30257]	[30625]	['Of the included studies, two were randomised controlled trials (277 women)4064and 24 were observational studies (19 cohort studies and five case-control studies, 468\u2009581 women).686970717273747576777879808182838485868788899091The studies evaluated the effects of dietary, physical activity, and other lifestyle interventions in pregnancy on maternal and fetal outcomes.']	women	NCBITAXON_EXT	[30325]	[30330]	BMJ_2012_May_17_344_e2088_T277
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_115	[30257]	[30625]	['Of the included studies, two were randomised controlled trials (277 women)4064and 24 were observational studies (19 cohort studies and five case-control studies, 468\u2009581 women).686970717273747576777879808182838485868788899091The studies evaluated the effects of dietary, physical activity, and other lifestyle interventions in pregnancy on maternal and fetal outcomes.']	women	UBERON_EXT	[30325]	[30330]	BMJ_2012_May_17_344_e2088_T366
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_115	[30257]	[30625]	['Of the included studies, two were randomised controlled trials (277 women)4064and 24 were observational studies (19 cohort studies and five case-control studies, 468\u2009581 women).686970717273747576777879808182838485868788899091The studies evaluated the effects of dietary, physical activity, and other lifestyle interventions in pregnancy on maternal and fetal outcomes.']	women	NCBITAXON_EXT	[30427]	[30432]	BMJ_2012_May_17_344_e2088_T278
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_115	[30257]	[30625]	['Of the included studies, two were randomised controlled trials (277 women)4064and 24 were observational studies (19 cohort studies and five case-control studies, 468\u2009581 women).686970717273747576777879808182838485868788899091The studies evaluated the effects of dietary, physical activity, and other lifestyle interventions in pregnancy on maternal and fetal outcomes.']	women	UBERON_EXT	[30427]	[30432]	BMJ_2012_May_17_344_e2088_T367
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_115	[30257]	[30625]	['Of the included studies, two were randomised controlled trials (277 women)4064and 24 were observational studies (19 cohort studies and five case-control studies, 468\u2009581 women).686970717273747576777879808182838485868788899091The studies evaluated the effects of dietary, physical activity, and other lifestyle interventions in pregnancy on maternal and fetal outcomes.']	pregnancy	GO_BP_EXT	[30584]	[30593]	BMJ_2012_May_17_344_e2088_T171
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_116	[30626]	[30871]	['The two included randomised trials evaluated physical activity and did not show an increase in meconium staining of amniotic fluid (relative risk 0.62, 0.20 to 1.90), uterine atony (0.93, 0.22 to 3.89), or chorioamnionitis (3.69, 0.15 to 88.13).']	meconium	UBERON_EXT	[30721]	[30729]	BMJ_2012_May_17_344_e2088_T368
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_116	[30626]	[30871]	['The two included randomised trials evaluated physical activity and did not show an increase in meconium staining of amniotic fluid (relative risk 0.62, 0.20 to 1.90), uterine atony (0.93, 0.22 to 3.89), or chorioamnionitis (3.69, 0.15 to 88.13).']	amniotic fluid	UBERON_EXT	[30742]	[30756]	BMJ_2012_May_17_344_e2088_T369
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_116	[30626]	[30871]	['The two included randomised trials evaluated physical activity and did not show an increase in meconium staining of amniotic fluid (relative risk 0.62, 0.20 to 1.90), uterine atony (0.93, 0.22 to 3.89), or chorioamnionitis (3.69, 0.15 to 88.13).']	uterine	UBERON_EXT	[30793]	[30800]	BMJ_2012_May_17_344_e2088_T370
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_118	[30949]	[31080]	['Most of the included studies evaluated the effect of severe reduction in energy intake in extreme conditions such as war or famine.']	intake	GO_BP_EXT	[31029]	[31035]	BMJ_2012_May_17_344_e2088_T172
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_119	[31081]	[31744]	['There was an increase in the rate of neural tube defects and cleft lip and palate in babies of women with extreme forms of dieting and on diets with a high glycaemic index during pregnancy (see appendix 4 on bmj.com).89The risk of coronary artery disease, metabolic syndrome, breast cancer, and diabetes was increased in infants born to mothers whose diet had been severely restricted because of famine.72There were no significant maternal or fetal adverse effects such as cord abnormalities, threatened miscarriage, meconium stained liquor, abnormal fetal heart rate pattern, maternal sepsis, or chorioamnionitis observed with physical activity during pregnancy.']	neural tube	UBERON_EXT	[31118]	[31129]	BMJ_2012_May_17_344_e2088_T371
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_119	[31081]	[31744]	['There was an increase in the rate of neural tube defects and cleft lip and palate in babies of women with extreme forms of dieting and on diets with a high glycaemic index during pregnancy (see appendix 4 on bmj.com).89The risk of coronary artery disease, metabolic syndrome, breast cancer, and diabetes was increased in infants born to mothers whose diet had been severely restricted because of famine.72There were no significant maternal or fetal adverse effects such as cord abnormalities, threatened miscarriage, meconium stained liquor, abnormal fetal heart rate pattern, maternal sepsis, or chorioamnionitis observed with physical activity during pregnancy.']	lip	UBERON_EXT	[31148]	[31151]	BMJ_2012_May_17_344_e2088_T372
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_119	[31081]	[31744]	['There was an increase in the rate of neural tube defects and cleft lip and palate in babies of women with extreme forms of dieting and on diets with a high glycaemic index during pregnancy (see appendix 4 on bmj.com).89The risk of coronary artery disease, metabolic syndrome, breast cancer, and diabetes was increased in infants born to mothers whose diet had been severely restricted because of famine.72There were no significant maternal or fetal adverse effects such as cord abnormalities, threatened miscarriage, meconium stained liquor, abnormal fetal heart rate pattern, maternal sepsis, or chorioamnionitis observed with physical activity during pregnancy.']	palate	UBERON_EXT	[31156]	[31162]	BMJ_2012_May_17_344_e2088_T373
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_119	[31081]	[31744]	['There was an increase in the rate of neural tube defects and cleft lip and palate in babies of women with extreme forms of dieting and on diets with a high glycaemic index during pregnancy (see appendix 4 on bmj.com).89The risk of coronary artery disease, metabolic syndrome, breast cancer, and diabetes was increased in infants born to mothers whose diet had been severely restricted because of famine.72There were no significant maternal or fetal adverse effects such as cord abnormalities, threatened miscarriage, meconium stained liquor, abnormal fetal heart rate pattern, maternal sepsis, or chorioamnionitis observed with physical activity during pregnancy.']	babies	UBERON_EXT	[31166]	[31172]	BMJ_2012_May_17_344_e2088_T374
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_119	[31081]	[31744]	['There was an increase in the rate of neural tube defects and cleft lip and palate in babies of women with extreme forms of dieting and on diets with a high glycaemic index during pregnancy (see appendix 4 on bmj.com).89The risk of coronary artery disease, metabolic syndrome, breast cancer, and diabetes was increased in infants born to mothers whose diet had been severely restricted because of famine.72There were no significant maternal or fetal adverse effects such as cord abnormalities, threatened miscarriage, meconium stained liquor, abnormal fetal heart rate pattern, maternal sepsis, or chorioamnionitis observed with physical activity during pregnancy.']	women	NCBITAXON_EXT	[31176]	[31181]	BMJ_2012_May_17_344_e2088_T279
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_119	[31081]	[31744]	['There was an increase in the rate of neural tube defects and cleft lip and palate in babies of women with extreme forms of dieting and on diets with a high glycaemic index during pregnancy (see appendix 4 on bmj.com).89The risk of coronary artery disease, metabolic syndrome, breast cancer, and diabetes was increased in infants born to mothers whose diet had been severely restricted because of famine.72There were no significant maternal or fetal adverse effects such as cord abnormalities, threatened miscarriage, meconium stained liquor, abnormal fetal heart rate pattern, maternal sepsis, or chorioamnionitis observed with physical activity during pregnancy.']	women	UBERON_EXT	[31176]	[31181]	BMJ_2012_May_17_344_e2088_T375
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_119	[31081]	[31744]	['There was an increase in the rate of neural tube defects and cleft lip and palate in babies of women with extreme forms of dieting and on diets with a high glycaemic index during pregnancy (see appendix 4 on bmj.com).89The risk of coronary artery disease, metabolic syndrome, breast cancer, and diabetes was increased in infants born to mothers whose diet had been severely restricted because of famine.72There were no significant maternal or fetal adverse effects such as cord abnormalities, threatened miscarriage, meconium stained liquor, abnormal fetal heart rate pattern, maternal sepsis, or chorioamnionitis observed with physical activity during pregnancy.']	dieting	GO_BP_EXT	[31204]	[31211]	BMJ_2012_May_17_344_e2088_T173
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_119	[31081]	[31744]	['There was an increase in the rate of neural tube defects and cleft lip and palate in babies of women with extreme forms of dieting and on diets with a high glycaemic index during pregnancy (see appendix 4 on bmj.com).89The risk of coronary artery disease, metabolic syndrome, breast cancer, and diabetes was increased in infants born to mothers whose diet had been severely restricted because of famine.72There were no significant maternal or fetal adverse effects such as cord abnormalities, threatened miscarriage, meconium stained liquor, abnormal fetal heart rate pattern, maternal sepsis, or chorioamnionitis observed with physical activity during pregnancy.']	pregnancy	GO_BP_EXT	[31260]	[31269]	BMJ_2012_May_17_344_e2088_T174
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_119	[31081]	[31744]	['There was an increase in the rate of neural tube defects and cleft lip and palate in babies of women with extreme forms of dieting and on diets with a high glycaemic index during pregnancy (see appendix 4 on bmj.com).89The risk of coronary artery disease, metabolic syndrome, breast cancer, and diabetes was increased in infants born to mothers whose diet had been severely restricted because of famine.72There were no significant maternal or fetal adverse effects such as cord abnormalities, threatened miscarriage, meconium stained liquor, abnormal fetal heart rate pattern, maternal sepsis, or chorioamnionitis observed with physical activity during pregnancy.']	coronary artery	UBERON_EXT	[31312]	[31327]	BMJ_2012_May_17_344_e2088_T376
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_119	[31081]	[31744]	['There was an increase in the rate of neural tube defects and cleft lip and palate in babies of women with extreme forms of dieting and on diets with a high glycaemic index during pregnancy (see appendix 4 on bmj.com).89The risk of coronary artery disease, metabolic syndrome, breast cancer, and diabetes was increased in infants born to mothers whose diet had been severely restricted because of famine.72There were no significant maternal or fetal adverse effects such as cord abnormalities, threatened miscarriage, meconium stained liquor, abnormal fetal heart rate pattern, maternal sepsis, or chorioamnionitis observed with physical activity during pregnancy.']	metabolic	GO_BP_EXT	[31337]	[31346]	BMJ_2012_May_17_344_e2088_T175
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_119	[31081]	[31744]	['There was an increase in the rate of neural tube defects and cleft lip and palate in babies of women with extreme forms of dieting and on diets with a high glycaemic index during pregnancy (see appendix 4 on bmj.com).89The risk of coronary artery disease, metabolic syndrome, breast cancer, and diabetes was increased in infants born to mothers whose diet had been severely restricted because of famine.72There were no significant maternal or fetal adverse effects such as cord abnormalities, threatened miscarriage, meconium stained liquor, abnormal fetal heart rate pattern, maternal sepsis, or chorioamnionitis observed with physical activity during pregnancy.']	breast	UBERON_EXT	[31357]	[31363]	BMJ_2012_May_17_344_e2088_T377
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_119	[31081]	[31744]	['There was an increase in the rate of neural tube defects and cleft lip and palate in babies of women with extreme forms of dieting and on diets with a high glycaemic index during pregnancy (see appendix 4 on bmj.com).89The risk of coronary artery disease, metabolic syndrome, breast cancer, and diabetes was increased in infants born to mothers whose diet had been severely restricted because of famine.72There were no significant maternal or fetal adverse effects such as cord abnormalities, threatened miscarriage, meconium stained liquor, abnormal fetal heart rate pattern, maternal sepsis, or chorioamnionitis observed with physical activity during pregnancy.']	infants	UBERON_EXT	[31402]	[31409]	BMJ_2012_May_17_344_e2088_T378
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_119	[31081]	[31744]	['There was an increase in the rate of neural tube defects and cleft lip and palate in babies of women with extreme forms of dieting and on diets with a high glycaemic index during pregnancy (see appendix 4 on bmj.com).89The risk of coronary artery disease, metabolic syndrome, breast cancer, and diabetes was increased in infants born to mothers whose diet had been severely restricted because of famine.72There were no significant maternal or fetal adverse effects such as cord abnormalities, threatened miscarriage, meconium stained liquor, abnormal fetal heart rate pattern, maternal sepsis, or chorioamnionitis observed with physical activity during pregnancy.']	born	GO_BP_EXT	[31410]	[31414]	BMJ_2012_May_17_344_e2088_T176
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_119	[31081]	[31744]	['There was an increase in the rate of neural tube defects and cleft lip and palate in babies of women with extreme forms of dieting and on diets with a high glycaemic index during pregnancy (see appendix 4 on bmj.com).89The risk of coronary artery disease, metabolic syndrome, breast cancer, and diabetes was increased in infants born to mothers whose diet had been severely restricted because of famine.72There were no significant maternal or fetal adverse effects such as cord abnormalities, threatened miscarriage, meconium stained liquor, abnormal fetal heart rate pattern, maternal sepsis, or chorioamnionitis observed with physical activity during pregnancy.']	cord	UBERON_EXT	[31554]	[31558]	BMJ_2012_May_17_344_e2088_T379
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_119	[31081]	[31744]	['There was an increase in the rate of neural tube defects and cleft lip and palate in babies of women with extreme forms of dieting and on diets with a high glycaemic index during pregnancy (see appendix 4 on bmj.com).89The risk of coronary artery disease, metabolic syndrome, breast cancer, and diabetes was increased in infants born to mothers whose diet had been severely restricted because of famine.72There were no significant maternal or fetal adverse effects such as cord abnormalities, threatened miscarriage, meconium stained liquor, abnormal fetal heart rate pattern, maternal sepsis, or chorioamnionitis observed with physical activity during pregnancy.']	miscarriage	GO_BP_EXT	[31585]	[31596]	BMJ_2012_May_17_344_e2088_T177
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_119	[31081]	[31744]	['There was an increase in the rate of neural tube defects and cleft lip and palate in babies of women with extreme forms of dieting and on diets with a high glycaemic index during pregnancy (see appendix 4 on bmj.com).89The risk of coronary artery disease, metabolic syndrome, breast cancer, and diabetes was increased in infants born to mothers whose diet had been severely restricted because of famine.72There were no significant maternal or fetal adverse effects such as cord abnormalities, threatened miscarriage, meconium stained liquor, abnormal fetal heart rate pattern, maternal sepsis, or chorioamnionitis observed with physical activity during pregnancy.']	meconium	CHEBI_EXT	[31598]	[31606]	BMJ_2012_May_17_344_e2088_T4
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_119	[31081]	[31744]	['There was an increase in the rate of neural tube defects and cleft lip and palate in babies of women with extreme forms of dieting and on diets with a high glycaemic index during pregnancy (see appendix 4 on bmj.com).89The risk of coronary artery disease, metabolic syndrome, breast cancer, and diabetes was increased in infants born to mothers whose diet had been severely restricted because of famine.72There were no significant maternal or fetal adverse effects such as cord abnormalities, threatened miscarriage, meconium stained liquor, abnormal fetal heart rate pattern, maternal sepsis, or chorioamnionitis observed with physical activity during pregnancy.']	meconium	UBERON_EXT	[31598]	[31606]	BMJ_2012_May_17_344_e2088_T380
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_119	[31081]	[31744]	['There was an increase in the rate of neural tube defects and cleft lip and palate in babies of women with extreme forms of dieting and on diets with a high glycaemic index during pregnancy (see appendix 4 on bmj.com).89The risk of coronary artery disease, metabolic syndrome, breast cancer, and diabetes was increased in infants born to mothers whose diet had been severely restricted because of famine.72There were no significant maternal or fetal adverse effects such as cord abnormalities, threatened miscarriage, meconium stained liquor, abnormal fetal heart rate pattern, maternal sepsis, or chorioamnionitis observed with physical activity during pregnancy.']	heart	UBERON_EXT	[31638]	[31643]	BMJ_2012_May_17_344_e2088_T381
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_119	[31081]	[31744]	['There was an increase in the rate of neural tube defects and cleft lip and palate in babies of women with extreme forms of dieting and on diets with a high glycaemic index during pregnancy (see appendix 4 on bmj.com).89The risk of coronary artery disease, metabolic syndrome, breast cancer, and diabetes was increased in infants born to mothers whose diet had been severely restricted because of famine.72There were no significant maternal or fetal adverse effects such as cord abnormalities, threatened miscarriage, meconium stained liquor, abnormal fetal heart rate pattern, maternal sepsis, or chorioamnionitis observed with physical activity during pregnancy.']	pregnancy	GO_BP_EXT	[31734]	[31743]	BMJ_2012_May_17_344_e2088_T178
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_120	[31746]	[31956]	['Discussion\n\nSummary of the findings\nDietary and lifestyle interventions in pregnancy are effective in reducing gestational weight gain without any adverse effect on the risk of babies small for gestational age.']	pregnancy	GO_BP_EXT	[31821]	[31830]	BMJ_2012_May_17_344_e2088_T179
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_120	[31746]	[31956]	['Discussion\n\nSummary of the findings\nDietary and lifestyle interventions in pregnancy are effective in reducing gestational weight gain without any adverse effect on the risk of babies small for gestational age.']	gestational	GO_BP_EXT	[31857]	[31868]	BMJ_2012_May_17_344_e2088_T180
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_120	[31746]	[31956]	['Discussion\n\nSummary of the findings\nDietary and lifestyle interventions in pregnancy are effective in reducing gestational weight gain without any adverse effect on the risk of babies small for gestational age.']	gestational	GO_BP_EXT	[31940]	[31951]	BMJ_2012_May_17_344_e2088_T181
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_121	[31957]	[32105]	['Compared with physical activity and a mixed approach, dietary interventions were associated with the greatest reduction in weight gain in pregnancy.']	pregnancy	GO_BP_EXT	[32095]	[32104]	BMJ_2012_May_17_344_e2088_T182
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_123	[32189]	[32363]	['There was an overall trend towards reduction in gestational diabetes, gestational hypertension, preterm birth, and intrauterine death with intervention compared with control.']	gestational	GO_BP_EXT	[32237]	[32248]	BMJ_2012_May_17_344_e2088_T183
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_123	[32189]	[32363]	['There was an overall trend towards reduction in gestational diabetes, gestational hypertension, preterm birth, and intrauterine death with intervention compared with control.']	gestational	GO_BP_EXT	[32259]	[32270]	BMJ_2012_May_17_344_e2088_T184
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_123	[32189]	[32363]	['There was an overall trend towards reduction in gestational diabetes, gestational hypertension, preterm birth, and intrauterine death with intervention compared with control.']	birth	GO_BP_EXT	[32293]	[32298]	BMJ_2012_May_17_344_e2088_T185
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_123	[32189]	[32363]	['There was an overall trend towards reduction in gestational diabetes, gestational hypertension, preterm birth, and intrauterine death with intervention compared with control.']	intrauterine	UBERON_EXT	[32304]	[32316]	BMJ_2012_May_17_344_e2088_T382
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_123	[32189]	[32363]	['There was an overall trend towards reduction in gestational diabetes, gestational hypertension, preterm birth, and intrauterine death with intervention compared with control.']	death	GO_BP_EXT	[32317]	[32322]	BMJ_2012_May_17_344_e2088_T186
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_124	[32364]	[32537]	['Diet in particular, significantly reduced the risk of pre-eclampsia, gestational diabetes, gestational hypertension, and preterm births compared with any other intervention.']	gestational	GO_BP_EXT	[32433]	[32444]	BMJ_2012_May_17_344_e2088_T187
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_124	[32364]	[32537]	['Diet in particular, significantly reduced the risk of pre-eclampsia, gestational diabetes, gestational hypertension, and preterm births compared with any other intervention.']	gestational	GO_BP_EXT	[32455]	[32466]	BMJ_2012_May_17_344_e2088_T188
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_126	[32643]	[32763]	['Furthermore, there was no evidence that the interventions reduced the rates of caesarean section or induction of labour.']	labour	GO_BP_EXT	[32756]	[32762]	BMJ_2012_May_17_344_e2088_T189
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_127	[32764]	[32915]	['The rating of evidence quality was moderate (see appendix 2 on bmj.com) for the lack of effect observed with interventions on size for gestational age.']	gestational	GO_BP_EXT	[32899]	[32910]	BMJ_2012_May_17_344_e2088_T190
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_128	[32916]	[33054]	['The quality of evidence for the benefit observed with interventions on gestational weight gain was moderate but low for clinical outcomes.']	gestational	GO_BP_EXT	[32987]	[32998]	BMJ_2012_May_17_344_e2088_T191
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_131	[33410]	[33587]	['Most of the published reviews on effects of dietary and lifestyle interventions on maternal and fetal outcomes were limited to specific groups of women or types of intervention.']	women	NCBITAXON_EXT	[33556]	[33561]	BMJ_2012_May_17_344_e2088_T280
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_131	[33410]	[33587]	['Most of the published reviews on effects of dietary and lifestyle interventions on maternal and fetal outcomes were limited to specific groups of women or types of intervention.']	women	UBERON_EXT	[33556]	[33561]	BMJ_2012_May_17_344_e2088_T383
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_134	[33844]	[33960]	['Reliable data were identified on clinically important outcomes related to weight and pregnancy by the Delphi survey.']	pregnancy	GO_BP_EXT	[33929]	[33938]	BMJ_2012_May_17_344_e2088_T192
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_141	[34692]	[34952]	['The quality across various outcomes assessed by GRADE was moderate for the benefit observed with gestational weight gain but low for other important obstetric outcomes such as pre-eclampsia, gestational diabetes, gestational hypertension, and preterm delivery.']	gestational	GO_BP_EXT	[34789]	[34800]	BMJ_2012_May_17_344_e2088_T193
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_141	[34692]	[34952]	['The quality across various outcomes assessed by GRADE was moderate for the benefit observed with gestational weight gain but low for other important obstetric outcomes such as pre-eclampsia, gestational diabetes, gestational hypertension, and preterm delivery.']	gestational	GO_BP_EXT	[34883]	[34894]	BMJ_2012_May_17_344_e2088_T194
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_141	[34692]	[34952]	['The quality across various outcomes assessed by GRADE was moderate for the benefit observed with gestational weight gain but low for other important obstetric outcomes such as pre-eclampsia, gestational diabetes, gestational hypertension, and preterm delivery.']	gestational	GO_BP_EXT	[34905]	[34916]	BMJ_2012_May_17_344_e2088_T195
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_141	[34692]	[34952]	['The quality across various outcomes assessed by GRADE was moderate for the benefit observed with gestational weight gain but low for other important obstetric outcomes such as pre-eclampsia, gestational diabetes, gestational hypertension, and preterm delivery.']	delivery	GO_BP_EXT	[34943]	[34951]	BMJ_2012_May_17_344_e2088_T196
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_145	[35378]	[35651]	['Further information is needed on characteristics of included women—such as age, ethnicity, socioeconomic status, parity, and underlying medical conditions—and characteristics of the interventions—such as frequency, duration, and intensity—that could influence the outcomes.']	women	NCBITAXON_EXT	[35439]	[35444]	BMJ_2012_May_17_344_e2088_T281
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_145	[35378]	[35651]	['Further information is needed on characteristics of included women—such as age, ethnicity, socioeconomic status, parity, and underlying medical conditions—and characteristics of the interventions—such as frequency, duration, and intensity—that could influence the outcomes.']	women	UBERON_EXT	[35439]	[35444]	BMJ_2012_May_17_344_e2088_T384
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_146	[35652]	[35806]	['We were limited in our ability to identify the optimal weight change in pregnancy with interventions that would minimise maternal and fetal complications.']	pregnancy	GO_BP_EXT	[35724]	[35733]	BMJ_2012_May_17_344_e2088_T197
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_149	[36178]	[36373]	['Although the Delphi panel of clinicians identified long term neurological sequelae and metabolic syndrome of the fetuses exposed to the intervention, they were not reported in any of the studies.']	neurological	UBERON_EXT	[36239]	[36251]	BMJ_2012_May_17_344_e2088_T385
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_149	[36178]	[36373]	['Although the Delphi panel of clinicians identified long term neurological sequelae and metabolic syndrome of the fetuses exposed to the intervention, they were not reported in any of the studies.']	metabolic	GO_BP_EXT	[36265]	[36274]	BMJ_2012_May_17_344_e2088_T198
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_151	[36537]	[36803]	['The evidence of any adverse effects from diet in pregnancy was usually from observational studies on extremes of weight reduction diets or those on intake of food with a very high or low glycaemic index.89These findings do not apply to the interventions we reviewed.']	pregnancy	GO_BP_EXT	[36586]	[36595]	BMJ_2012_May_17_344_e2088_T199
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_151	[36537]	[36803]	['The evidence of any adverse effects from diet in pregnancy was usually from observational studies on extremes of weight reduction diets or those on intake of food with a very high or low glycaemic index.89These findings do not apply to the interventions we reviewed.']	intake of	GO_BP_EXT	[36685]	[36694]	BMJ_2012_May_17_344_e2088_T200
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_151	[36537]	[36803]	['The evidence of any adverse effects from diet in pregnancy was usually from observational studies on extremes of weight reduction diets or those on intake of food with a very high or low glycaemic index.89These findings do not apply to the interventions we reviewed.']	food	CHEBI_EXT	[36695]	[36699]	BMJ_2012_May_17_344_e2088_T5
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_152	[36804]	[36945]	['We also observed that reduction in weight gain in pregnancy was not associated with an increase in babies who were small for gestational age.']	pregnancy	GO_BP_EXT	[36854]	[36863]	BMJ_2012_May_17_344_e2088_T201
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_152	[36804]	[36945]	['We also observed that reduction in weight gain in pregnancy was not associated with an increase in babies who were small for gestational age.']	gestational	GO_BP_EXT	[36929]	[36940]	BMJ_2012_May_17_344_e2088_T202
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_153	[36946]	[37101]	['Observational studies on physical activity in pregnancy did not show any significant adverse maternal or fetal outcome for activities of varying intensity.']	pregnancy	GO_BP_EXT	[36992]	[37001]	BMJ_2012_May_17_344_e2088_T203
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_154	[37103]	[37358]	['Clinical and practical implications\nOur findings suggest that interventions based on diet in pregnancy would reduce the gestational weight gain by 4 kg, on average, compared with 0.7 kg and 1.0 kg with physical activity and a mixed approach, respectively.']	pregnancy	GO_BP_EXT	[37196]	[37205]	BMJ_2012_May_17_344_e2088_T204
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_154	[37103]	[37358]	['Clinical and practical implications\nOur findings suggest that interventions based on diet in pregnancy would reduce the gestational weight gain by 4 kg, on average, compared with 0.7 kg and 1.0 kg with physical activity and a mixed approach, respectively.']	gestational	GO_BP_EXT	[37223]	[37234]	BMJ_2012_May_17_344_e2088_T205
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_155	[37359]	[37519]	['Dietary interventions were most effective in reducing complications such as pre-eclampsia, gestational diabetes, gestational hypertension, and preterm delivery.']	gestational	GO_BP_EXT	[37450]	[37461]	BMJ_2012_May_17_344_e2088_T206
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_155	[37359]	[37519]	['Dietary interventions were most effective in reducing complications such as pre-eclampsia, gestational diabetes, gestational hypertension, and preterm delivery.']	gestational	GO_BP_EXT	[37472]	[37483]	BMJ_2012_May_17_344_e2088_T207
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_155	[37359]	[37519]	['Dietary interventions were most effective in reducing complications such as pre-eclampsia, gestational diabetes, gestational hypertension, and preterm delivery.']	delivery	GO_BP_EXT	[37510]	[37518]	BMJ_2012_May_17_344_e2088_T208
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_158	[37809]	[38156]	['The diet based interventions effective in reducing weight gain in pregnancy included a balanced diet of 18-24 kJ/kg, a low glycaemic diet with unprocessed whole grains, fruits, beans and vegetables, and a healthy diet with a maximum of 30% fat, 15-20% protein, and 50-55% carbohydrate, with energy intake individualised to the needs of the mother.']	pregnancy	GO_BP_EXT	[37875]	[37884]	BMJ_2012_May_17_344_e2088_T209
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_158	[37809]	[38156]	['The diet based interventions effective in reducing weight gain in pregnancy included a balanced diet of 18-24 kJ/kg, a low glycaemic diet with unprocessed whole grains, fruits, beans and vegetables, and a healthy diet with a maximum of 30% fat, 15-20% protein, and 50-55% carbohydrate, with energy intake individualised to the needs of the mother.']	glycaemic	GO_BP_EXT	[37932]	[37941]	BMJ_2012_May_17_344_e2088_T210
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_158	[37809]	[38156]	['The diet based interventions effective in reducing weight gain in pregnancy included a balanced diet of 18-24 kJ/kg, a low glycaemic diet with unprocessed whole grains, fruits, beans and vegetables, and a healthy diet with a maximum of 30% fat, 15-20% protein, and 50-55% carbohydrate, with energy intake individualised to the needs of the mother.']	unprocessed	SO_EXT	[37952]	[37963]	BMJ_2012_May_17_344_e2088_T290
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_158	[37809]	[38156]	['The diet based interventions effective in reducing weight gain in pregnancy included a balanced diet of 18-24 kJ/kg, a low glycaemic diet with unprocessed whole grains, fruits, beans and vegetables, and a healthy diet with a maximum of 30% fat, 15-20% protein, and 50-55% carbohydrate, with energy intake individualised to the needs of the mother.']	fat	CHEBI_EXT	[38049]	[38052]	BMJ_2012_May_17_344_e2088_T6
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_158	[37809]	[38156]	['The diet based interventions effective in reducing weight gain in pregnancy included a balanced diet of 18-24 kJ/kg, a low glycaemic diet with unprocessed whole grains, fruits, beans and vegetables, and a healthy diet with a maximum of 30% fat, 15-20% protein, and 50-55% carbohydrate, with energy intake individualised to the needs of the mother.']	fat	CHEBI_EXT	[38049]	[38052]	BMJ_2012_May_17_344_e2088_T386
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_158	[37809]	[38156]	['The diet based interventions effective in reducing weight gain in pregnancy included a balanced diet of 18-24 kJ/kg, a low glycaemic diet with unprocessed whole grains, fruits, beans and vegetables, and a healthy diet with a maximum of 30% fat, 15-20% protein, and 50-55% carbohydrate, with energy intake individualised to the needs of the mother.']	protein	CHEBI_EXT	[38061]	[38068]	BMJ_2012_May_17_344_e2088_T7
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_158	[37809]	[38156]	['The diet based interventions effective in reducing weight gain in pregnancy included a balanced diet of 18-24 kJ/kg, a low glycaemic diet with unprocessed whole grains, fruits, beans and vegetables, and a healthy diet with a maximum of 30% fat, 15-20% protein, and 50-55% carbohydrate, with energy intake individualised to the needs of the mother.']	protein	CHEBI_EXT	[38061]	[38068]	BMJ_2012_May_17_344_e2088_T287
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_158	[37809]	[38156]	['The diet based interventions effective in reducing weight gain in pregnancy included a balanced diet of 18-24 kJ/kg, a low glycaemic diet with unprocessed whole grains, fruits, beans and vegetables, and a healthy diet with a maximum of 30% fat, 15-20% protein, and 50-55% carbohydrate, with energy intake individualised to the needs of the mother.']	carbohydrate	CHEBI_EXT	[38081]	[38093]	BMJ_2012_May_17_344_e2088_T8
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_158	[37809]	[38156]	['The diet based interventions effective in reducing weight gain in pregnancy included a balanced diet of 18-24 kJ/kg, a low glycaemic diet with unprocessed whole grains, fruits, beans and vegetables, and a healthy diet with a maximum of 30% fat, 15-20% protein, and 50-55% carbohydrate, with energy intake individualised to the needs of the mother.']	intake	GO_BP_EXT	[38107]	[38113]	BMJ_2012_May_17_344_e2088_T211
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_159	[38157]	[38336]	['Provision of regular input on planned nutritional intake from early pregnancy through dedicated dietetic teams in primary and secondary care has the potential to improve outcomes.']	nutritional	GO_BP_EXT	[38195]	[38206]	BMJ_2012_May_17_344_e2088_T212
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_159	[38157]	[38336]	['Provision of regular input on planned nutritional intake from early pregnancy through dedicated dietetic teams in primary and secondary care has the potential to improve outcomes.']	intake	GO_BP_EXT	[38207]	[38213]	BMJ_2012_May_17_344_e2088_T213
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_159	[38157]	[38336]	['Provision of regular input on planned nutritional intake from early pregnancy through dedicated dietetic teams in primary and secondary care has the potential to improve outcomes.']	pregnancy	GO_BP_EXT	[38225]	[38234]	BMJ_2012_May_17_344_e2088_T214
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_159	[38157]	[38336]	['Provision of regular input on planned nutritional intake from early pregnancy through dedicated dietetic teams in primary and secondary care has the potential to improve outcomes.']	pregnancy	UBERON_EXT	[38225]	[38234]	BMJ_2012_May_17_344_e2088_T387
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_159	[38157]	[38336]	['Provision of regular input on planned nutritional intake from early pregnancy through dedicated dietetic teams in primary and secondary care has the potential to improve outcomes.']	dietetic	GO_BP_EXT	[38253]	[38261]	BMJ_2012_May_17_344_e2088_T215
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_160	[38337]	[38424]	['Overweight and obese women benefit the most and could be targeted in clinical practice.']	women	NCBITAXON_EXT	[38358]	[38363]	BMJ_2012_May_17_344_e2088_T282
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_160	[38337]	[38424]	['Overweight and obese women benefit the most and could be targeted in clinical practice.']	women	UBERON_EXT	[38358]	[38363]	BMJ_2012_May_17_344_e2088_T388
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_163	[38645]	[38874]	['With lack of individual data on important factors such as age, ethnicity, socioeconomic status, compliance, and other risk factors, we are limited in our explanation for the benefit observed with diet compared with other methods.']	individual	NCBITAXON_EXT	[38658]	[38668]	BMJ_2012_May_17_344_e2088_T283
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_166	[39074]	[39205]	['In “mixed approaches” the individual components might not be delivered to the same standard as in studies that focus on diet alone.']	delivered	GO_BP_EXT	[39135]	[39144]	BMJ_2012_May_17_344_e2088_T216
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_167	[39206]	[39540]	['Secondly, compliance might have been better in trials with a diet only intervention than other methods because of its relative simplicity and perceived safety in contrast with physical activity in pregnancy.9394Thirdly, specific components of the diet, such as fibre, might have benefits that are not evident with other interventions.']	pregnancy	GO_BP_EXT	[39403]	[39412]	BMJ_2012_May_17_344_e2088_T217
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_167	[39206]	[39540]	['Secondly, compliance might have been better in trials with a diet only intervention than other methods because of its relative simplicity and perceived safety in contrast with physical activity in pregnancy.9394Thirdly, specific components of the diet, such as fibre, might have benefits that are not evident with other interventions.']	fibre	CHEBI_EXT	[39467]	[39472]	BMJ_2012_May_17_344_e2088_T9
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_168	[39541]	[40064]	['Raised triglyceride concentrations in pregnancy are associated with the risk of pre-eclampsia.95There is a known reduction in the incidence of pre-eclampsia by up to 70% associated with a fall in the concentrations of triglycerides in women with the highest quarter of dietary fibre intake compared with the lowest quarter after adjustment for confounders.96The high fibre in the dietary intervention of the included studies could have influenced the beneficial effect observed with reduction in the rates of pre-eclampsia.']	triglyceride	CHEBI_EXT	[39548]	[39560]	BMJ_2012_May_17_344_e2088_T10
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_168	[39541]	[40064]	['Raised triglyceride concentrations in pregnancy are associated with the risk of pre-eclampsia.95There is a known reduction in the incidence of pre-eclampsia by up to 70% associated with a fall in the concentrations of triglycerides in women with the highest quarter of dietary fibre intake compared with the lowest quarter after adjustment for confounders.96The high fibre in the dietary intervention of the included studies could have influenced the beneficial effect observed with reduction in the rates of pre-eclampsia.']	pregnancy	GO_BP_EXT	[39579]	[39588]	BMJ_2012_May_17_344_e2088_T218
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_168	[39541]	[40064]	['Raised triglyceride concentrations in pregnancy are associated with the risk of pre-eclampsia.95There is a known reduction in the incidence of pre-eclampsia by up to 70% associated with a fall in the concentrations of triglycerides in women with the highest quarter of dietary fibre intake compared with the lowest quarter after adjustment for confounders.96The high fibre in the dietary intervention of the included studies could have influenced the beneficial effect observed with reduction in the rates of pre-eclampsia.']	triglycerides	CHEBI_EXT	[39759]	[39772]	BMJ_2012_May_17_344_e2088_T11
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_168	[39541]	[40064]	['Raised triglyceride concentrations in pregnancy are associated with the risk of pre-eclampsia.95There is a known reduction in the incidence of pre-eclampsia by up to 70% associated with a fall in the concentrations of triglycerides in women with the highest quarter of dietary fibre intake compared with the lowest quarter after adjustment for confounders.96The high fibre in the dietary intervention of the included studies could have influenced the beneficial effect observed with reduction in the rates of pre-eclampsia.']	women	NCBITAXON_EXT	[39776]	[39781]	BMJ_2012_May_17_344_e2088_T284
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_168	[39541]	[40064]	['Raised triglyceride concentrations in pregnancy are associated with the risk of pre-eclampsia.95There is a known reduction in the incidence of pre-eclampsia by up to 70% associated with a fall in the concentrations of triglycerides in women with the highest quarter of dietary fibre intake compared with the lowest quarter after adjustment for confounders.96The high fibre in the dietary intervention of the included studies could have influenced the beneficial effect observed with reduction in the rates of pre-eclampsia.']	women	UBERON_EXT	[39776]	[39781]	BMJ_2012_May_17_344_e2088_T389
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_168	[39541]	[40064]	['Raised triglyceride concentrations in pregnancy are associated with the risk of pre-eclampsia.95There is a known reduction in the incidence of pre-eclampsia by up to 70% associated with a fall in the concentrations of triglycerides in women with the highest quarter of dietary fibre intake compared with the lowest quarter after adjustment for confounders.96The high fibre in the dietary intervention of the included studies could have influenced the beneficial effect observed with reduction in the rates of pre-eclampsia.']	fibre	CHEBI_EXT	[39818]	[39823]	BMJ_2012_May_17_344_e2088_T12
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_168	[39541]	[40064]	['Raised triglyceride concentrations in pregnancy are associated with the risk of pre-eclampsia.95There is a known reduction in the incidence of pre-eclampsia by up to 70% associated with a fall in the concentrations of triglycerides in women with the highest quarter of dietary fibre intake compared with the lowest quarter after adjustment for confounders.96The high fibre in the dietary intervention of the included studies could have influenced the beneficial effect observed with reduction in the rates of pre-eclampsia.']	fibre	CHEBI_EXT	[39908]	[39913]	BMJ_2012_May_17_344_e2088_T13
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_169	[40065]	[40531]	['The economic evaluation undertaken by the National Institute for Health and Clinical Excellence on non-pharmacological interventions for weight management outside pregnancy reported that diet based interventions were cheaper than interventions based on physical activity.97With the clear benefit in gestational weight gain observed with dietary interventions in pregnancy, there is a potential for this strategy to be also cost effective compared with other methods.']	pharmacological	CHEBI_EXT	[40168]	[40183]	BMJ_2012_May_17_344_e2088_T14
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_169	[40065]	[40531]	['The economic evaluation undertaken by the National Institute for Health and Clinical Excellence on non-pharmacological interventions for weight management outside pregnancy reported that diet based interventions were cheaper than interventions based on physical activity.97With the clear benefit in gestational weight gain observed with dietary interventions in pregnancy, there is a potential for this strategy to be also cost effective compared with other methods.']	management	GO_BP_EXT	[40209]	[40219]	BMJ_2012_May_17_344_e2088_T219
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_169	[40065]	[40531]	['The economic evaluation undertaken by the National Institute for Health and Clinical Excellence on non-pharmacological interventions for weight management outside pregnancy reported that diet based interventions were cheaper than interventions based on physical activity.97With the clear benefit in gestational weight gain observed with dietary interventions in pregnancy, there is a potential for this strategy to be also cost effective compared with other methods.']	pregnancy	GO_BP_EXT	[40228]	[40237]	BMJ_2012_May_17_344_e2088_T220
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_169	[40065]	[40531]	['The economic evaluation undertaken by the National Institute for Health and Clinical Excellence on non-pharmacological interventions for weight management outside pregnancy reported that diet based interventions were cheaper than interventions based on physical activity.97With the clear benefit in gestational weight gain observed with dietary interventions in pregnancy, there is a potential for this strategy to be also cost effective compared with other methods.']	gestational	GO_BP_EXT	[40364]	[40375]	BMJ_2012_May_17_344_e2088_T221
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_169	[40065]	[40531]	['The economic evaluation undertaken by the National Institute for Health and Clinical Excellence on non-pharmacological interventions for weight management outside pregnancy reported that diet based interventions were cheaper than interventions based on physical activity.97With the clear benefit in gestational weight gain observed with dietary interventions in pregnancy, there is a potential for this strategy to be also cost effective compared with other methods.']	pregnancy	GO_BP_EXT	[40427]	[40436]	BMJ_2012_May_17_344_e2088_T222
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_170	[40533]	[40837]	['Recommendations for future research\nSynthesis of patient level data by individual patient data meta-analysis is needed to assess any differential effect of the benefits observed with interventions in various groups based on BMI, age, ethnicity, socioeconomic status, parity, and risk status in pregnancy.']	pregnancy	GO_BP_EXT	[40827]	[40836]	BMJ_2012_May_17_344_e2088_T223
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_171	[40838]	[41328]	['Availability of the raw data will substantially increase the power to detect baseline factors that truly modify the intervention effect98and will enable intervention effects to be quantified for clinically relevant groups.99In addition, individual patient data meta-analysis will be able to assess whether the improvement in clinical outcomes is related to reduction in gestational weight gain alone or if there is any added benefit from the type of intervention resulting in weight change.']	gestational	GO_BP_EXT	[41208]	[41219]	BMJ_2012_May_17_344_e2088_T224
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_172	[41329]	[41451]	['It will also allow the magnitude of benefit from weight change in pregnancy to be quantified for both the mother and baby.']	pregnancy	GO_BP_EXT	[41395]	[41404]	BMJ_2012_May_17_344_e2088_T225
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_172	[41329]	[41451]	['It will also allow the magnitude of benefit from weight change in pregnancy to be quantified for both the mother and baby.']	baby	UBERON_EXT	[41446]	[41450]	BMJ_2012_May_17_344_e2088_T390
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_173	[41452]	[41593]	['This will allow us to implement those weight management interventions that show clear benefit with specific weight gain targets in pregnancy.']	pregnancy	GO_BP_EXT	[41583]	[41592]	BMJ_2012_May_17_344_e2088_T226
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_178	[42177]	[42361]	['Conclusion\nUntil now, the recommendations for weight management in pregnancy have mainly focused on obese and overweight women without an emphasis on a particular type of intervention.']	pregnancy	GO_BP_EXT	[42244]	[42253]	BMJ_2012_May_17_344_e2088_T227
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_178	[42177]	[42361]	['Conclusion\nUntil now, the recommendations for weight management in pregnancy have mainly focused on obese and overweight women without an emphasis on a particular type of intervention.']	women	NCBITAXON_EXT	[42298]	[42303]	BMJ_2012_May_17_344_e2088_T285
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_178	[42177]	[42361]	['Conclusion\nUntil now, the recommendations for weight management in pregnancy have mainly focused on obese and overweight women without an emphasis on a particular type of intervention.']	women	UBERON_EXT	[42298]	[42303]	BMJ_2012_May_17_344_e2088_T391
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_182	[42687]	[42824]	['They should generate data for determining the most efficient means for improving outcomes with weight management strategies in pregnancy.']	pregnancy	GO_BP_EXT	[42814]	[42823]	BMJ_2012_May_17_344_e2088_T228
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_183	[42826]	[43523]	['What is already known on this topic\nExcessive weight gain in pregnancy is associated with adverse maternal and fetal outcomes\nInterventions to manage weight in pregnancy have the potential to reduce adverse outcomes to mother and baby\nInterventions based on diet or physical activity, or both, in pregnancy could influence maternal and fetal weight and obstetric outcomes\n\nWhat this study adds\nDiet and lifestyle interventions in pregnancy can reduce maternal weight gain in pregnancy\nThere is no significant overall effect on outcomes related to fetal weight\nDiet based interventions are the most effective in reducing maternal gestational weight gain compared with other methods\n\nPubMed Central:']	pregnancy	GO_BP_EXT	[42887]	[42896]	BMJ_2012_May_17_344_e2088_T229
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_183	[42826]	[43523]	['What is already known on this topic\nExcessive weight gain in pregnancy is associated with adverse maternal and fetal outcomes\nInterventions to manage weight in pregnancy have the potential to reduce adverse outcomes to mother and baby\nInterventions based on diet or physical activity, or both, in pregnancy could influence maternal and fetal weight and obstetric outcomes\n\nWhat this study adds\nDiet and lifestyle interventions in pregnancy can reduce maternal weight gain in pregnancy\nThere is no significant overall effect on outcomes related to fetal weight\nDiet based interventions are the most effective in reducing maternal gestational weight gain compared with other methods\n\nPubMed Central:']	pregnancy	GO_BP_EXT	[42986]	[42995]	BMJ_2012_May_17_344_e2088_T230
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_183	[42826]	[43523]	['What is already known on this topic\nExcessive weight gain in pregnancy is associated with adverse maternal and fetal outcomes\nInterventions to manage weight in pregnancy have the potential to reduce adverse outcomes to mother and baby\nInterventions based on diet or physical activity, or both, in pregnancy could influence maternal and fetal weight and obstetric outcomes\n\nWhat this study adds\nDiet and lifestyle interventions in pregnancy can reduce maternal weight gain in pregnancy\nThere is no significant overall effect on outcomes related to fetal weight\nDiet based interventions are the most effective in reducing maternal gestational weight gain compared with other methods\n\nPubMed Central:']	pregnancy	GO_BP_EXT	[43123]	[43132]	BMJ_2012_May_17_344_e2088_T231
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_183	[42826]	[43523]	['What is already known on this topic\nExcessive weight gain in pregnancy is associated with adverse maternal and fetal outcomes\nInterventions to manage weight in pregnancy have the potential to reduce adverse outcomes to mother and baby\nInterventions based on diet or physical activity, or both, in pregnancy could influence maternal and fetal weight and obstetric outcomes\n\nWhat this study adds\nDiet and lifestyle interventions in pregnancy can reduce maternal weight gain in pregnancy\nThere is no significant overall effect on outcomes related to fetal weight\nDiet based interventions are the most effective in reducing maternal gestational weight gain compared with other methods\n\nPubMed Central:']	pregnancy	GO_BP_EXT	[43256]	[43265]	BMJ_2012_May_17_344_e2088_T232
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_183	[42826]	[43523]	['What is already known on this topic\nExcessive weight gain in pregnancy is associated with adverse maternal and fetal outcomes\nInterventions to manage weight in pregnancy have the potential to reduce adverse outcomes to mother and baby\nInterventions based on diet or physical activity, or both, in pregnancy could influence maternal and fetal weight and obstetric outcomes\n\nWhat this study adds\nDiet and lifestyle interventions in pregnancy can reduce maternal weight gain in pregnancy\nThere is no significant overall effect on outcomes related to fetal weight\nDiet based interventions are the most effective in reducing maternal gestational weight gain compared with other methods\n\nPubMed Central:']	pregnancy	GO_BP_EXT	[43301]	[43310]	BMJ_2012_May_17_344_e2088_T233
BMJ_2012_May_17_344_e2088	BMJ_2012_May_17_344_e2088_183	[42826]	[43523]	['What is already known on this topic\nExcessive weight gain in pregnancy is associated with adverse maternal and fetal outcomes\nInterventions to manage weight in pregnancy have the potential to reduce adverse outcomes to mother and baby\nInterventions based on diet or physical activity, or both, in pregnancy could influence maternal and fetal weight and obstetric outcomes\n\nWhat this study adds\nDiet and lifestyle interventions in pregnancy can reduce maternal weight gain in pregnancy\nThere is no significant overall effect on outcomes related to fetal weight\nDiet based interventions are the most effective in reducing maternal gestational weight gain compared with other methods\n\nPubMed Central:']	gestational	GO_BP_EXT	[43455]	[43466]	BMJ_2012_May_17_344_e2088_T234
